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LB Luria broth 
LS Linsmaier and Skoog 
M Molar 
MCS Multiple cloning site 
MDR  Multidrug-resistant 
MEP Methylerythritol phosphate pathway 
MIC Minimum inhibitory concentration 
min Minute 
ML Maximum likelihood 
ml Milliliter 
mM Millimolar 
MPAPs Monocyclic Polyprenylated Acylphloroglucinols 
MPPBP 3-prenyl-2,4,6-trihydroxybenzophenone 
MPGR Medicinal plants genomics resource 
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MRSA Methicillin-resistant Staphylococcus aureus 
mRNA Messenger RNA 
MS Mass spectroscopy 
MSTFA N-methyl-N-(trimethylsilyl)-trifluoroacetamide 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form) 
NCBI National Center for Biotechnology Information 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 
Nhe Neisseria mucosa heidelbergensis 
nm Nanometer 
NO Nitric Oxide 
OD Optical density 
ORF Open reading frame 
Pac Pseudomonas alcaligenes 
PAF Platelet-activating factor 
PAL Phenylalanine ammonia lyase 
PAP 2,4,6-trihydroxyacetophenone 
PCR Polymerase chain reaction 
PDE4 Phosphodiesterase-4 
PEG 4000 Polyethylene glycol 4000 
PDT Photodynamic therapy  
PFTase  Protein farnesyl transferases  
PGE2 Prostaglandin E2 
PGGTase Protein geranylgeranyl transferases 
pI Isoelectric point 
PKS Polyketide synthase 
PPAPs Polycyclic Polyprenylated Acylphloroglucinols 
PPTS Protein prenyltransferases  
PT  Prenyltransferase 
RACE Rapid Amplification of cDNA Ends 
RNA Ribonucleic acid 
rpm Revolution per minute 
Rf Retention factor 
RT Reverse transcription 
Rt Retention time 
s Second 
s.d. Standard deviation 
Sal Streptomyces albus 
SDS Sodium dodecyl sulfate 
Sf9 Spodoptera frugiperda cell line 
Sma Serratia marcescens 
SMART Switching Mechanism At 5' end of RNA Transcript 
SOC  Super optimal broth with catabolite repression 
Ta Annealing temperature of a primer 
TAE Tris-acetate-EDTA 
Taq Thermus aquaticus 
TdT Terminal deoxynucleotidyl transferase 
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TEMED N,N,N′,N′-tetramethylethylenediamine 
Tm Tm Melting temperature of a primer 
TMH Transmembrane helices 
TP Transit peptide 
TPA 12-O-tetradecanoylphorbol-13-acetate 
Tris Tris(hydroxymethyl)aminomethane 
TRPC6 Transient receptor potential channel 6 
TXS Trihydroxyxanthone synthase 
USER Uracil-specific excision reagent 
UTR Untranslated region 
UV Ultraviolet 
Vmax Maximum velocity of an enzyme-catalysed reaction 
VPS Valerophenone synthase 
X6H Xanthone 6-hydroxylase 
Xho Xanthomonas holcicola 
YFP Yellow fluorescent protein 
 
Amino acids 
      
Alanine  A  Ala  Leucine  L  Leu 
Arginine  R  Arg  Lysine  K  Lys 
Asparine  N  Asn  Methionine  M  Met 
Aspartic  D  Asp  Phenylalanine  F  Phe 
Cysteine  C  Cys  Proline  P  Pro 
Glutamic  E  Glu  Serine  S  Ser 
Glutamine  Q  Gln  Threonine  T  Thr 
Glycine  G  Gly  Tryptophan  W  Trp 
Histidine  H  His  Tyrosine  Y  Tyr 
Isoleucine  I  Ile  Valine  V  Val 
 
Nucleotides 
      
A  Adenine  K Keto G, and T 
C  Cytosine  R  Purine A, and G 
G  Guanine  Y Pyrimidine  C, and T 
T  Thymine  B Not A C, G, and T 
U  Uracil  D Not C A, G, and T 
W Weak A, and T H Not G A, C, and T 
S Strong G, and C V Not T A, C, and G 
M Amino  A, and C N Any A, C, G, and T 
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1 Introduction 
1.1 The genus Hypericum 
Hypericum is a flowering plant genus, which belongs to the Hypericaceae plant family, previously 
taxonomically classified as the subfamily Hypericoideae within the family Guttiferae (Clusiaceae). 
However, recent molecular and phylogenetic analyses showed that it is a distinct family 
comprising nine genera, namely Cratoxylum, Eliea, Harungana, Hypericum, Lianthus, 
Santomasia, Thornea, Triadenum, and Vismia. The genus Hypericum constitutes the largest genus 
among those of Hypericaceae (Crockett and Robson, 2011). To date, it contains more than 500 
species (Christenhusz and Byng, 2016; Robson, 2016). Commonly, these species appear as herbs, 
shrubs or, to a lesser extent, trees. The species occupy different habitats worldwide, specifically in 
temperate regions and high areas in the tropics of North America, North Africa, Europe, and West 
Asia (Crockett and Robson, 2011; Marrelli et al., 2016). The yellow flowers of members of the 
genus bloom around the St. John’s day on June the 24th, therefore, it is commonly known as St. 
John’s wort (Miller, 1998). 
In classical antiquity, Hypericum sp. were used as a component of antidote solutions. In the Middle 
Ages, genus members were thought to ward off evil spirits, which can inhabit a person and cause 
the symptoms of lack of interest and low mood, defined nowadays as depression. Accordingly, 
this group of plants was assigned the name Hypericum (from the Greek word hyper meaning 
‘above’ and eikon meaning icon or picture) and they were used to protect the religious symbols 
and pictures (Crockett and Robson, 2011; Nürk, 2011). In folk medicines, various Hypericum 
species are used for their wide bioactivity range including antidiuretic, antimalarial, 
hepatoprotective, renal antispasmodic and diuretic effects (Guedes et al., 2012; Stojanovic et al., 
2013). These biological activities are attributed to the vast affluence of metabolites belonging to 
various chemical groups  (Tanaka et al., 2010; Crockett and Robson, 2011; Liu et al., 2013b; Zhao 
et al., 2015; Marrelli et al., 2016; Liu et al., 2017). Representative examples of Hypericum 
secondary metabolites are displayed in Table 1. 
Table 1: Examples of secondary metabolites from different chemical classes identified in the 
genus Hypericum 
Chemical class Example References 
Biflavonoids Amentoflavone (Baureithel et al., 1997) 
Flavonoids Rutin, hyperoside, isoquercitrin, 
quercitrin, quercetin 
(Noldner and Schotz, 
2002; Don et al., 2004) 
Naphthodianthrones Hypericin, pseudohypericin (Gadzovska et al., 2005; 
Liu et al., 2007) 
Phenylpropanoids Chlorogenic acid (Seabra and Correia 
Alves, 1989) 
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Polycyclic polyprenylated 
acylphloroglucinols (PPAPs) 
Hyperforin, adhyperforin, 
sampsoniones, 
hypericumoxides, hypercohins 
(Gurevich et al., 1971; 
Hu and Sim, 2000; 
Klingauf et al., 2005; 
Liu et al., 2013b; Liu et 
al., 2017) 
Tannins and procyanidins Procyanidin, catechin, 
epicatechin 
(Ploss et al., 2001) 
Xanthones Mangiferin, biyouxanthones, 
hyperixanthone A 
(Chen and Chen, 1985; 
Tanaka et al., 2004; 
Xiao et al., 2010) 
 
One of the most important species in the genus is Hypericum perforatum. Main chemical 
constituents of H. perforatum are the naphthodianthrones hypericin and pseudohypericin and the 
polycyclic polyprenylated acylphloroglucinols (PPAPs) hyperforin and adhyperforin (Beerhues, 
2011). The former category found application in cancer photodynamic diagnosis and therapy 
(PDT) (Karioti and Bilia, 2010). Extracts of plants are widely used for the treatment of mild to 
moderate depression, which is mainly attributed to the content of hyperforins (Kasper et al., 2006). 
In addition, they are used topically to medicate wounds and abrasions by virtue of the anti-
inflammatory, antimicrobial, and tissue growth stimulatory activities, caused by the main 
constituent and model PPAP hyperforin (Russo et al., 2013; Woelfle et al., 2014). Because of the 
broad biological activities of hyperforin, PPAPs from other members of the genus Hypericum have 
drawn the attention to be studied. The present research work focuses on PPAPs from H. sampsonii. 
 
Figure 1: Main active constituents of H. perforatum. 
1.2 Hypericum sampsonii 
1.2.1 Botany and occurrence 
Hypericum sampsonii Hance is a perennial herbaceous plant. The natural habitats are stream sides, 
thickets, roadsides, grassy places, and cultivated margins. The plant is native to the Far East 
countries China, Hong Kong, Northeast India, South Japan, Myanmar, Taiwan, and North Vietnam 
(Robson, 2016). The erect field herb grows to a length of 20 to 80 cm with single or few stems 
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originating from decumbent rooting base. Leaves are oblanceolate with an entire margin, rounded 
to obtuse apex, 1 cm to 3.5 cm, and are arranged in perfoliate pairs having intramarginal dark 
glands. Venation of the leaves contains 4-5 pairs of main laterals from midrib, branching and 
uniting near the margin. The corolla has five bright yellow petals with entire or subentire margin 
and the calyx is composed of five sepals 1-3 mm long. The capsule is 4-5 mm, broadly ovoid 
exceeding sepals. The seeds are orange-brown, 1 mm long, cylindric, not carinate or appendiculate 
with finely ribbed-scalariform testa (Robson, 2001). The in vitro grown plant, used throughout this 
study (2.1.1.1 and 3.1.1.1), was shorter, about 10 cm long, and the leaves had nearly the same 
length as in field grown herb, 1-2.5 cm.  
 
Figure 2: Hypericum sampsonii. A) Whole in vitro plantlet. B) Leaf from a pot-grown plant. 
1.2.2 Why Hypericum sampsonii? 
1.2.2.1 Therapeutic Uses 
H. sampsonii is a Chinese herb used in folk medicine to treat various disorders. The herbal extracts 
are used for the treatment of snakebites, diarrhea, backache, burns, and swellings (Xiao et al., 
2007). In Taiwan, the plant is used as a detoxifying agent, to relieve swelling, and as anti-hepatitis 
and anti-hepatoma drug (Lin and Wu, 2003).  It contains a wide variety of prenylated acyl- and 
benzoylphloroglucinol metabolites, including prenylated xanthones. Predominantly, the 
antibacterial and cytotoxic activities of the plant are largely attributed to the contents of prenylated 
xanthones and acylphloroglucinols, respectively (Demirkiran, 2007; Xiao et al., 2010; Xin et al., 
2011a)  
1.2.2.2 Bioactive constituents of H. sampsonii 
1.2.2.2.1 Xanthones 
The first report about H. sampsonii secondary metabolites was published by Chen and Chen 
(1985), who reported five xanthones including the antibacterial xanthone C-glucoside mangiferin 
(Biswas et al., 2015), its isomer isomangeferin, and hyperxanthone. The later was again identified 
in 2004 from the anti-hepatitis B fraction of the whole herb (Don et al., 2004). 
A B
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Table 2: Xanthones from H. sampsonii. 
Name Plant part Biological activities References 
Mangiferin and 
isomangiferin 
Whole herb Antibacterial (Chen and Chen, 1985; 
Biswas et al., 2015) 
Hypericumxanthone A and B Aerial parts Antibacterial (Xin et al., 2011a) 
Hyperixanthone A Roots Antibacterial (Xiao et al., 2008) 
Hyperxanthone  Whole herb Anti-hepatitis B (Chen and Chen, 1985; 
Don et al., 2004) 
Sulfonated xanthones Whole herb Cytotoxic  (Hong et al., 2004) 
Patulone ---- Anti-inflammatory 
and PAF* inhibitor  
(Li et al., 2004; 
Yamakuni et al., 2006) 
Sampsone C  Aerial parts  ---- (Xin et al., 2011b) 
1,3,6,7-
Tetrahydroxyxanthone and 
2-prenyl-1,3,5,6-
tetrahydroxyxanthone 
Whole herb ---- (Don et al., 2004) 
* PAF= Platelet activating factor 
Two sulfonated xanthones, namely 1,3-dihydroxy-5-methoxyxanthone-4-sulfonate and 1,3-
dihydroxy-5-O-β-D-glycopyranosylxanthone-4-sulfonate, showed moderate activity against the 
P388 cell line with ED50 of 3.46 and 15.69 μmol/l, respectively (Hong et al., 2004). Patulone, 1,2-
dihydro-3,6,8-trihydroxy-1,1-bis-(3-methyl-but-2-enyl)-xanthen-2,9-dione, isolated for the first 
time from Hypericum patulum (Ishiguro et al., 1997), was also identified in H. sampsonii (Li et 
al., 2004). It inhibited strongly (more than 60%) the exogenous platelet activating factor (PAF)- 
induced hypotension in mice. PAF mediates many diseases such as allergy, inflammation, 
thrombosis, and asthma (Oku et al., 2005). This diprenylated compound also inhibits the release 
of prostaglandin PGE2 and COX-1 activity in a dose-dependent manner and inhibits NF-κB, which 
regulates the transcription of genes involved in the inflammation pathway (Yamakuni et al., 2006).  
Bioassay-guided fractionation utilizing a multidrug-resistant (MDR) Staphylococcus aureus strain 
resulted in the isolation of a potent antibacterial prenylated agent,  hyperixanthone A, which 
showed minimum inhibitory concentration (MIC) of 2 µg/ml in comparison to the positive 
standard (norfloxacin) with an MIC of 32 µg/ml (Xiao et al., 2008). Later, Two moderately-active 
antibacterial prenylated xanthones were isolated from the aerial parts of H. sampsonii, namely 
hypericumxanthone A and B, with an MIC against methicillin-resistant Staphylococcus aureus 
(MRSA) of 16 and 32 µg/ml, respectively (Xin et al., 2011a). 
1.2.2.2.2 Polycyclic polyprenylated acylphloroglucinols (PPAPs) 
H. sampsonii is the richest source of PPAPs so far detected. Non-caged derivatives (1.3.1), as well 
as over 50 PPAPs, belong to adamantane- and homoadamantane-type, have been reported from 
the plant (Yang et al., 2018). Examples of bioactive Hs-PPAPs are represented in Table 3 and 
Figure 3. 
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Table 3: PPAPs from H. sampsonii. 
Name plant part biological activity References 
Sampsonione A-R  Whole herb, roots Cytotoxic  (Hu and Sim, 2000; Xiao 
et al., 2007; Zhu et al., 
2014) 
Hypersampsones A-X Aerial parts Cytotoxic (Lin and Wu, 2003; Zeng 
et al., 2009; Zeng et al., 
2012; Tian et al., 2016)  
Sampsonols A-F  Aerial parts Cytotoxic (Xin et al., 2012) 
Hyperisampsines A-O  Aerial parts Cytotoxic, A, and D 
are anti-HIV 
(Zhu et al., 2014; Zhu et 
al., 2015; Zhu et al., 2017) 
Norsampsones A-E Aerial parts Cytotoxic (Tian et al., 2014; Tian et 
al., 2017) 
Hyperhexanone A  Aerial parts Cytotoxic (Zhu et al., 2016) 
Dioxasampsone A and 
B  
Aerial parts Cytotoxic (Tian et al., 2014) 
Sampsone A Aerial parts Antibacterial (Xin et al., 2011b) 
Peroxysampsone A and 
B  
Roots Antibacterial (Xiao et al., 2010) 
Hypersampsonone A-G  Aerial parts Phosphodiesterase 
inhibition 
(Zhang et al., 2016) 
Epoxyplukenetione A Aerial parts ---- (Zhu et al., 2014) 
Plukenetione C Roots ---- (Xiao et al., 2010) 
 
Sampsoniones A and I showed activity against mouse lymphocytic leukemia (P388) at 13 µg/ml 
and 6.9 µg/ml, respectively (Hu and Sim, 2000). Hypersampsones A-F had mild cytotoxic activity 
against MS-G2 hepatoma (Lin and Wu, 2003), whereas the cytotoxicity of hypersampsones S and 
R was against the HeLa cell line at a concentration of 20 µM (Tian et al., 2016). Sampsonols A 
and B exhibited significant cytotoxicity against a number of cancer cell lines including human 
breast (MCF-7), hepatoma (HepG2), colon (HT-29), and lung (A549) tumor cell lines with IC50s 
ranging from 13 to 28 μM (Xin et al., 2012). All hypersampsin series members had a significant 
cytotoxicity with IC50 values in the range 0.56-3.00 μM against different cell lines. Hypersampsins 
A and D additionally had an anti-HIV activity with EC50 values of 2.97 and 0.97 μM, respectively 
(Zhu et al., 2014). The decarbonyl PPAP, norsampsone C, caused inhibition of Hela cell 
proliferation at a concentration of 20 μM (Tian et al., 2014). The underlying mechanism of the 
cytotoxic activity of Hs-PPAPs was attributed to the transcriptional inhibition of the nuclear 
retinoid x receptor (RXRα), which mediates numerous physiological processes, for example, 
calcium homeostasis, embryogenesis, and lipid and glucose metabolism, their transcriptional 
downregulation inducing apoptosis (Wu et al., 2014; Tian et al., 2017).   
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Figure 3: Chemical constituents of H. sampsonii. 
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Peroxisampsone A, a polyprenylated benzophenone peroxide, exhibited norfloxacin-comparable 
activity against fluoroquinolone-resistant Staphylococcus aureus with an MIC value of 110 µM, 
while the MIC value of the positive control norfloxacin was 100 µM. The activity is assumed to 
be due to the presence of the peroxide group in its structure (Xiao et al., 2010). Another 
antibacterial prenylated xanthone, namely sampsone A, showed moderate anti-methicillin-
resistant Staphylococcus aureus (MRSA) activity with an MIC of 32 μg/ml (Xin et al., 2011b). 
Hypersamsonone A had a potent phosphodiesterase inhibitory activity with IC50 of 8.08 μM 
(Zhang et al., 2016). Phosphodiesterase-4 (PDE4) plays a crucial rule in cell signaling and is a 
potential drug target for the treatment of inflammation, asthma, chronic obstructive pulmonary 
disease and Alzheimer’s disease (Zhang et al., 2005).  
1.2.2.2.3 Other chemical constituents  
Apart from PPAPs, Don et al. (2004) isolated different classes of compounds from the whole herb 
of H. sampsonii including O-prenylated benzophenones assigned the names 2,6-dihydroxy-4-[(E)-
5-hydroxy-3,7-dimethylocta-2,7-dienyloxy]benzophenone and 2,6-dihydroxy-4-[(E)-7-hydroxy-
3,7-dimethylocta-2-enyloxy]benzophenone, the anthraquinone emodin,  a bisanthraquinone 
glycoside, two flavonoids kaempferol and quercetin and their 3-O-glucopyranosides. Similar to H. 
perforatum, the plant is characterised by the distribution of dark glands, in which the 
naphthodianthrones hypericin and pseudohypericin were identified (Liu et al., 2007).  
1.3 Polycyclic polyprenylated acylphloroglucinol derivatives (PPAPs) 
They are a group of compounds possessing a fascinating highly oxygenated acylphloroglucinol-
derived polycyclic nucleus decorated with prenyl groups of different lengths (C5 or C10), giving 
them diamond-like structures, high chemical diversity, and intriguing biological activities 
(Ciochina and Grossman, 2006; Yang et al., 2018). Biosynthetically, PPAPs are a hybrid group of 
natural products derived from the mevalonate or methylerythritol phosphate and the polyketide 
pathways (Yang et al., 2015). According to the most recent database of PPAPs published by 
Grossman (2018), the number of identified natural PPAPs is 618, mainly isolated from members 
of the Hypericaceae, Clusiaceae and related plant families of the Clusioid clade. A total of 146 
structures thereof are caged. 
1.3.1 Classification of PPAPs 
Based on the complexity of their structures, PPAPs are classified into two main groups: (i) the 
uncaged compounds with either bicyclo[3.3.1]nonane-2,4,9-trione or bicyclo[3.2.1]octane-2,4,8-
trione and (ii) the caged PPAPs with tri- or tetracyclo structures. According to the relative position 
of the benzoyl or aliphatic acyl group on the bicyclo scaffold and according to the most recent 
structural revisions, PPAPs were classified into the two classes A and B (Yang et al., 2018). In 
contrast, Cuesta-Rubio et al. (2001) and Ciochina and Grossman (2006) classified PPAPs into the 
three classes A, B, and C (Figure 4 A). Type A PPAPs have the acyl group attached to C-1, which 
is adjacent to the quaternary carbon C-8. However, the acyl group in type B PPAPs is attached to 
the C-3 position of the bicyclo skeleton. Interestingly, there are more than 20 PPAPs of type B, 
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which have a xanthone nucleus and were mainly reported for the genera Garcinia and Symphonia 
such as  garcimultiflorone I and 3,16-oxyguttiferone A, respectively (Figure 4 B)  (Cottet et al., 
2015; Fu et al., 2015; Grossman, 2018). The rare type C PPAPs have a C-1 acyl group but the 
quaternary center is distant at C-6 (Ciochina and Grossman, 2006). Type C PPAPs represented 
only three structures from the 600 naturally occurring PPAPs, namely garcinielliptones K, L and 
M (Weng et al., 2004). 
 
 
 
Figure 4: Types of PPAPs. A) Previously described types of PPAPs adapted from Ciochina 
and Grossman (2006). B) Examples of PPAPs with a xanthone nucleus. Numbering indicates 
the relative position of the acyl group on the bicycle skeleton. C) Structure reassignment of 
garcinielliptones K-M to the corresponding type A skeletons, denoting the obsolescence of 
type C PPAPs. Adapted from Yang et al. (2018).  
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Yang et al. (2017a) revised and reassigned their structures to the corresponding type A, where the 
positions of substituents at the bridgehead of the bicyclo skeleton were switched from their original 
assignment, depending on detailed spectroscopic data and quantum computational chemistry. This 
led to announce the obsolescence of type C PPAPs (Figure 4 C) and to prove that the structure of 
garcinielliptone K is identical to the previously known compound propolone C (Hernández et al., 
2005). 
Caged PPAPs are sub-grouped into two classes bearing either adamantane 
(tricyclo[3.3.1.1]decane) or homoadamantane (tricyclo[4.3.1.1]undecane) cores (Yang et al., 
2018). Some examples are represented in Figure 5.  Plukenetione A, isolated from Clusia 
plukenetii was the first identified PPAP of the adamantane-type (Henry et al., 1996). Since then, 
about 33 structure with either type A or type B arrangement or their corresponding seco-structures, 
for example, hypersubone A from H. subsessile (Liao et al., 2015), were identified. 
Homoadamantane-type PPAPs are 49 structures, which follow only type A arrangement, for 
example, pseudohenone G isolated from H. pseudohenryi (Yang et al., 2017b). 
 
Figure 5: Examples of caged PPAPs of adamantane (plukenetion A), seco-adamantane 
(hypersubone A), and homoadamantane (pseudohenone G) types. 
1.3.2 Bioactivities of selected PPAPs 
1.3.2.1 Type A PPAPs 
Hyperforin (Figure 1) is the best-known member of type A PPAPs and responsible for the 
antidepressant activity of H. perforatum (Kasper et al., 2006). The rigorous mechanism of action 
is not totally defined but the most recent studies suggest neurotransmitters-reuptake inhibition 
through activating the transient receptor potential channel 6 (TRPC6) (Bouron and Lorrain, 2014; 
Friedland and Harteneck, 2015) as an action mechanism. Besides, hyperforin has cognitive- and 
memory-enhancing properties and acts as neuroprotective against Alzheimer’s disease neuropathy 
(Griffith et al., 2010). Through lipoxygenase inhibition (Medina et al., 2006; Sosa et al., 2007) and 
inhibition of prostaglandin E synthase (Koeberle et al., 2011), hyperforin was proved to have 
potent anti-inflammatory activities. It can also down-regulate many signaling pathways controlling 
angiogenesis and proliferation of leukemic cells and induce apoptosis (Quiney et al., 2006; 
Martinez-Poveda et al., 2010). Furthermore, hyperforin displayed antibacterial (Schiavone et al., 
2013; Hernandez-Lopez et al., 2014), antimalarial (Verotta et al., 2007), larvicidal (Mitsopoulou 
et al., 2014), antioxidant (Meinke et al., 2012),  and estrogenic (Kwon et al., 2016) activities. 
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Garsubellin A (Figure 6) is one of the oldest type A PPAPs. It was isolated from the tree Garcinia 
subelliptica (Fukuyama et al., 1998). It boosts the choline acetyltransferase activity in the cultures 
of P10 rat septal neurons, thus increasing the concentration of the neurotransmitter acetylcholine, 
and offers a lead opportunity for treating neurodegenerative diseases like Alzheimer's disease 
(Fukuyama et al., 1997). The compound has a potent anti-inflammatory effect by inhibiting the 
release of β-glucuronidase and the inflammatory mediator histamine (Jing‐Ru et al., 2003). 
1.3.2.2 Type B PPAPs 
Garcinol (Figure 6), isolated from Garcinia sp. (Baliga et al., 2011) is a known example for type 
B PPAPs. Recent reports about the biological activities of the compound showed its high cytotoxic 
activity, which is mainly mediated by inhibition of several cell signaling pathways (Saadat and 
Gupta, 2012; Wang et al., 2015b; Behera et al., 2016). Earlier investigations of the compound 
proved its antioxidant and antifungal activities (Padhye et al., 2009; Jackson et al., 2015). Recently, 
garcinol showed significant antidiabetic activity against streptozotocin-induced diabetes in rats 
(Madhuri and Naik, 2017; Mali et al., 2017). 
Two C-7 epimeric PPAPs were isolated from Clusia sp., namely clusianone and 7-epi-clusianone 
(Piccinelli et al., 2005). Both showed potent HIV inhibitory activity (Garnsey et al., 2011). 
Moreover, clusianone induced the death of HepG2 cells through the distraction of the membrane 
potential of rat liver mitochondria (Reis et al., 2014). 7-epi-clusianone has an antimicrobial activity 
against the acid-producing bacteria, Streptococcus mutans (Almeida et al., 2008) and is considered 
a potential agent for fighting worldwide-distributed dental caries (Forssten et al., 2010; Branco-
de-Almeida et al., 2011). It also reliefs bronchospasm via activation of epithelium-, NO-, and 
cGMP-dependent pathways (Coelho et al., 2008). Structures of both epimers are shown in Figure 
6. 
 
Figure 6: Examples of biologically active PPAPs. 
1.3.3 Biosynthesis of PPAPs 
Biosynthesis of PPAPs is achieved generally in a two-staged biogenetic scheme. The first step is 
the construction of the aromatic acylphloroglucinol nucleus, which undergoes the second stage. 
This decoration involves the attachment of prenyl groups of different lengths at different positions 
on the skeleton formed (Beerhues, 2011). 
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1.3.3.1 First stage: formation of aromatic nuclei 
Through the catabolism of aliphatic branched chain amino acids (BCAAs), namely leucine, 
isoleucine, and valine, the branched short-chain acyl-CoAs valeryl-, 2-methylbutyryl- and 
isobutyryl-CoAs, respectively, are formed. The reaction starts by the transamination of a BCAA, 
followed by oxidative decarboxylation of the formed ketoacid intermediate (Goese et al., 1999; 
Karppinen et al., 2007) and a suitable carboxyl CoA ligase (CCL) (Xu et al., 2013). Differently, 
aromatic-CoA esters are developed via the catabolism of the amino acid phenylalanine starting 
from its deamination by the enzyme phenylalanine ammonia lyase (PAL) to form a trans-cinnamic 
acid (Ritter and Schulz, 2004; Dreßen et al., 2017), which proceeds in either of two ways to form 
benzoyl-CoA. The first pathway is CoA dependent through cinnamate CoA ligase (CNL) to form 
cinnamoyl-CoA, followed by β-oxidative C2 shortening. Alternatively, a CoA-independent non-β-
oxidative pathway is followed through the formation of benzaldehyde and benzoic acid as 
intermediates (Abd El-Mawla and Beerhues, 2002). Via catalysis of cinnamate 4-hydroxylase 
(C4H) and p-coumarate-CoA ligase, cinnamic acid is converted to p-coumaroyl-CoA (Gaid et al., 
2011). The CoA thioesters formed, valeryl-, 2-methylbutyryl-, isobutyryl-, benzoyl-, and p-
coumaroyl-CoA  are the starting building blocks for the aromatic nuclei, 2,4,6-
trihydroxyisovalerophenone (246TrHiVP), 2-methyl -2´,4´,6´-trihydroxybutyrophenone (2MBP), 
2,4,6-trihydroxyisobutyrophenone (246TrHiBP), 2,4,6-trihydroxybenzophenone (246TrHBP), 
and naringenin chalcone, respectively. The CoA esters are condensed with three molecules of 
malonyl-CoA by means of suitable type III polyketide synthases, namely isobutyrophenone 
synthase (BUS), valerophenone synthase (VPS), benzophenone synthase (BPS), or chalcone 
synthase (CHS) to form a linear tetraketide intermediate, which in turn cyclizes via intramolecular 
Claisen condensation to yield the acylphloroglucinol scaffold (Okada and Ito, 2001; Liu et al., 
2003; Klingauf et al., 2005; Karppinen et al., 2007). This polyketide pathway was confirmed for 
biosynthesis of the phlorisobutyrophenone core by feeding radiolabeled glucose to the sprouts of 
H. perforatum and subsequent analysis of isolated hyperforin (Adam et al., 2002).  
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Figure 7: Polyketide biosynthetic cascade for the formation of acyl- and benzoylphloroglucinols. A) Formation of 
acylphloroglucinols. B) Formation of benzoylphloroglucinols. C) Formation of tetrahydroxyxanthones from 
phlorobenzophenone. D) Formation of naringenin from naringenin chalcone. 4-CL, 4-coumaroyl CoA-ligase;  BD, benzaldehyde 
dehydrogenase; BPS, benzophenone synthase; BUS, butyrophenone synthase; BZL, benzoate CoA-ligase; C4H, cinnamate 4-
hydroxylase; CCL, carboxyl CoA-ligase; CHI, chalcone isomerase; CHS, chalcone synthase; CNL, cinnamate CoA-ligase; 
CoASH, coenzyme A; CYP, cytochrome P450; PAL, phenylalanine ammonia lyase; TXS, trihydroxyxanthone synthase; VPS, 
valerophenone synthase; X6H, xanthone 6-hydroxylase. 
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The phlorbenzophenone (246TrHBP) scaffold can subsequently undergo 3'-hydroxylation and 
either ortho or para regiospecific phenol coupling by bifunctional CYP enzymes, namely 
CYP81AA1 and CYP81AA2, to form 1,3,5- and 1,3,7-trihydroxyxanthone skeletons, respectively 
(El-Awaad et al., 2016). An additional 6-hydroxylation step is catalyzed by xanthone 6-
hydroxylase (X6H) on the trihydroxyxanthone skeletons formed to give rise to either 1,3,5,6- or 
1,3,6,7-tetrahydroxyxanthones (1356THX or 1367THX) (Schmidt et al., 2000). The flavanone 
naringenin is formed in a one-step reaction after naringenin chalcone formation via stereospecific 
cyclization catalyzed by chalcone isomerase (CHI) (Jez et al., 2000). Naringenin is metabolized 
by further downstream processes to other subgroups of flavonoids (Ferrer et al., 2008).   
1.3.3.2 Second stage: attachment of prenyl side chains 
This step involves the attachment of isoprenoid units of different hydrocarbon chain lengths 
(prenyl, C5; geranyl, C10; farnesyl, C15; etc.) to the formerly formed aromatic prenyl acceptors 
(1.3.3.1). All isoprenoid units are derived from the five-carbon prenyl diphosphate, dimethylallyl 
diphosphate (DMAPP), or its structural analog isopentenyl diphosphate (IPP; see 1.4.1). Both C5 
units are biosynthesized through either of two different metabolic pathways (Figure 8). The first 
one is the cytoplasmic mevalonate pathway, where IPP is built up from the condensation of three 
molecules of acetyl CoA (Goldstein and Brown, 1990). Finally, an isomerase rearranges it to the 
more active isomer DMAPP (Cornforth et al., 1966). Alternatively, in higher plants, bacteria, 
algae, and some protozoa, both C5 units are formed via the methylerythritol phosphate pathway 
(MEP), which occurs in the plastids. DMAPP and IPP are biosynthesized from a common 
precursor formed from pyruvate and glyceraldehyde-3-phosphate (Rohmer, 1999; Eisenreich et 
al., 2004). 
 
Introduction 
 
14 
 
 
Figure 8: Alternative pathways for the biosynthesis of the five-carbon prenyl diphosphate 
units. IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate. 
Acylphloroglucinol moieties undergo enzyme-catalyzed addition of prenyl and/or geranyl groups, 
derived mainly (>98%) from the mevalonate-independent (MEP) pathway (Beerhues, 2011), by 
the action of a group of enzymes called prenyltransferases (PTs) (Zuurbier et al., 1998). Similar to 
the biosynthesis of β-bitter acids in hop (Li et al., 2015), acylphloroglucinols are prenylated and/or 
geranylated to afford monocyclic polyprenylated acylphloroglucinol derivatives (MPAP). The 
MPAP intermediate cyclizes in two different ways to support the formation of all type A and type 
B PPAPs. An additional DMAPP moiety is added to one of the geminal prenyl groups of the MPAP 
by a nucleophilic addition mechanism to give rise to a tertiary carbocation. Attack of C-1 of the 
intermediate on the pendant carbocation (or the analogous pyrophosphate) results in the formation 
of the bridged system of type A PPAP, whereas  C-5-attack gives a type B arrangement of PPAP 
(Cuesta-Rubio et al., 2001; Liao et al., 2015) (Figure 9). The complexity and structural diversity 
of PPAPs are created and supported through different types of acyl groups, from which the PPAP 
is derived, and the downstream processes, which take place on the cyclized and bridged type A or 
type B skeletons. Examples are the number and position of isoprenoid substituents, their degree of 
oxidation and respective locations on the formed ether rings, and various secondary cyclization 
mechanisms, such as aldol, Diels-Alder, etc. (Yang et al., 2018). These mechanisms together with 
structural diversity due to various down-stream biosynthetic sequences are illustrated by the 
postulated biosynthesis of the members of the sampsonione series isolated from H. sampsonii (Hu 
and Sim, 2000) (Figure 10). 
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Figure 9: Proposed biosynthetic cascade for type A and type B PPAPs. 
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Figure 10: Proposed biosynthesis of sampsoniones A, B, C, D, F, G, J, and I. Adapted from 
Hu and Sim (2000). 
1.4 Prenyltransferases 
Prenyltransferases (PTs) are a group of enzymes that catalyze the transfer of prenyl residues from 
different prenyl donors to an acceptor molecule.  PTs constitute an important branch of the larger 
prenyl converting enzyme family, which is responsible for the biosynthesis of terpenoid and 
meroterpenoid skeletons (Brandt et al., 2009). According to the most recent estimates, more than 
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63,000 terpenoid natural products including steroids, carotenoids, ubiquinones, menaquinones, 
and plastoquinones are identified from microbial, fungal, animal, and mostly plant origins 
(Winkelblech et al., 2015).  
1.4.1 Classification and functions of prenyl converting enzymes 
Prenyl converting enzymes are classified mainly into four groups, namely hydrolase/lyases, 
terpene cyclases (synthases), transferases, and a fourth heterogenous group, which includes 
members that cannot be assigned to other classes, such as geranylgeranyl hydrogenase or squalene 
epoxidase (Figure 11). Their catalytic activities begin with the detachment of the diphosphate 
from a prenyl moiety either by hydrolysis via the effect of hydrolases/lyases or as a leaving group 
forming an intermediate allylic prenyl cation (Brandt et al., 2009). Elimination of the 
pyrophosphate of GPP through hydrolysis leads to the formation of prototypical acyclic 
monoterpene geraniol (Banthorpe et al., 1983). Downstream rearrangements, oxidations and/or 
reduction provide other acyclic monoterpenes such as linalool, citral, citronellol (Banthorpe et al., 
1972). Terpene cyclases (synthases) use the allylic cation to execute an intramolecular 
electrophilic addition to an ethylene double (C=C) bond to result in the formation of a cyclic cation, 
which mediates the biosynthesis of a broad assortment of mono-, di- or oligo-terpenes such as 
limonene, α- and β-pinene, and camphene (Bouvier et al., 2005). On the other hand, 
prenyltransferases require a second aliphatic or aromatic substrate (nucleophilic acceptor) to 
transfer the allylic carbocation to it. Prenyltransferases (PTs) are subdivided into oligoprenyl 
diphosphate synthases, protein, tRNA and aromatic prenyltransferases (Heide, 2009; Yazaki et al., 
2009; Dumelin et al., 2012; Palsuledesai and Distefano, 2015). Prenyl diphosphate synthases are 
responsible for the elongation of the carbon backbone of isoprenoids by sequential condensation 
of C5 units via head-to-tail or head-to-head coupling (head corresponds to the diphosphate group 
and tail to the prenyl chain). According to the stereochemistry of the formed double bond, they are 
classified to trans- or cis-PTs (Poulter, 2006; Liu et al., 2013a; Winkelblech et al., 2015). Protein 
prenyltransferases (PPTs) like farnesyl transferases (PFTase) or protein geranylgeranyl 
transferases type I (PGGTaseI) and type II (PGGTaseII) transfer FPP and GGPP, respectively, to 
the sulfur atom of a cysteine residue of the target protein in a “CaaX box” at the C-terminus. This 
prenylation enhances the interactions between prenylated proteins and membranes, which is 
considered as a cellular regulation and post-translational mechanism (Strickland et al., 1998; Gelb 
et al., 2006; Guo et al., 2008). Other PPTs catalyze C3- or O-prenylation of a tyrosyl residue 
(McIntosh et al., 2011). Geranylated RNA was discovered in some bacterial species, where the 
geranyl residue is attached to the sulfur atom in two 5-methylaminomethyl-2-thiouridine 
nucleotides (Dumelin et al., 2012). Aromatic prenyltransferases (aPTs) catalyse the formation of 
C-C, C-O, or C-N bonds between a prenyl donor and an aromatic substrate (usually a phenol or 
indole derivative). Based on  differences in structure, sequences, binding motifs, and solubility, 
they can be classified into two main groups enclosing (i) the superfamilies of soluble aPTs, i.e. the 
ABBA family with the CloQ/NphB group and the dimethylallyl tryptophan synthase (DMATS) 
family, and (ii) the membrane-bound aPTs, e.g. members of the UbiA family (Heide, 2009). 
Aromatic prenyltransferases are discussed below in detail (1.4.2) 
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Figure 11: Classification of prenyl converting enzymes. 
1.4.2 Aromatic prenyltransferases 
Aromatic prenyltransferases illustrate, to a far extent, the chemical and biological diversification 
of natural products by utilizing a wide range of aromatic substrates (Heide, 2009; Yazaki et al., 
2009). Therefore, they were intensively studied during the past decades.  
1.4.2.1 Aromatic prenyltransferases of the ABBA family 
Members of this family are common among bacteria and fungi. They constitute a soluble aPT 
group with a distinctive structure of repeating units of αββα, after which the family was named 
and which form a barrel-like cylinder. Based on the nature of the accepted substrates, they are sub-
classified into two categories. The first one is the CloQ/NphB group identified from bacteria and 
fungi, which catalyze the prenylations of quinones, naphthalenes, phenazines, and phenolic 
compounds (Heide, 2009). The notation of this group is assigned to the first members CloQ and 
NphB, which were isolated from Streptomyces roseochromogenes and several Streptomyces sp., 
respectively (Pojer et al., 2003; Kuzuyama et al., 2005). The former attaches a prenyl residue to 4-
hydroxyphenylpyruvic acid as a step in clorobiocin biosynthesis, while the latter catalyzes the 
geranylation of 1,3,6,8-tetrahydroxynaphthalene. Later, other members belonging to this group 
were identified (Winkelblech et al., 2015). 
The second group is the dimethylallyl tryptophan synthase (DMATS) superfamily, the most 
investigated sub-class of the aPTs. Members of this family are identified mainly from fungi and to 
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less extent from bacteria. Structurally, they resemble those of CloQ/NphB (soluble with barrel 
structure), the characteristic difference lays in the acceptor molecules. They transfer a prenyl 
moiety to an indole system including tryptophan and tryptophan-containing cyclic dipeptides, from 
which their name comes. Although their catalytic activities are not dependent on the use of cation, 
the usage of metal ions enhances their activities (Yu and Li, 2012; Fan et al., 2014; Winkelblech 
and Li, 2014). The first characterized member of the DMATS superfamily, namely DmaW, was 
reported from Claviceps purpurea (Gebler and Poulter, 1992; Tsai et al., 1995). It catalyzed the 
prenylation of tryptophan at position C-4 in the biosynthesis of ergot alkaloids.  
1.4.2.2 Aromatic prenyltransferases of the UbiA superfamily 
The identifier of this family of aPTs is UBiA, a prenyltransferase isolated from E. coli, which 
catalyzes the addition of an all-trans-octaprenyl moiety onto 4-hydroxybenzoic acid (4HB; Figure 
12) within the biosynthetic cascade of ubiquinones, which is important for the mitochondrial 
respiration inside living cells (Melzer and Heide, 1994). UBiA PTs are distributed in plant and 
bacteria kingdoms and contribute remarkably to the biosynthesis of primary metabolites (for 
example vitamin K2, menaquinone; vitamin E, tocopherols) and secondary plant and bacterial 
natural products (Yazaki et al., 2009; Wang et al., 2014; Zeyhle et al., 2014). UBiA family 
members greatly differ in their structure, folding and amino acid sequence from the 
aforementioned ABBA family (1.4.2.1). They are membrane-bound PTs possessing α-membrane 
spanning peptide helices connected together by amino acid loops containing two highly conserved 
aspartate-rich motifs with the amino acid sequence DXXXD, where the first motif is thought to be 
involved in the coordination to the divalent metal ion, which is, apart from the ABBA family, 
essential for the activity, and the second binds to the aromatic substrates (usually a phenolic 
system). Through evolution, they acquire a signaling peptide at the N-terminus of the protein 
targeting it to the membranes of different organelles inside the cell (Heide, 2009; Yazaki et al., 
2009; Karamat et al., 2014; Zeyhle et al., 2014).  
 
Figure 12: Catalytic activity of UBiA from E. coli, the prototype of the UBiA superfamily of 
aromatic prenyltransferases. 
1.4.3 Plant aromatic prenyltransferases 
In plants, aromatic prenyltransferases play an important role in both the primary metabolism and 
the derivatization of natural products. The attachment of isoprene residues to structurally different 
aromatic skeletons including acylphloroglucins, flavonoids, phenylpropanes, xanthones, and 
coumarins generates a large number of aromatic or even dearomatized secondary metabolites 
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(Yazaki et al., 2009). A characteristic feature of plant aPTs is the presence of the extended 
aspartate-rich motifs N(D/Q)xxDxxxD and KDxxDxxGD. The N-terminal signal peptide targets 
the proteins mostly to the chloroplast envelop (Figure 13). However, it is still open whether they 
are localized to the outer or inner membrane (Sasaki et al., 2008; Munakata et al., 2016). 
 
Figure 13: An illustration of the topology of plant aPTs, which possess an N-terminal transit 
peptide (light green) and a varying number of transmembrane helices connected by amino 
acid loop regions with two aspartate-rich motifs (boxed), whose orientation within the 
membrane is still to be defined.  
There were only a few reports about plant aPTs in the last 16 years since the discovery of the plant 
4HB geranylating enzymes LePGT-1 and LePGT-2 from Lithospermum erythrorhizon, which are 
involved in the biosynthesis of the naphthoquinone shikonin (Table 4) (Yazaki et al., 2002). 
Table 4: Examples of reactions catalyzed by plant aromatic prenyltransferases (aPT), 
ordered chronologically. 
aPT Species  Acceptor Donor Product Biosynthetic 
target 
Reference  
LePGT-1 Lithospermum 
erythrorhizon 
 
GPP 
 
Shikonin (Yazaki et 
al., 2002) 
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SfN8DT Sophora 
flavescens 
 
DMAPP 
 
Flavanon G (Sasaki et 
al., 2008) 
GmG4DT Glycine 
max 
 
DMAPP 
 
Glyceollin I (Akashi et 
al., 2009) 
HlPT-1 Humulus 
lupulus 
 
DMAPP 
 
Bitter acids and 
xanthohumol 
(Tsurumaru 
et al., 2012) 
CsPT-1 Cannabis 
sativa 
 
GPP 
 
Δ9-Tetrahydro-
cannabinol 
(Page and 
Boubakir, 
2014) 
PcPT Petroselinum 
crispum 
 
DMAPP 
 
Coumarins (Karamat et 
al., 2014) 
ClPT1 Citrus limon 
 
GPP 
 
Coumarins (Munakata 
et al., 2014) 
HcPT Hypericum 
calycinum 
 
DMAPP 
 
Hyperxanthone 
E 
(Fiesel et 
al., 2015) 
PsPT1/ 
PsPT2 
Pastinaca 
sativa 
 
DMAPP 
 
Coumarins (Munakata 
et al., 2016) 
 
Despite the great medicinal value of the prenylated natural products, information about aPTs and 
their role in the biosynthesis of secondary metabolites is still limited. Due to their limited yield 
and the lack of a full biosynthetic scheme or even a convenient synthetic scheme (see 5.5.1 
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and 5.5.2), the clinical application of the majority of prenylated natural products is yet restricted. 
Elucidation of the biosynthetic pathways and characterization of the involved aPTs offer a tool for 
the biotechnological production of PPAPs either through chemoenzymatic synthesis or genetically 
engineered microbes.  
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1.5 The aim of the work 
The biosynthesis of polycyclic polyprenylated acylploroglucinol derivatives (PPAPs) involves the 
prenylation of acyl- and/or benzoylphloroglucinol derivatives, which is achieved by the catalytic 
action of a group of enzymes named aromatic prenyltransferases (aPTs). Acylphloroglucinol 
accepting prenyltransferases, involved in the biogenesis of bitter acids, were identified from 
Humulus lupulus (Li et al., 2015). To date, no prenyltransferases using the acylphloroglucinol 
skeleton were published from the genus Hypericum, although it is one of the richest genera in 
PPAPs. Specifically, no aPTs catalyzing the prenylation of the benzophenone scaffold as an 
acceptor molecule were identified in planta, neither at the biochemical nor the molecular level. 
The goal of the present study is cDNA cloning, functional expression, and characterization of the 
prenyltransferases involved in the biosynthesis of PPAPs from H. sampsonii. Due to the absence 
of public transcriptomic data for the plant, quite a low expression level, and the membrane 
integration nature of aPTs, which all hamper the work on plant aPTs, two molecular biological 
approaches have been appointed in order to identify aPT sequences from H. sampsonii.  The first 
one is homology-based cloning, which makes use of the available transcriptomic information about 
H. perforatum and adopts the data of aPTs identified in H. calycinum, based on a subtracted library 
established in our laboratory (Gaid et al., 2012). The second approach is to use degenerate primers 
designed according to the conserved amino acid sequences of plant aPTs. The work should flow 
through the following steps: 
- Investigation of the metabolic profile of in vitro-grown H. sampsonii plants for the 
presence of PPAPs, prenylated intermediates, and aromatic cores. 
- Amplification of putative aPT coding sequences or aPT gene core fragments from H. 
sampsonii cDNA and genomic DNA, respectively. 
- Obtaining 5'- and/or 3'- ends for the coding sequence fragments by rapid amplification of 
cDNA ends (RACE). 
- Due to the challenging heterologous expression of membrane-integrated enzymes, the full-
length aPTs are expressed in insect and yeast expression systems. 
- Syntheses of biosynthetic intermediates as enzymatic substrates and reference compounds 
for production and structural identification of enzymatic products. 
- Testing the activity of microsomal fractions using potential substrates. 
- Characterization of the active recombinant proteins with respect to molecular and kinetic 
properties. 
- Once the activity of the recombinant enzymes is investigated and their characterization is 
established, the subcellular localization of the aPTs is determined by transient expression 
of aPT-yellow fluorescent protein (YFP) fusions in Nicotiana benthamiana.
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2 Materials 
2.1 Biological materials  
2.1.1 Plant materials 
2.1.1.1 Hypericum sampsonii 
Hypericum sampsonii Hance is native to East Asia. A sample of the plant was settled in the 
Herbarium of the Institute of Botany, the Chinese Academy of Sciences, Beijing, China (Specimen 
number 01262860). The seeds, provided from Zhejiang Normal University, Jinhua, China, were 
germinated as described elsewhere (Huang et al., 2012) at Key Laboratory of Plant Molecular 
Physiology, Institute of Botany, The Chinese Academy of Sciences. The seeds and developed 
seedlings were later used in the current study after propagation by Dr. Benye Liu in our laboratory 
as described later (3.1.1). 
2.1.1.2 Nicotiana benthamiana 
Pot plant was cultivated at the experimental station of the Institute of Pharmaceutical Biology at 
the Technical University of Braunschweig, Germany. 
2.1.2 Cloning and expression strains 
2.1.2.1 Bacterial strain 
 
Strain name  Genotype 
Escherichia coli DH5α  F′ φ80lacZΔM15 end A1 rec A1 hsdR17(rk- mk+) supE44 thi-1 
λ- gyrA96relA1 Δ(lacZYA-argFV169) deoR 
Agrobacterium tumefaciens C58C1(RifR) 
pMP90 (GentR) 
2.1.2.2 Insect cells 
Strain name  Supplier 
Spodoptera frugiperda  
Gibco® Sf9  
InvetrogenTM, Life Technologies GmbH 
2.1.2.3 Yeast strain 
Strain name  Genotype 
Saccharomyces cerevisiae 
INVSc1 (Invetrogen) 
MATa his3D1 leu2 trp1-289 ura3-52 MAT his3D1 leu2 trp1-289 
ura3-52 
2.2 Chemicals 
Chemical  Manufacturer 
2,3′,4,4′,6-Pentahydroxynenzophenone (maclurin)  Aldrich 
2,3′,4,6-Tetrahydroxybenzophenone  Lab collection 
2,4,6-Trihydroxybenzophenone  ICN Biomedicals 
2-Hydroxybenzophenone  Merck 
2-Mercaptoethanol (β-ME)  Roth 
4-Hydroxybenzophenone  Fluka 
Acetic acid  Roth 
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Acrylamide/Bisacrylamide 30%  Bio-Rad 
Acetosyringone Sigma-Aldrich 
Agar Kobe  Applichem 
Ammonium bicarbonate  Fischer scientific 
Ammonium hydroxide Riedel-de Haën 
Ammonium persulfate (APS)  Roth 
Ampicillin  Roth 
Bacto casamino acids  Difco 
Betaine  Sigma-Aldrich 
Bovine serum albumin (BSA)  Sigma-Aldrich 
Bromophenol blue  Aldrich 
CaCl2.2H2O  Roth 
Cellulose MN 2100 Merck 
Chloroform  Sigma-Aldrich 
Chloroform (GC grade) Sigma-Aldrich 
CoCl2.6H2O  Riedel-de Haën 
Coomassie blue (G250 and R250)  Merck 
CuCl2 Fluka 
CuSO4.5H2O  Riedel-de Haën 
DOWEX® AG 50W-X8, 100–200 mesh Sigma-Aldrich 
Ethanol  VWR 
Ethyl acetate  VWR 
Na2EDTA.2H2O  Roth 
Ferric chloride Roth 
FeSO4.7H2O  Riedel-de Haën 
Formic acid  Roth 
Galactose  Roth 
Geranyl chloride Sigma-Alderich 
Glass beads  Sigma-Aldrich 
Glucose  Roth 
Glycerol  Roth 
Glycine  Roth 
HCl  VWR 
Isobutyric acid  Sigma-Alderich 
Isopropanol  VWR 
KCl  Roth 
KH2PO4  Roth 
KI  Riedel-de Haën 
KNO3  Roth 
Mangiferin  Avachem 
Methanesulfonic acid  Sigma-Aldrich 
Methanol VWR Chemicals 
Methanol HPLC Fischer Chemicals 
MgCl2.6H2O  Fluka 
MgSO4.7H2O  Roth 
Midori Green  Nippon Genetics GmbH 
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MnCl2 Merck 
MnSO4.H2O  Riedel-de Haën 
Myo-inositol  Roth 
Na2MoO4.2H2O  Merck 
NaCl  Roth 
NaOH  Roth 
NH4NO3  Roth 
N-methyl-N-(trimethylsilyl)-trifluoroacetamide (MSTFA) ABCR 
o-Phosphoric acid  Fischer-Scientific 
PEG 4000  Fluka 
Peptone from casein  Roth 
peqGold Universal Agarose  Peqlab 
Phenol  Roth 
Phloroglucinol  Acros 
Phosphorus pentoxide  Acros 
Polyvinylpyrrolidone  Sigma-Aldrich 
Potassium acetate  Roth 
Prenyl bromide Sigma-Alderich 
Prenyl chloride Sigma-Aldrich 
silica gel 60 (0.040–0.063 mm) Merck 
Silica C18 (reversed phase) Merck 
Sodium dodecyl sulfate (SDS)  Roth 
Sorbitol  Roth 
Sucrose  Diadem 
Sulfosalicylic acid Merck 
Tetramethylethylenediamine (TEMED)  Roth 
Tetrabutylammonium hydrogen pyrophosphate Sigma-Alderich 
Thiamine hydrochloride  Sigma-Aldrich 
tris(hydroxymethyl) aminomethane (Tris)  Roth 
Xylene cyanol FF  Roth 
Yeast extract  Applichem 
Yeast nitrogen base without amino acids  Sigma 
ZnSO4.7H2O  Riedel-de Haën 
 
2.3 Vectors  
Plasmid Name  Use Origin 
pJET1.2 Blunt cloning of PCR 
products 
CloneJET PCR Cloning Kit 
(Thermo Fisher) 
pESC-URA Functional expression in yeast 
cells 
Agilent 
pFastBacTM 1 Transfer vector for expression 
in insect cells 
InvetrogenTM, Life 
Technologies GmbH 
pCAMBIA2300-35S-N-term-
YFP u 
USER cloning for localization  university of Copenhagen 
(Nour-Eldin et al., 2006) 
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pCAMBIA2300-35S-C-term-
YFP u 
USER cloning for localization  university of Copenhagen 
(Nour-Eldin et al., 2006) 
Helper plasmid K19 To prevent the rejection of the 
transfected heterologous PTs 
in N. benthamiana during 
localization study    
AG Prof. Dr. Hänsch, 
Institute of plant biology, TU 
Braunschweig  
EqFP611-DsRED Cytoplasmic control during 
localization study  
AG Prof. Dr. Hänsch, 
Institute of plant biology, TU 
Braunschweig 
2.4 Primers  
2.4.1 Primers derived from Hypericum sp.  
Primer no. Primer Name Sequence 5ʹ → 3ʹ 
1F HcPT-2_NheI_for AATGCTAGCATGGAGCTCTCCCGGATGCTTAAATTTCC 
1R HcPT-2_HindIII_re AATAAGCTTCTAAACGAAAGGAAGCAGAATATACTGCACAACG 
2F 290_pFastBac_For ATTGAATTCATGGAGCTCTCCCGGATGC 
2R 290_pFastBac_Re ATTCTCGAGCTAAACGAAAGGAAGCAGAATATACTGC 
3F hpa_8393_for AATGGATCCATGGAGCTCTCCATTTTCCCGTCCTCTC 
3R hpa_8393_rev AATCTCGAGTTAGATGAAAGGGAAGAGGGCGTACTCGG 
4F PT4472_R_EX AATGGTACCCTAAATAAACGGGAACAATAAAGTTTG 
4R PT4472_F_EX AATGGATCCATGGAAATCTCCCGATTGC 
5F 339F ATTGAATTCATGGAGGTTTCTCGATTGCCATCG 
5R 339R ATTAAGCTTCTAGATGAAGGGGAGCAAGATAAATTGC 
6F Tex-for ATTGGATCCATGGACGTTTCCAGTTCTGCTTTCACAC 
6R Tex-rev ATTGGTACCCTAGAGGAATGGAAGCGTGATAAACTGC 
7F HpPT015370BamHI- F ATTGGATCCATGGAGTCTCTACGTTTGGTCTC 
7R HpPT015370KpnI-R ATTGGTACCTCATCTAATGAATGGGATCAGTAAG 
8F HcPT1_XhoI_F AATCTCGAGATGGATAATCTATCCCTCTCCCTTCC 
8R HcPT1_KpnI_R AATGGTACCCTAAATAAAAGGAAATATGGCCCACTCTGC 
9F 470F ATTGAATTCATGGAGATCTCTCTTGCTTTCCTTCATCTGC 
9R 470R ATTCTCGAGCTAGATGAAGGGAAGTAGGATTAAGTGGGC 
10F 9252-for_BamHI ATTGGATCCATGGCCTTCTCTCCATTACTTTCATC 
10R 9252-rev_KpnI ATTGGTACCCTAGATAAAAAGAAATAGGATGTACTCGG 
11F 15764_BamHI_f AATGGATCCATGGAGACCTTTCGCTTTCCCTC 
11R 15764_ XhoI_r AATCTCGAGTTAAATGAATGGAAACAGCAAAATTTGGACAAG 
12F HpPT19471BamHI-F ATTGGATCCATGGATATCTCACGCACAATATC 
12R HpPT19471KpnI-R ATTGGTACCCTAAATAAAAGGATGAAGTATAAACTCG 
 
2.4.2 Primers used for core fragments amplification, 3′ and 5′ RACE 
Primer Name Sequence 5ʹ → 3ʹ 
PT_Deg_for GAAMYWGAYARGATWAAYAARCC 
PT_Deg_rev ATCTCCNTYNRYRTCWGRWANATC 
Hs_deg2_5R_rev_1 ATGGAGTACGATGATGCAACCAAC  
Hs_deg2_3R_for_1 GAATGGATTCGGTCAATTCTTCGTC  
Hs_deg6_5R_rev_1 GTCGGTGTCTGGAAGATCTTTTAATATG 
Hs_deg6_5R_rev_2 ACACCGCTCCGACTATTAGTAAGCAG  
Hs_deg6_5R_rev_3 TAGAGCTCCGGCTATGACCAAGCCG  
Hs_deg6_3R_for_1 GCCTTACTTACCTTTAGCTTCC 
Hs_degL_5R_rev_1 TGCTGACGCCACCAACAATAACAAGAC  
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Hs_degL_5R_rev_2 AGAATTTAGTGTTCCCGCTGTTAGC  
Hs_degS_5R_rev_1 AACGGAATATAATGAATGCACCACC  
HsPT5_Fragment_f TTCTGACATGGACGGAGATAG 
3'UTR_Hs_290 TCGACACATACGCATATGTTCG 
 
2.4.3 Primers used for cloning in pFastBacI 
Primer Name Sequence 5ʹ → 3ʹ 
HsPT1_EcoRI_fo AAAGAATTCATGGAGCTCTCCCGGATGCCTTCATC 
HsPT1_XhoI_rev ATTCTCGAGCTAAATGAAAGGGAACAATAAC 
HsPT2_BamHI_for ATTGGATCCATGGAGGTTTCTCGGTTGC 
HsPT2_KpnI_rev AAAGGTACCCTAGATGAATGGAAGCATG 
HsPT3_EcoRI_for ATTGAATTCATGGAGACCTTCCGCTTTCC 
HsPT3_XhoI_rev AAACTCGAGTCAGATGAATGGAAACAAC 
HsPT4_BamHI_for AATGGATCCATGGAAATCTCCCGATTGCCTTCATC 
HsPT4_KpnI_rev AATGGTACCCTAGATGAACGGAAACAGGAAAAG 
HsPT5_EcoRI_for ATTGAATTCATGGAGCTCTCCCGGATGC 
HsPT5_XhoI_rev ATTCTCGAGCTAGATGAAAGGAAGCAGAACATACTG 
 
2.4.4 Primers used for cloning in pESCUra 
Primer Name Sequence 5ʹ → 3ʹ * 
HsPT1_y_SaII_fo AATGTCGACATGGAGCTCTCCCGGATGCCTTCATC 
HsPT1_y_PacI_rev AAATTAATTAACTAAATGAAAGGGAACAATAAC 
HsPT3_y_BamHI_fo AATGGATCCATGGAGACCTTCCGCTTTCC 
HsPT5_Y_EcoRI_for ATTGAATTCATGGAGCTCTCCCGGATGC 
HsPT5_Y_PacI_rev ATATTAATTAACTAGATGAAAGGAAGCAGAACATACTGC 
HsPT6_Y_EcoRI_for ATTGAATTCATGGAGTCTCTACGTTTGGTCTCC 
HsPT6_Y_PacI_rev ATATTAATTAATCATCTAATGAATGGGATCAG 
HsPT7_EcoRI_for ATTGAATTCATGGCCTTCTCTCCATTAC 
HsPT7_PacI_rev AAATTAATTAACTAGATAAAAAGAAATAGG 
* Restriction sites added to the primers were underlined 
2.4.5 Primers used for cloning in N. benthamiana 
Primer Name Sequence 5ʹ → 3ʹ 
PT2_SP_For GGCTTAAUATGATGGAGGTTTCTCG 
PT2_YatC_Rev GGTTTAAUccGCAGATGAATGGAAGC * 
PT2_YatN_Rev GGTTTAAUCTAGATGAATGGAAGC 
PT2_NoSP_For GGCTTAAUATGTTTGCCTCCCGTAGTAAGC ** 
PT5_SP_For GGCTTAAUATGGAGCTCTCC 
PT5_YatC_Rev GGTTTAAUccGCAGATGAAAGGAAGC * 
PT5_YatN_Rev GGTTTAAUCTAGATGAAAGGAAGC 
PT5_NoSP_For GGCTTAAUATGCGCCGGATGGTTGC ** 
* cc is added to compensate frameshift with YFP and GCA false stop codon, ** ATG artificial 
start codon 
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2.4.6 SMART II RACE primers 
Primer Name Sequence 5ʹ → 3ʹ 
SMART II™ oligo AAGCAGTGGTATCAACGCAGAGTACGCGGG 
3′-RACE CDS primer AAGCAGTGGTATCAACGCAGAGTAC(T)30VN 
5′-RACE CDS primer (T)25VN 
RACE long CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCA
GAGT 
RACE short CTAATACGACTCACTATAGGGC 
RACE nested AAGCAGTGGTATCAACGCAGAGT 
 
2.5 Enzymes 
2.5.1 Enzymes used for reverse transcription (RT)  
Enzyme name  Manufacturer 
BD PowerScript™ Reverse Transcriptase BD Biosciences 
RevertAid™ HMinus Reverse Transcriptase  Thermo Scientific 
SMARTScribe™ Reverse Transcriptase  Takara 
 
2.5.2 Enzymes used for polymerase chain reaction (PCR)  
Enzyme name  Manufacturer 
peqGOLD Taq DNA polymerase  Peqlab 
Phusion® Hot Start II High-Fidelity DNA Polymerase  Thermo Scientific 
 
2.5.3 Restriction endonucleases 
Enzyme name  Restriction site sequence 5ʹ→ 3ʹ Manufacturer 
BamHI  G▼GATCC  Thermo Scientific 
BstBI TT▼CGAA Thermo Scientific 
EcoRI  G▼AATTC  Thermo Scientific 
HindIII  A▼AGCTT  Thermo Scientific 
KpnI GGTAC▼C Thermo Scientific 
NheI G▼CTAGC Thermo Scientific 
Nt.BbvCl CC▼TCAGC New England Biolabs 
PacI  TTAAT▼TAA  Thermo Scientific 
SalI G▼TCGAC Thermo Scientific 
SmaI CCC▼GGG Thermo Scientific 
XhoI C▼TCGAG Thermo Scientific 
 
2.5.4 Miscellaneous enzymes 
Enzyme name  Manufacturer 
DNA Blunting Enzyme (CloneJET PCR Cloning 
Kit) 
Thermo Scientific 
FastAP Thermosensitive Alkaline Phosphatase  Thermo Scientific 
RiboLock™ RNase Inhibitor  Thermo Scientific 
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RNase A  Thermo Scientific 
RNase-free DNase I  Qiagen 
T4 DNA ligase  Thermo Scientific 
USER-Enzyme mix  New England Biolabs GmbH 
 
2.6 Kits 
Name  Purpose  Manufacturer 
Bac-to-Bac® Baculovirus 
Expression System * 
Insect expression system Invitrogen™, Life Technologies 
GmbH 
BD SMART™ RACE 
cDNA Amplification Kit 
5'- and 3'-rapid 
amplification of cDNA ends 
(RACE) 
BD Biosciences 
Cellfectin® II reagent * Insect expression system Invitrogen™, Life Technologies 
GmbH 
CloneJET PCR Cloning Kit Blunt cloning of PCR 
products 
Thermo Fisher 
COMBINA 11 S Testing presence/absence of 
glucose in yeast media 
HUMAN Gesellschaft für 
Biotechnica und Diagnostica 
GmbH 
innuPREP DOUBLEpure 
Kit  
DNA purification from 
PCR, digestion mixture and 
agarose gel 
Analytik Jena 
RNeasy® Plant Mini Kit  RNA isolation from H. 
calycinum 
cell cultures 
Qiagen 
S.c. EasyComp™ 
Transformation Kit 
Preparation and 
transformation of 
yeast competent cells 
Invitrogen 
* Materials used for insect expression were kindly provided by Prof. Sönke. Behrends (Institute 
of Pharmacology, Toxicology and Clinical Pharmacy, Technical University of Braunschweig) 
2.7 Culture media 
2.7.1 Plant cultivating media 
MS medium   Final concentration 
Macro-nutrients  10X stock solution  
CaCl2.2H2O  4.4  g/l  440.0  mg/l 
FeSO4.7H2O  278.0  mg/l  27.8  mg/l 
KH2PO4  1.7  g/l  170.0  mg/l 
KNO3  19.0  g/l  1900.0  mg/l 
MgSO4.7H2O  3.7  g/l  370.0  mg/l 
Na2EDTA.2H2O  413.0  mg/l  41.3  mg/l 
NH4NO3  16.5  g/l  1650.0  mg/l 
Micro-nutrients 1000X stock solution   
H3BO3  6.54  g/l  6.54 mg/l 
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CoCl2.6H2O  25.0  mg/l  25.0  μg/l 
KI  830.0  mg/l  830.0  μg/l 
MnSO4.H2O  16.9  g/l  16.9  mg/l 
Na2MoO4.2H2O  250.0  mg/l  250.0  μg/l 
ZnSO4.7H2O  8.6  g/l  10.6  mg/l 
Vitamins and amino acids 100X stock solution   
Glycine   2 mg/l 
Myo-inositol  1.0  g/100ml  100.0  mg/l 
Nicotinic acid   0.5 mg/l 
Pyridoxine hydrochloride   0.5 mg/l 
Thiamine hydrochloride  1.0  mg/100ml  0.1  mg/l 
- The pH is adjusted to 6.0 and the medium is autoclaved at 120° C for 20 minutes. 
2.7.2 Bacterial culture media  
SOC medium   Final concentration 
Yeast extract  5.0  g/l  0.5  % (w/v) 
Peptone from casein  20.0  g/l  2.0  % (w/v) 
NaCl  467.6  mg/l  10.0  mM 
KCl  186.4  mg/l  2.5  mM 
MgSO4. 7H2O (1M)  5.0  ml/l  5.0  mM 
MgCl2 (1M)  5.0  ml/l  5.0  mM 
Dextrose (1M)  20.0  ml/l  20.0  mM 
- The pH is adjusted to 7.5. 
- The first four components are dissolved in 970 ml distilled water and autoclaved. Afterward, 
the sterile-filtered solutions of the last three components are added. 
YEP medium  Final concentration 
Bacto peptone  10 g/l 1 % (w/v) 
NaCl 4.69 g/l 0.085 M 
Yeast extract 10 g/l 1 % (w/v) 
Agar (for solid medium) 20 g/l 2 % (w/v) 
 
A. tumefaciens activation medium Final concentration 
Acetosyringone 150 μM 
MES buffer 0.01 M 
MgCl2 0.01 M 
 
2.7.3 Yeast culture media 
YPD medium   Final concentration 
Yeast extract  10.0  g/l  1.0  % (w/v) 
Peptone from casein  20.0  g/l  2.0  % (w/v) 
Dextrose  20.0  g/l  2.0  % (w/v) 
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- The first two components are dissolved in 900 ml distilled water and autoclaved. Afterward, 
100 ml of sterile filtered 20% (w/v) dextrose solution are added. 
- For solid medium, 2% (w/v) agar is added before autoclaving. 
 
Synthetic dextrose minimal medium 
(SD dropout or SGI medium) 
Final concentration 
Bacto casamino acids  1.0  g/l  0.10  % (w/v) 
Dextrose  20.0  g/l  2.0  % (w/v) 
Yeast nitrogen base (with or 
without amino acids) 
6.7  g/l  0.67  % (w/v) 
- The first two components are dissolved in 900 ml distilled water and autoclaved. Afterward, 
100 ml of sterile filtered 20% (w/v) dextrose solution are added. 
- For solid medium, 2% (w/v) agar is added before autoclaving. 
 
YPGE medium   Final concentration 
Yeast extract  10.0  g/l  1.0  % (w/v) 
Peptone from casein  10.0  g/l  1.0  % (w/v) 
Dextrose  5.0  g/l  0.5  % (w/v) 
Ethanol  30.0  ml/l  3.0  % (v/v) 
- The first two components are dissolved in 945 ml distilled water and autoclaved. Afterward, 25 
ml of sterile-filtered 20% (w/v) dextrose solution and 30 ml absolute ethanol are added. 
2.7.4 Insect culture media 
Basic medium  Final concentration 
Sf-900TM SFM Invitro TM, Life 
Technologies GmbH  
                                                                                                                                                                                                 
Sf9-medium    
Sf-900TM SFM    
Fetal bovine serum  100 g/l 
Penicillin/ Streptomycin  10 g/l 
 
2.8 Buffers and solutions  
2.8.1 Buffers used for RNA extraction 
RNA extraction buffer Final concentration 
CTAB  20 mg/ml 
EDTA  25  mM 
NaCl  2 M 
PVP  20  mg/ml 
Spermidin  0,5 mg/ml 
TRIS-HCl  100 mM 
β-Mercaptoethanol   20 ml/l 
- pH was adjusted at 8 
- β-Mercaptoethanol was added directly before use 
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SSTE buffer Final concentration 
EDTA  1 mM 
NaCl  1 M 
SDS  5  mg/ml 
Tris-HCl  10 mM 
- pH was adjusted to 8 
2.8.2 Buffers used for plasmid isolation from E. coli 
Buffer I  Final concentration 
Na2EDTA.2H2O  10 mM 
RNase A 10 Μg/ml 
Tris  50 mM 
- The pH is adjusted to 8 with 1N HCl 
- RNase is added immediately before use 
 
Buffer II  Final concentration 
NaOH  0.2  M 
SDS  1  % (w/v) 
 
Buffer III  Final concentration 
Potassium acetate  3  M 
- The pH of buffer III is adjusted to 5.5 with glacial acetic acid 
2.8.3 Buffer used for plasmid isolation from yeast 
Yeast cracking solution  Final concentration 
Tris  10  mM 
Na2EDTA.2H2O  1  mM 
NaCl  100  mM 
SDS  1  % (w/v) 
Triton X-100  2  % (v/v) 
- The pH is adjusted to 8.5 with 1N HCl 
2.8.4 Buffers used for microsomal protein isolation from Insect cells 
Sonication Buffer Final concentration 
Glycerol  0.1  ml/ml 
Na2EDTA.2H2O  1  mM 
Tris-HCl  50  mM 
 
Buffer A Final concentration 
Glycerol  0.1  ml/ml 
NaCl 300  mM 
Tris-HCl  50  mM 
- The pH of both buffers was adjusted to 7.5  
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2.8.5 Buffers used for microsomal protein isolation from yeast 
TEK buffer  Final concentration 
Na2EDTA.2H2O  1 mM 
KCl  0.1 M 
Tris-HCl pH 7.4 *  50 mM 
 
TES buffer  Final concentration 
Na2EDTA.2H2O  1  mM 
Sorbitol  0.6  M 
Tris-HCl pH 7.4 * 50 mM 
- The pH of both buffers was adjusted to 7.4  
* From 1M stock buffer 
 
2.8.6 Buffers and solutions used for agarose gel electrophoresis 
50X TAE buffer    Final concentration 
Na2EDTA.2H2O  18.612  g/l  50  mM 
Tris  242.28  g/l  2  M 
- The pH is adjusted to 8.0 with glacial acetic acid 
 
6X DNA loading dye    Final concentration 
Bromophenol blue  15  mg/50 ml  0.03  % (w/v) 
Glycerol  30  ml/50 ml  60  % (v/v) 
Na2EDTA.2H2O  1.117  g/50 ml  60  mM 
Tris  60.6  mg/50 ml  10  mM 
Xylene cyanol FF  15  mg/50 ml  0.03  % (w/v) 
- The pH is adjusted to 7.6 with 1N HCl 
- Stored in -20 °C without autoclaving 
2.8.7 Solution for the determination of protein concentration 
Bradford dye solution    Final concentration 
Coomassie blue G250  100  mg/l  0.01  % (w/v) 
Ethanol absolute  50  ml/l  5  % (v/v) 
o-phosphoric acid (85%)  100  ml/l  10  % (v/v) 
- Coomassie blue is dissolved first in ethanol and then o-phosphoric acid is added. 
- The solution is filtered before use and kept at 4 °C away from light. 
2.8.8 Buffers used for the synthesis of geranyl pyrophosphate 
Ion exchange buffer   Final concentration 
NH4HCO3 2 g 0.25 mM 
Isopropyl alcohol 20 ml 2% v/v 
Deionized water 980 ml   
Chromatography buffer buffer   Final concentration 
NH4HCO3 (dissolved in 250 ml dH2O) 4 g 0.5 mM 
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Isopropyl alcohol 500 ml 50% v/v 
Acetonitrile 250 ml 25% v/v 
Spray reagents   Volume 
1st reagent     
Sulfosalicylic acid   1 g 
Ethanol   60 ml 
water   40 ml 
2nd reagent     
FeCl3   2 g 
Ethanol   80 ml 
Water   20 ml 
  
2.9 Equipment 
2.9.1 General equipment 
Equipment  Model  Manufacturer 
Autoclave  Systec VX-120  Systec 
Balance  2254  Sartorius 
Balance  Kern 572  Kern & Sohn Gmbh 
Balance  LA230S  Sartorius 
Centrifuge  1-15K Sigma 
Centrifuge  Avanti J-30I  Beckmann Coulter 
Centrifuge  Avanti J-E  Beckmann Coulter 
Centrifuge  Biofuge 13  Heraeus 
Centrifuge  GS6R  Beckmann Coulter 
Centrifuge  Universal 32 R  Hettich 
Deep freezer (-80 °C)  MDF-U53V  Sanyo 
Dry block heater  Dri-Block DB-3D  Techne 
Electrophoresis chamber for 
agarose gels  
Wide Mini-Sub Cell GT  Bio-Rad 
Fraction collector Ultrorac® 7000 LKB-Produkter 
Glass column dimensions 40 X 11 cm - 
Glass column dimensions 25 X 6.5 cm - 
Heating circulator water 
bath  
TopTech MW-4  Julabo 
Laminar air flow  LaminAir HLB2472 BS  Heraeus 
Lyophilizer Gamma -20  Christ Lyophilizing apparatuses 
GmbH 
Magnetic stirrer MR Hei-standard Heidolph Instruments GmbH & 
CO. KG 
Magnetic stirrer Ret basic IKA®-Werke GmbH & CO. KG 
MicroPulser  BioRad laboratories GmbH 
Microscope  Laborlux 11  Leitz 
Microscope (confocal laser 
scanning) 
cLSM-510META connected 
to Axiovert 200M 
Carl Zeiss 
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pH meter  pH 325  WTW GmbH 
Rotary evaporator  W60  Heidolph 
Rotational Vacuum 
Concentrator  
RVC 2-18  Christ 
Shaker incubator  Multitron  Infors HT 
Shaker incubator  KF4  Infors HT 
Sonifier 250 Barson Ultrasonics corporation 
Spectrophotometer  SimpliNano™  GE Lifesciences 
Spectrophotometer  Ultrospec 1000  Pharmacia Biotech 
Spectrophotometer  UVmini-1240  Schimadzu 
Thermocycler  T-Professional basic 
gradient  
Biometra 
Ultrasound water path SonorexTK30 BANDELIN electronic GmbH & 
CO. KG 
Diaphragm vacuum pumps 
with programmable digital 
vacuum controller 
VCZ 224  Ilmvac 
Vortex shaker  VF2  IKA 
Vortex shaker  Vortex Genie 2 Digital  Scientific industries (Si) 
Water purification system  Arium 611  Sartorius 
 
2.9.2 Equipment for chromatographic and spectroscopic analysis 
Equipment  Model  Manufacturer 
HPLC  Agilent 1260 Infinity 
System  
Agilent 
Pump  G1311C Quaternary Pump 
VL  
Agilent 
Auto sampler  G1329B ALS  Agilent 
Column oven  G1316A TCC  Agilent 
Column  HyperClone ODS 120A 
(C18, 4.6 × 150 mm, 5 μ)  
Phenomenex 
Diode Array Detector  G1315D DAD VL  Agilent 
Software  Agilent ChemStation for LC 
3D System Rev. 
B.04.03(16) 
Agilent 
HPLC  LaChrom Elite System  VWR-Hitachi 
Pump  L-2130  VWR-Hitachi 
Degasser  Model 2005 Degasser  VWR-Hitachi 
Auto sampler  L-2200  VWR-Hitachi 
Column  ZORBAX Eclipse Plus (C18, 
4.6 × 100 mm, 
3.5 μ) 
Agilent 
Diode Array Detector  L-2455  VWR-Hitachi 
Software  EZChrom Elite vers. 3.3.2 
SP1  
Agilent 
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GC-MS  6890 gas chromatograph Agilent 
Column ZB5-MS column (30 m, 
0.25 mm i.d., 0.25 mm ft) 
Phenomenex 
Derivatization’s oven GC 5890 A Hewlett-Packard Company 
Mass spectrometer Joel  Agilent 
Software chemstation Agilent 
Mass spectrometer  3200 QTRAP LC/MS/MS 
System  
AB Sciex 
Software  Analyst vers. 1.4.2  AB Sciex 
NMR spectrometer Avance II 600, 5 mm TCI 
CryoProbe 
Bruker Co. 
Thin layer 
chromatography 
0.1 cellulose (20 x 20 cm) Merk Millipore Co. 
Thin layer 
chromatography 
0.2 silica gel 60 F254 (20 x 
20 cm) 
Merk Millipore Co. 
Thin layer 
chromatography 
0.2 Nano-Sil C18-100 UV254 
(10 x 10 cm) 
MACHEREY-NAGEL GmbH 
& Co. KG 
 
2.10 Databases and software 
2.10.1 Software 
Name, web address*  Use 
Bioedit 7.2.5 Multiple sequence alignment  
Chromas Lite 2.1.1 
http://technelysium.com.au/  
Visualization of the sequencing chromatograms 
from *.ab1 files. 
Lasergene - DNAStar 7.0  A package composed of various individual 
programs for DNA and protein sequence analysis. 
Those programs include: MegAlign: generates 
pairwise and multiple 
sequence alignments of protein or DNA showing 
consensus strength and percent identity matrices. 
EditSeq: helpful in editing protein and nucleotide 
sequences. SeqMan: assembles Contigs from 
individual overlapping sequences. SeqBuilder: 
generates plasmid maps, shows existing restriction 
sites within a given nucleotide sequence and 
predicts restriction digestion results. 
Primer premier 5.0  Design of primers for RACE experiments. 
MEGA 7.0 
http://www.megasoftware.net/  
Construction of phylogenetic trees (Kumar et al., 
2016)  
Wsearch Pro 
http://www.wsearch.com.au  
Mass spectral date reduction 
ZEN 2.3 (Carl Zeiss) Visualization of images generated by LASER 
scanning microscope. 
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2.10.2 Online databases and tools 
Databases name and web address  Use, description 
NCBI protein and nucleotide databases 
http://www.ncbi.nlm.nih.gov/protein  
http://www.ncbi.nlm.nih.gov/nuccore  
Retrieving amino acid and nucleotide 
sequences of deposited prenyltransferases. 
MPGR database 
http://medicinalplantgenomics.msu.edu/  
A repository of the transcriptomic and 
metabolomic data of 14 medicinal plants, 
including H. perforatum. 
OneKP database http://www.onekp.com  Transcriptomic data of over 1000 plants 
including H. perforatum. 
PhytoMetaSyn database 
http://www.phytometasyn.ca/index.php  
Transcriptomic data of 75 plant species 
including H. perforatum. 
 
Online tools: Website 
BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi  
ChloroP 1.1 Server  http://cbs.dtu.dk/services/ChloroP/  
DoubleDigest Calculator  https://www.thermofisher.com/de/de/home/brands/ther
mo-scientific/molecular-biology/thermo-scientific-
restriction-modifying-enzymes/restriction-enzymes-
thermo-scientific/double-digest-calculator-thermo-
scientific.html  
ExPASy translate tool http://web.expasy.org/translate/  
iPSORT  http://ipsort.hgc.jp/index.html  
MWG Primer-check  http://ecom2.mwgdna.com/services/oligo/apploligos.tcl?
ot=OLIGO_PCR   
Oligo Analysis Tool https://www.eurofinsgenomics.eu/en/ecom/tools/oligo-
analysis/   
Oligo Calc  http://basic.northwestern.edu/biotools/OligoCalc.html  
PROTEIN CALCULATOR v. 3.4  http://protcalc.sourceforge.net/  
SOSUI Prediction of Membrane 
Proteins  
http://harrier.nagahama-i-bio.ac.jp/sosui/  
TargetP 1.1 Server  http://cbs.dtu.dk/services/TargetP/  
TMHMM Server v. 2.0  http://cbs.dtu.dk/services/TMHMM/  
* All listed websites have been successfully accessed on Juni 01, 2018
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3 Methods 
3.1 Eukaryotes Cultivation Methods 
3.1.1 Cultivation of plants used in the current study 
3.1.1.1 Hypericum sampsonii 
In vitro plantlets were grown on Murashige and Skoog medium (MS; section 2.7.1) (Murashige 
and Skoog, 1962) enriched with 3% (w/v) sucrose and 0.6% (w/v) agar. Prior to autoclaving the 
pH value of the medium was adjusted to 5.7. A 16/8 hours light/dark photoperiod at 25 ± 2 °C was 
employed as the growth conditions for the seedlings. Four and six-week-old seedlings were used 
for RNA extraction and metabolite identification, respectively (Gaid et al., 2016). 
3.1.1.2 Nicotiana benthamiana 
Nicotiana benthamiana was cultivated in steamed potting soil at acclimatized room at 24 °C, 65% 
humidity and with lighting for 12 hours per day (30 μmol/m2s). Plants were re-cultivated under 
the same conditions after 2 to 3 weeks after seeding time. 
3.1.2 Cultivation of Spodoptera frugiperda (Sf9 cell line) 
The immortalized insect cell line Sf9 (2.1.2.2) derived from ovarian cells of the Moth Spodoptera 
frugiperda served as a host. Sf9 cells were easily transfected with the baculovirus Autographa 
californica multicapsid nucleopolyhedrovirus (AcMNPV), which was very well suited for the 
expression of proteins based on recombinant bacmids/baculoviruses. The Sf9 cells were analyzed 
as 50-500 ml samples in Sf9 medium (2.7.4) at 27 °C and 140 rpm in shaker incubator under sterile 
conditions and after every 3-4 days, by diluting the cell suspension with fresh Sf9 medium, the 
optical density (OD) of the cells was maintained between 1 x106- 10 x106 cells/ml (Schneider and 
Seifert, 2010). The procedure was maintained at the lab. of Prof. Sönke Behrends (Institute of 
Pharmacology, Toxicology and Clinical Pharmacy, Technical University of Braunschweig). 
3.2 Chemical Methods 
Some of the potential substrates were not commercially available, which necessitates their 
synthesis via chemical or enzymatic approaches.  
3.2.1 Synthesis of 3-mono- and 3,5-di-prenylated-2,4,6-trihydroxybenzophenone 
A modified method according to Pepper et al. (2014) was used. KOH (1 g) was added to a 
suspension of 1 g of 2,4,6-trihydroxybenzophenone in 8 ml water. Prenyl bromide (1 ml; Sigma-
Aldrich, Steinheim, Germany) was added dropwise over 30 min to the mixture and stirred in ice 
for 90 min then the reaction was stopped by the addition of 4 ml 1 N HCl. The reaction mixture 
was extracted with ethyl acetate (3 X 10 ml) and the organic extract was dried over anhydrous 
Na2SO4 followed by concentration under vacuum. The extract was fractioned over a silica gel 
column (silica gel 60, 0.040–0.063 mm from Merck, Darmstadt, Germany; column dimensions 40 
X 11 cm) with a gradient of dichloromethane/ methanol the fractions collected and screened by 
TLC (silica gel 60 F254; Merck, Darmstadt, Germany) and developed using a system of 
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dichloromethane: methanol 95:5 to result in 3 fractions. 3-Monoprenylated 2,4,6-
trihydroxybenzophenone (MPPBP) was purified from fraction no. 2 employing a reversed phase 
silica C18 (column dimensions 25 X 6.5 cm) using a methanol/ water gradient to yield 60 mg of a 
yellow solid, which was identified by 1H NMR and 13C NMR. Data for MPPBP: Rf = 0.58 
(DCM/MeOH, 95:5); 1H NMR (600 MHz, MeOD) δ 7.54 (m, 2H), 7.42 (m, 1H), 7.32 (m, 2H), 
5.87 (s, 1H), 5.22 (t, J= 1.4 Hz, 1H), 3.23 (d, J= 7.1, 2H), 1.75 (s, 3H), 1.66 (s, 3H) ; 13C NMR 
(150 MHz, CDCl3) δ 201.1 (Cq, C=O), 164.3 (Cq, C˗O), 163.4 (Cq, C˗O), 160.5 (Cq, C˗O), 143.6 
(Cq, C˗C), 131.7 (CH), 131.2 (Cq, C˗C), 129.2 (CH), 128.5 (CH), 124.5 (CH), 108.3 (Cq, C˗C), 
105.3 (Cq, C˗C), 95.3 (CH), 26.0 (CH3), 22.3 (CH2), 17.9 (CH3). 
3,5-Diprenylated 2,4,6-trihydroxybenzophenone (DPPBP) was purified from fraction 1 over a 
reversed phase column using a reversed phase silica C18 using a methanol/ water gradient. It was 
identified by 1H NMR and 13C NMR. Data for DPPBP: Rf = 6.9 (DCM/MeOH, 95:5); 
1H NMR 
(600 MHz, CDCl3) δ 7.64 (dd, J= 8, 1.5, 2H), 7.57 (t, J= 1.2, 1H), 7.5 (m, 2H), 5.22 (t, J= 1.3, 
2H), 3.35 (d, J= 7.4, 4H), 1.78 (s, 6H), 1.74 (s, 6H); 13C NMR (150 MHz, CDCl3) δ 198.0 (Cq, 
C=O), 161.0 (Cq, C˗O), 157.6 (Cq, C˗O), 140.3 (Cq, C˗C), 135.1 (Cq, C˗C), 132.1 (CH), 129.0 
(CH), 128.0 (CH), 121.8 (CH), 106.3 (Cq, C˗C), 104.5 (Cq, C˗C), 25.8 (CH3), 21.8 (CH2), 17.9 
(CH3). 
A third reaction product (bi-product) was purified from fraction 1, which was mis-conducted 
before identification as DPPBP due to the same molecular mass indicated by ESI-MS/MS analysis. 
It was then identified as a benzopyran derivative, which can be formed due to the intramolecular 
cyclization of the adjacent o-prenyl group with the hydroxyl group on the adjacent carbon atom or 
formed as an artifact after synthesis during extraction or purification.  
 
3.2.2 Synthesis of 2,4,6-trihydroxyphlorisobutyrophenone 
2,4,6-Trihydroxyisobutyrophenone (246TrHiBP) was obtained employing Friedel-Crafts 
acylation (van Klink et al., 1999) through the reaction of 3.15 g phloroglucinol (Merck, Darmstadt, 
Germany) with 1.159 ml isobutyric (Sigma-Aldrich, Steinheim, Germany) acid in the presence of 
6.67 g AlCl3 (Merck, Darmstadt, Germany) and 25 ml POCl3 (Sigma-Aldrich, Steinheim, 
Germany) under argon gas. The reaction mixture was poured over ice to break the reaction which 
was later extracted with dichloromethane. The product was purified on preparative silica gel plates 
(silica gel 60 F254, 20 X 20 cm plates, thickness 1mm; Merck, Darmstadt, Germany) using a 
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mobile system of Petroleum ether: Ethylacetate 7: 3 (Rf = 0.28). The structure was confirmed by 
comparing its MS/MS fragmentation pattern with an authentic reference. 
 
3.2.3 Synthesis of 1,3,6,7-tetrahydroxyxanthone 
1,3,6,7-Tetrahydroxyxanthone (1367THX) was prepared by Dr. Gaid. The product was obtained 
via acid hydrolysis of mangiferin (Avachem, San Antonio, TX, USA) (Guo et al., 2015). 
Mangiferin (30 mg) was dissolved in 5 ml HI and 111 mg phenol (Mainland, Pharmazeutische 
Fabrik, Frankfurt am Main, Germany). The mixture was refluxed for 6 hours at 150 °C. Saturated 
NaHCO3 (3 ml) was then added and the mixture was fractioned with ethyl acetate and water. The 
aqueous phase was heated under reflux to evaporate the left iodide, acidified with HCl and 
extracted twice with equal volume ethyl acetate. The combined organic extract was dried with a 
rotary evaporator to yield 1367THX whose structure was confirmed based on a comparison of its 
mass fragmentation with a reference. 
3.2.4 Synthesis of geranyl pyrophosphate (GPP) 
The protocol applied for the synthesis of GPP was modified after the original one described by 
Woodside et al. (1988). Here, the synthesis was started from the second stage because of the 
commercial availability of the starting material 1-chloro-3,7-dimethylocta-2,6-diene (geranyl 
chloride). The reaction was performed in absolutely dry conditions under nitrogen gas in 3 neck 
flask. One neck was equipped with a septum to allow the drawing of air (with a syringe) while 
flushing the flask with nitrogen from the other neck. 5 gm tetrabutylammonium hydrogen 
pyrophosphate trihydrate ((Bu4N)3P2O7H) dissolved in dry acetonitrile were stirred under nitrogen 
with 4.8 ml 1-chloro-3,7-dimethylocta-2,6-diene (geranyl chloride) which is added after the 
evacuation of the air through the septum with a syringe. The entire reaction mixture was then dried 
using a rotary evaporator to result in a viscous yellowish-brown mass. 
The residue was dissolved in ion exchange buffer (2.8.8), applied to the DOWEX® AG 50W-X8 
cation exchange column (ammonium form). One day before the reaction, The NH4
+ form of the 
resin was generated by washing Dowex AG 50W-X8 (H+ form) in a fritted-glass funnel with four 
portions (each 200 ml) of concentrated ammonium hydroxide. Afterward, the resin was washed 
with deionized water until the pH of the filtrate drops to pH 7, then twice with 200 ml portions of 
the ion-exchange buffer. The washed resin is suspended in 200 mL of ion exchange buffer and 
slurry was packed into the column (4 × 15 cm column). The column was loaded and eluted with 360 
ml ion exchange buffer and the resulting bale yellow eluate was frozen then lyophilized.  
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The resulting white powder was dissolved in 5 mL of 0.05 M ammonium bicarbonate (2.8.8), and 
the solution was mixed with 20 ml of 1:1 (v/v) acetonitrile: isopropyl alcohol and the contents are 
mixed vigorously by vortexing and a white precipitate was brought about. The suspension was 
centrifuged for 5 min at 2000 rpm. The supernatant was transferred with a pipette in a new tube, 
and the precipitate was suspended again in 5 mL of 0.05 M NH4HCO3, and the extraction was 
repeated. This was followed by three additional extractions using a solution composed of (2 ml 
0.05 M ammonium bicarbonate + 4 ml acetonitrile + 4 ml isopropyl alcohol). The supernatant was 
pooled (nearly 80 ml) was concentrated to a volume of 5 ml then dissolved in 5 ml chromatography 
buffer (2.8.8). 
The desired compound was then purified on a cellulose column washed with deionized water, 0.1 
N HCl, 0.1 NaOH and 1:1 2-propanol: water and packed exactly as mentioned in the original 
protocol (Woodside et al., 1988) eluted with chromatography buffer. About 150 fractions each 15 
ml were collected employing a fraction collector. Each third fraction was run over a cellulose TLC 
plate (2.9.2) with the chromatography buffer as a mobile phase. The plate was sprayed with a 
freshly prepared sulfosalicylic acid solution, dried in the air then with fresh ferric chloride solution 
(2.8.8). Pyrophosphate group- containing compounds appear as white spots on a pink background. 
GPP-containing fractions were combined together and freeze-dried. The resulting solid (with 
strong lemon odor) was dissolved in MeOH: NH4OH 7: 3 solution to a final concentration of 50 
mM. 
 
3.2.5 Synthesis of dimethylallyl pyrophosphate (DMAPP) 
Based on the same protocol, the synthetic step described previously (3.2.4) were applied with the 
alteration of the starting material as 1-chloro-3-methylbut-2-ene (prenyl chloride) instead of prenyl 
chloride to obtain the corresponding pyrophosphate derivative. 
 
3.2.6 Upscaled enzymatic production of 8-prenyl-1,3,6,7-tetrahydroxyxanthone  
The potential substrate 8-prenyl-1,3,6,7-tetrahydroxyxanthone is not available commercially. 
Based on the current study the regioselective enzymatic formation is the optimum way for its 
production. One thousand time standard incubations (3.5.5.1) were done utilizing the optimum 
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conditions for maximum yield where 2.5 mg THX was incubated with 0.4 mM DMAPP and ≈ 100 
mg of membrane protein prepared from yeast-expressing HsPT8PX (HsPT2). Products were 
extracted 3 times with ethyl acetate and evaporated under vacuum (106 bar, 45 °C) till dryness. 
Pure 8PX was isolated from the extract using semi-preparative HPLC (3.6.1). The resultant pure 
8PX (1.5 mg) was dissolved in 457 μl methanol to give a 10 mM stock solution. 
3.2.7  Profiling of PPAPs core from Hypericum sampsonii 
Three grams whole in vitro 6 weeks-old seedlings were collected and homogenized with sea-sand. 
The homogenate was ground again with the addition of ≈ 10 ml methanol for 5 min at room 
temperature. The entire mixture was filtered under vacuum. Extraction and filtration were repeated 
twice. The combined methanol extract was then dried on a rotary evaporator at 50 ℃ till complete 
dryness. The residue was dissolved in 1 ml methanol HPLC, a 25 time diluted 25 µl aliquots were 
analyzed by HPLC (3.6.1). After initial analysis, the extract was fractioned by semi-preparative 
HPLC via injecting successive aliquots of 50 μl to result in 5 fractions. Fractions were then 
evaporated under nitrogen gas, each dissolved in 1 ml methanol afterward the molecular masses 
were confirmed via ESI-MS/MS. Lastly, GC-MS analyses were performed using the silylated 
fractions (3.6.3). 
3.3 Molecular Biology Methods 
3.3.1 Isolation of nucleic acids 
3.3.1.1 Isolation of total RNA 
Various methods were performed to confirm a high RNA quality and yield. Extraction of RNA 
was carried out with special caution due to the single-stranded nature of RNA and the ubiquitous 
occurrence of RNases that can degrade it.  
3.3.1.1.1 Extraction with commercial kits 
Entire 4-week-old H. sampsonii seedlings were collected and washed. One sample of 100 mg was 
used for RNA extraction using (Qiagen) following the manufacturer’s protocol. 
3.3.1.1.2 Extraction according to Jaakola protocol 
Based on RNA extraction developed by Jaakola et al. (2001) an RNA extraction protocol suitable 
for phenol-rich plant tissues was developed similar to that modified by Fiesel (2016). Plant tissue 
was disrupted and homogenized in liquid nitrogen. Two samples of plant material, each 
approximately 100 mg, were added each with 750 μl preheated RNA extraction buffer 
(section 2.8.1) and incubated at 65 °C for 10 min and was vortexed briefly every 2 min. CTAB 
was added as a detergent for the separation of polysaccharides, EDTA as a complexing agent, β-
mercaptoethanol as antioxidant and PVP as stabilizer and adsorbent of polyphenols. The mixture 
was centrifuged at 4 °C and 10,000 x g for 10 min. The supernatant was separated and extracted 
twice with chloroform: isoamyl alcohol (24:1) phases were then separated by centrifugation at 
13000 rpm at room temperature for 10 min. RNA was precipitated overnight at 4 °C by adding a 
¼ volume of 10 M LiCl to the hydrophilic supernatant. The RNA was trapped at 4 °C and 18,000 
x g for 20 min, the supernatant was decanted and the pellets were washed two times successively 
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with 500 μl cold ethanol 70% (v / v) and dissolved each in 100 μl SSTE buffer (section 2.8.1). 
Dissolved samples were combined and extracted once with phenol: chloroform: isoamyl alcohol 
(125: 24: 1) and once with chloroform: isoamyl alcohol (24: 1) to remove any residual DNA 
contamination. RNA was re-precipitated by the addition of ice-cold ethanol at -20 °C for 2 h, 
centrifuged at 4 °C washed twice with cold ethanol and, after removal of the supernatant dried at 
37 °C for 30 min in a vacuum concentrator finally suspended in 30- 50 μl RNase-free dH2O. 
3.3.1.2 Isolation of plasmid DNA from E. coli 
Alkaline lysis method was used which based on selective lysis of large linear DNA in alkaline 
medium but leaving the small circular DNA intact (Birnboim and Doly, 1979). The denatured 
DNA together with proteins are neutralized and precipitated while plasmid DNA remains 
dissolved. A single colony of transformed E. coli was inoculated in a 5 ml LB tube supplemented 
with 10 μl of 100 mg/ml ampicillin solution for positive selection of bacterial cells accommodating 
plasmids contain an ampicillin resistance gene. After overnight (16- 18 h) incubation at 37 °C and 
200 rpm, cells in 2 ml of the overnight culture were pelleted in by centrifugation for 5 min at 5000 
rpm.  Pellets were resuspended in 300 μl of ice-cooled buffer I containing freshly-added RNase A 
(2.8.2). 300 μl of the alkaline buffer (buffer II, 2.8.2) were added, then the tubes were mixed by 
moving upside down 6 times and incubated at room temperature for 5 min.  An equal amount of 
neutralizing buffer III (2.8.2) was gently mixed, then the whole mixture was incubated on ice for 
20 min which resulted in the precipitation of chromosomal DNA and proteins. The precipitate was 
discarded through centrifugation for 10 min at 14000 rpm, while 800 μl of the supernatant were 
vigorously vortexed with an equal volume of chloroform; separation of the two phases achieved 
after centrifugation for 10 min at 14000 rpm. Precipitation of plasmid DNA was done by the 
addition of 490 μl isopropanol to 700 μl of the aqueous phase after transferring to a new 1.5 ml 
Eppendorf (70 % of the aqueous phase volume), followed by vortexing and centrifugation for 30 
min at 14000 rpm. After discarding the supernatant the pellet was washed with 500 μl of 70 % 
ethanol, centrifuged for 10 min at 14000 rpm. The supernatant was again removed and the 
precipitated plasmid was dried in a rotational vacuum concentrator and finally dissolved in 30- 50 
μl of deionized water.  
The isolated plasmids were tested either by restriction digestion or by PCR for the presence of the 
insert before sequencing the results were analyzed as would be described later by agarose gel 
electrophoresis (3.3.6). 
3.3.1.3 Isolation of plasmid DNA from Saccharomyces cerevisiae 
To control whether the tested transformed yeast colony contains the expected plasmid, plasmids 
were isolated according to the protocol developed by Hoffman and Winston (1987). Colonies 
harboring the right plasmid were selected for subsequent expression procedure. 
Two ml overnight yeast culture were centrifuged for 5 min at 5000 rpm to pellet the cells, the cells 
were again suspended in the residual medium left after discarding the supernatant. To the 
suspension 200 μl of the yeast cracking solution (2.8.3), 200 μl of phenol: chloroform (1:1) and 
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300 mg of acid-washed glass beads were added. The whole suspension was vigorously vortexed 
for 2 min, then centrifuged for 10 min at 13000 rpm. The aqueous phase was separated and further 
used to precipitate the DNA by adding 70% of its volume isopropanol. After precipitation of DNA, 
washing, drying, dissolution was continued as described under section 3.3.1.2. A disadvantage of 
this method is the low quality of the isolated plasmids (protein and RNA contaminations), 
nevertheless, it was enough to be used as a template to confirm the correct inserts by PCR 
amplification. 
3.3.1.4 Isolation of DNA from agarose gels 
DNA fragments with the right expected size were purified using the innuPREP DOUBLEpure Kit 
(Analytik Jena). First, the gel matrix was solubilized in 650 μl solubilizing buffer for 10 min at 50 
°C. The solubilized gel was transferred to nucleospin column where DNA is adsorbed to the silica 
membrane, and other components of the mixture were removed after centrifugation (1 min at 8000 
rpm) and washing twice by the washing buffer. Then the column was dried by centrifugation at 
maximum speed for 2 minutes. Finally, DNA was eluted by the addition of ≈ 15 µl of the dH2O. 
3.3.1.5 Direct isolation of target DNA from reaction mixtures 
The same principle and kit as mentioned in 3.3.1.4 but the digestion or dephosphorylated reaction 
mixture was mixed with 500 µl of the binding buffer then transferred to the separation column, 
centrifuged at 12000 rpm for 1 min, washed once and then the process is continued as before. 
3.3.2 Quantification of nucleic acids 
The concentration of nucleic acids was determined spectrophotometrically by measuring the 
absorbance of a 1:100 diluted sample at wavelength 260 nm. Beer-Lambert equation was applied. 
𝐶 =
𝐴260
𝐿
 𝑥 𝜀 𝑥 𝐷 
Where, 
C is the concentration of the nucleic acid sample in ng/µl 
A260 is the absorbance of the nucleic acid sample at 260 nm 
L is the path length in cm 
ɛ is the extinction coefficient (50 µg/ml for double-stranded DNA, 33 µg/ml for single-
stranded DNA and 40 µg/ml for RNA) 
D is the dilution factor 
 
The ratio A260/A280 was obtained for the determination of the purity of the isolated nucleic acid. 
Due to the interference of genomic DNA, proteins or some reagents commonly used in nucleic 
acids isolation a value of ≥ 1.8 and ≤ 2 was sought. Unlogical higher values indicate contamination 
with genomic DNA and lower values imply the high amount of contaminants that have absorption 
at λ280 like proteins and/ or phenols. 
3.3.3 Reverse transcription 
3.3.3.1 General reverse transcription 
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Total RNA was revers-transcribed to get complementary DNA (cDNA) for subsequent cloning of 
prenyltransferases. A special RNA-dependant DNA polymerase (RevertAid™ H Minus Reverse 
Transcriptase (RT; 2.5.1) was used. In reverse transcription, the use of an oligo (dT) primer 
directed to the polyadenylated sequence at the 3' end of each mRNA molecule, specifically 
transcribing the mRNA from the total RNA. The synthesized cDNA was used to search for new 
prenyltransferase (PT) fragments using degenerate primers as well as cloning of complete PT 
genes. This process was done as reported by the manufacturer. Initially, the reaction components 
with RNA were pipetted together (Table 5). For initial denaturation of secondary structures, RNA 
was heated briefly and after a short incubation on ice added to Master Mix (MM). Finally, the 
reaction was stopped completely by heat inactivation of the RT. The obtained cDNA utilized as a 
template for PCR (3.3.5) or stored at -20 °C until use. 
Table 5: Standard reverse transcription protocol. 
Step Components Volume 
 Template RNA 3-7 µl * 
 Oligo(dT)-Primer (10 µM) 1 µl 
 dH2O ad 12.5 µl 
Denaturation 65 °C for 5 min 
 Put on ice for 5 min 
 5x Reaction buffer 4 µl 
 RiboLock™ RNase Inhibitor 0.5 µl 
 dNTP-Mix (each 10 mM) 2 µl 
 RevertAid™ H Minus Reverse Transcriptase 1 µl 
 Total volume 20 µl 
Reverse transcription 42 °C for 90 min 
Heat deactivation 70 °C 10 min 
* correspond to 1- 2 µg 
3.3.3.2 Reverse transcription for SMART RACE suitable cDNA 
For the identification of unknown 3' and 5' ends of genes and for the two-sided extension of 
incomplete cDNA fragments to the untranslated region (3'-UTR / 5'-UTR) finds Clontech's 
SMART™ RACE cDNA Amplification Kit a good use (Chenchik et al., 1998). In the reverse 
transcription of this RACE application (rapid amplification of cDNA ends), the cDNA strand was 
simultaneously supplemented by a known anchor sequence at the 3' or 5' end during the synthesis, 
which allowed, in a subsequent RACE-PCR, the amplification of unknown cDNA sequences 
between known middle fragment and the respective anchor sequence. 
The 3'-RACE was accomplished as described under 3.3.3.1. An oligo (dT) primer with an 
additional known sequence at its 5 'end (3'-RACE CDS primer A; 2.4.6) was used, After attaching 
the primer to the complementary poly (A) tail of the mRNA, the 3' end of the newly synthesized 
cDNA strand can be amplified. 
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Specific reverse transcription for the 5' extension (5'-RACE) is required, in addition to a gene-
specific or an oligo (dT) -Primers (5'-RACE primer A; 2.4.6), a special reverse transcriptase with 
built-in terminal transferase activity (SMARTScribe ™ RT). After reading and reaching the 5' end 
of the mRNA template, it adds 3- 5 cytosine moieties to the 3' end of the newly synthesized cDNA 
strand. Thus, allowing the SMART II™ A oligo to complement the introduced cytosine, which 
known as template switching, thus allow the oligo to serve as a template for the SMARTScribe™ 
RT. The RT recognized this single-stranded overhang, changed the template of mRNA on the 
SMART II™ A oligo, hence introducing the anchor into the RACE-ready cDNA. The SMART™ 
RACE cDNA Amplification Kit was used according to the manufacturer's instructions. Pipetting 
scheme and thermocycler program steps are listed in Table 6. 
Table 6: 5`- RACE reverse transcription’s protocol. 
Step Components Volume 
 Template RNA 2.75 µl 
 5‘-CDS Primer A (10 µM) 1 µl 
Denaturation 72 °C for 3 min 
 42 °C for 2 min 
 5x Reaction buffer 2 µl 
 DTT (20 mM) 1 µl 
 dNTP-Mix (each 10 mM) 1 µl 
 SMARTer II™ A Oligo (12 µM) 1 µl 
 RiboLock™ RNase Inhibitor (40 U/ µl) 0.25 µl 
 SMART Scribe™ RT (100 U/µl) 1 µl 
 Total volume 10 µl 
Reverse transcription 42 °C for 90 min 
Heat deactivation 70 °C 10 min 
 
3.3.4 Primer design 
Several points should be taken into consideration while designing primers to bind specifically to 
the desired gene or fragment and yield a good amount of it. 
1. Primer length: should be between 18-24 nucleotides 
2. GC content: a GC content between 40- 60% is ideal. Long stretches of guanine or cytosine 
bases should be avoided to prevent mispriming and it is better to end the primer with G or 
C. This clamp allows to anchor the primer on its template for efficient priming. 
3. Melting temperature of the primer: Tm ranges between 55 °C and 65 °C would be sufficient 
for most of the templates. Ideally, the difference between forward and reverse primers 
should not be more than 2 °C. A primer with rather higher Tm is needed when the template 
is a mix of DNA or cDNA.  
4. It is advisable to prevent complementarity within a primer to avoid hairpin formation or 
between forward and reverse primers to hamper the development of primer dimers which 
affect the yield of the desired band. This could be checked using the oligo cal. online tool 
http://biotools.nubic.northwestern.edu/OligoCalc.html  
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5.  Sequence homology to other parts of the template should be as minimal as possible to 
avoid amplification of undesired regions of the template. 
6. A restriction site at 5′-end of the primer is added when the next step was restriction 
digestion for subsequent cloning. In this case, 3 more nucleotides are added before the 
restriction site to help the enzyme cut the linear amplified DNA. The introduced 
nucleotides (anchor sequence and the restriction site) should not be considered while 
calculating the melting temperature of the primer. 
7. By designing a reverse primer the reverse complementary sequence of the template is taken 
into consideration. 
Uracil-containing primers that are compatible with USER cloning technique (2.4.5) were 
generated by the introduction of a tail of 8 nucleotides, present in the PacI cassette inserted into 
pCAMBIA2300-35S, to their specific PT sequence. The sequence GGCTTAAU was added to the 
forward primer to have the arrangement 5′-GGCTTAAU+ target PT-specific sequence-3′, the 
reverse primer is 5′-GGTTTAAU+ target PT-specific reverse complementary sequence-3′.  
Reverse primers for amplifying PTs were inserted into C-terminal fusion vectors, where the YFP 
is in frame with PT, were designed by replacing the stop codon with non-stop codon triplet (false 
stop codon). Two cytidine residues were also introduced to compensate frame shift to result in a 
primer with the structure 5′-GGTTTAAU+cc+ false stop codon+ reverse complementary upstream 
sequence of stop codon-3′. Truncated PTs, lacking the transit peptide, were amplified using a 
forward primer that inserts an artificial start codon before the TP-downstream sequence to result 
in a primer that has the arrangement 5′-GGCTTAAU+ artificial ATG+ downstream sequence of 
TP-3′. The primer design for amplifying the reverse primer depends whether the YFP was fused 
before the N-terminal or after the C-terminal of the introduced truncated PT. 
3.3.5 Polymerase Chain Reaction (PCR) 
Kary Mullis was awarded the Nobel Prize for Chemistry in 1993 for inventing the polymerase 
chain reaction (PCR). This technique is applied to obtain a high copy number of the template DNA 
through an exponential amplification of a desired target of the template by means of an enzyme 
called DNA polymerase, where the newly formed DNA is used as a template for the next 
amplification cycle, from which comes the name chain reaction (Mullis, 1994). The enzyme adds 
nucleotides to the 3′ end of a primer that anneals specifically to the DNA template. Thus the 
components of a PCR are DNA template, a pair of primers that are hybridized in opposite 
directions, a mixture of deoxynucleotide triphosphates (dNTPs) and a DNA polymerase.  
The reaction is completed in 3 stages: 
1. Denaturation: the separation of the DNA double strands to produce single-stranded DNA 
by heating the DNA for 30 s at 95–98 °C to disrupt the hydrogen bonds between the 
complementary bases. 
2.  Annealing: allowing the primers anneal to their target at the template via dropping off the 
temperature to 45–70 °C.  Usually, the annealing temperature (Ta) used is 3–5 °C below 
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the Tm of the primers, to prevent non-specific annealing to other template DNA molecules 
present in the reaction mixture. 
3. Extension: this step is carried out at 72 °C, the best temperature for DNA polymerase 
activity. The duration of this step depends on the length of the amplified fragment and the 
speed by which the enzyme adds nucleotides to the newly synthesized strand. Roughly it 
should be 1 min for each 1 kDa. 
This three-stage amplification can be repeated within a single PCR. Providing sufficient supply 
of all required synthesis components, 25- 35 cycles could be done, thus generating large 
amounts of DNA in a short time. Various PCR applications differ by the temperature programs 
used, additives and by the DNA polymerases used. The PCR product is analyzed by agarose 
gel electrophoresis (3.3.6) and could be separated as previously described (3.3.1.4) 
3.3.5.1 Standard PCR 
This PCR approach was used during the course of this work for amplification of PT fragments, to 
check the presence of expected inserts in the ligation constructs and RACE amplicons. For this 
PCR Taq-polymerase served as DNA polymerase. The reaction runs as described in Table 7. 
Table 7: Standard PCR components and thermocycler steps. 
Step no. Function Components Volume 
  Template DNA (250- 500 ng) 1 µl 
  For. Primer (10 µmol) 1 µl 
  Rev. Primer (10 µmol) 1 µl 
  dH2O 12 µl 
1 Pre-heating 95 °C then pause 
2 Initial denaturation 95 °C for 180 sec 
3 Adding the second reaction mix  72 °C then pause 
  10x Reaction buffer 2.5 µl 
  dNTP-Mix (each 10 mM) 1 µl 
  dH2O 6.25 µl 
  Taq-polymarase (1.25 U/µl) 0.25 µl 
  Total volume 25 µl 
4 Denaturation 95°C for 30 sec 
5 Annealing Ta °C for  30 sec 
6 Extension Go to step 4, 34 x 72 °C for 150 sec  
7 Final extension 72 °C for 600 sec 
8 Storage 12 °C then pause 
 
3.3.5.2 High-fidelity DNA polymerases PCR  
In this type of PCR, a polymerase with exonuclease activity is used, which is able to excise an 
inserted mismatched nucleotide. Consequently, the fidelity of replication is assured and the 
resulting products have always blunt ends. Phusion Hot Start II DNA Polymerase was used for 
this PCR. Proofreading PCRs were applied when absolutely correct DNA sequences are required 
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such as cloning of genes into expression vectors. Reaction components and thermocycler program 
steps are demonstrated in Table 8 and Table 9 respectively. 
Table 8: proofreading PCR components. 
Components Volume 
Template DNA (1- 10 ng) 1 µl 
For. Primer (10 µmol/µl) 1.25 µl 
Rev. Primer (10 µmol/µl) 1.25 µl 
5x Reaction buffer 5 µl 
dNTP-Mix (each 10 mM) 0.5 µl 
Phusion Hot Start II DNA Polymerase (2/µl) 0.5 µl 
dH2O ad 25 µl 
 
Table 9: cycling program of proofreading PCR. 
Step Function   Temperature  Time (sec) Cycles Go to step 
1 Lid and pre-heating 98 °C Pause   
2 Initial denaturation  98 °C  30    
3 Denaturation  98 °C  10   
4 Annealing  Tm* + 3 °C  30   
5 Extension  72 °C  150 34 3 
6 Final extension  72 °C  600    
7 Storage  12 °C  Pause   
* Lower Tm of the primer pair 
3.3.5.3 Touchdown PCR 
The reaction ingredients of this PCR type are the same as standard PCR. However, the main 
difference is in the cycling program (Table 10). Touchdown PCR was applied to enhance the 
efficacy and specificity of amplification through stepwise coverage of a wider range of annealing 
temperatures. Here, during the first phase of cycling the chosen Ta is equal or 2 °C below the lower 
Tm of the primers followed by 10 cycles each with 0.5 °C decrease in the Ta to enrich the target 
DNA. 
Table 10: Thermocycler program for touchdown PCR. 
Step Function Temperature  Time (sec) ∆ T Cycles Go to step 
1 Lid and pre-heating 95 °C Pause    
2 Initial denaturation 95 °C  180     
3 Denaturation 95°C 30    
4 Annealing Tm -2 °C  30 − 0.5 °C   
5 Extension 72 °C 150  9 3 
6 Denaturation 95 °C  10 s    
7 Annealing Tm -7 °C  30 s     
8 Extension 72 °C  150  34 6 
9 Final extension 72 °C  600     
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10 Storage 12 °C  Pause    
 
3.3.6 Agarose gel electrophoresis  
It was used for the analysis and separation of PCR or digestion products. Electrophoresis is mainly 
a sieving process where DNA fragments are separated according to their sizes in a cross-linked 
agarose matrix by applying an electric field across the gel matrix. DNA molecules migrate along 
the gel matrix to the positive pole as a result of having negatively charged phosphate groups in the 
DNA backbone. A linear relation exists between the logarithm of the fragment size and its relative 
migration distance through the gel. A typical agarose gel is 1% which is suitable for DNA fragment 
sizes range 0.2- 20 Kb but the concentration can be modified for some purposes. A lower or higher 
concentration of 0.5 % or 2% were used to increase the resolution efficiency for better detection 
of large and small fragments (≈ 500 bp) respectively. 
For the preparation of standard 1% agarose gel, 800 mg of agarose was boiled with 80 ml of 1X 
TAE buffer (2.8.6) till complete dissolution of agarose powder. The gel is cooled out to about 60 
°C then 3 µl Midori Green were added and comprehensively mixed with gel solution, the mixture 
is added to suitable gel tray and a comb is applied to it. After solidification of the gel, the comb is 
removed and the tray is transferred to the gel chamber. A mixture of the samples to be analyzed 
with the loading dye (2.8.6) is loaded in the gel wells. The gel was run in TAE buffer for 30–35 
min at 120 V and 400 mA. To identify the size of analyzed DNA fragments 5 µl of DNA ladder 
were loaded into one of the wells. When the run is completed the gel was visualized with a UV-
equipped transilluminator. When needed a gel band was cut and the DNA entrapped inside it was 
purified as described under 3.3.1.4). 
In addition, agarose gel electrophoresis was utilized to control the purity and integrity of RNA. In 
this respect, the gel was prepared as described above and the RNA sample is mixed carefully with 
RNase inhibitor in addition to the loading buffer.  
3.3.7 RACE 
DNA sequences that lack the information at 5′- or 3′- ends can be elongated by applying RACE 
techniques to get the full-length sequence (Frohman et al., 1988). For the preparation of RACE 
suitable cDNA during reverse transcription, a known anchor sequence synthesized and fused 
behind the unknown end of the cDNA strand (3.3.3.2). Special RACE primers are added to the 
reaction, which can anneal specifically to the anchor sequences introduced to cDNA ends. In 
addition, a gene-specific primer (GSP) was added to the reaction that was derived from the known 
middle fragment to obtain the unknown sequence lying between the GSP and the anchor sequence. 
In case of 5′-RACE the GSP is designed as a reverse primer and 5′-RACE ready cDNA is 
employed as a template, while in 3′-RACE it would be a forward primer and 3′-RACE ready cDNA 
served as a template. 
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Practically, the cDNA template was used to extend the target CDS either in the direction of the 3′ 
or the 5′ end (3′-RACE PCR / 5′- RACE PCR) in separate PCRs. The RACE long primer used in 
the first PCR (2.4.2) lengthened the anchor sequence in the DNA synthesis towards a GSP. This 
PCR product served as a template for a second RACE PCR in which a primer, whose sequence is 
complementary to the extended anchor sequence of RACE long, called RACE short primer (2.4.2) 
is applied. RACE short was combined with a more downstream GSP within the known CDS 
sequence from the first PCR at the respective desired end. In this way, both the yield and the 
specificity of RACE-PCR products was greatly enhanced. However, the RACE technique was 
combined with standard, proofreading or touchdown PCR applications to identify the missing CDS 
ends. 
3.3.8 Sequencing 
The DNA sequences of purified plasmids and/or DNA constructs were controlled on behalf of the 
companies Eurofins MWG Operon or Source Bioscience Sequencing. The concentration of the 
samples was adjusted with dH2O to nearly 100 ng/μl according to the requirements of the service 
providers and, if required, premixed with the sequencing primers matching the respective plasmid. 
Sequencing results were bio-informatically analyzed using Lasergene - DNAStar 7.0 (2.10.1).  
3.3.9 Construction of sequencing and expression plasmids 
3.3.9.1 pJET 1.2 cloning 
All identified prenyltransferases, their middle fragments, and RACE products were ligated into the 
vector pJET1.2/blunt (CloneJET PCR Cloning Kit; 2.6) for the purpose of sequencing. This linear 
cloning vector benefits from an interesting selection mechanism based on the existence of a lethal 
gene which is disrupted by insertion of DNA molecule into the vector’s cloning site. Therefore, 
only cells containing the recombinant plasmids can survive and proliferate which cancels the need 
for blue/white screening. 
After manufacturing instruction, the kit can be used for ligating blunt-end proofread PCR products 
directly using blunt-end ligation protocol (Table 11) or 3′-dA overhang-bearing Taq-polymerase 
PCR products through doing an initial blunting step employing the supplied blunting enzyme that 
possesses an exonuclease activity (Table 12). Ligation mixture can be used immediately for 
transformation or stored at -20°C. 
Table 11: pJET 1.2 blunt-end ligation protocol. 
Function Component  Volume 
 2X Reaction Buffer  5  µl 
 purified blunt-end DNA fragment 1  µl * 
 pJET1.2/blunt Cloning Vector (50 ng/µl)  0.5 µl 
 T4 DNA Ligase  0.5 µl 
 dH2O ad 10 µl 
 Total volume  10 µl 
Ligation Incubate at 22°C for 10 min 
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Table 12: pJET 1.2 Sticky-end ligation protocol. 
Function Component  Volume 
 2X Reaction Buffer  5 µl 
 purified PCR product with sticky-ends 1 µl * 
 DNA blunting Enzyme  0.5 µl 
 dH2O 2.5 µl 
 Total volume  9 µl 
Blunting Incubate 70 °C for 5 min, then Chill on ice 
 pJET1.2/blunt Cloning Vector (50 ng/µL)  0.5 µl 
 T4 DNA Ligase  0.5 µl 
 Total volume  10 µl 
Ligation Incubate at 22 °C for 10 min 
 * Containing 50- 150 ng 
3.3.9.2 Cloning of expression vectors 
3.3.9.2.1 Restriction digestion 
Restriction endonucleases of type II that recognize a palindromic nucleotide sequence (usually 4- 
8 bases, known as restriction site) were used. Type II restriction Enzymes cut within or near their 
restriction sites generating sticky or blunt ends suitable for subsequent ligation with the vector 
when it is cut by means of the same enzymes. During the course of this work, only sticky end 
ligation was used to insert a gene into an expression vector (2.3). The restriction sites introduced 
to the primers during the designing process were chosen so that they are absent from the insert 
DNA but present in multiple cloning sites of the utilized vector. 
For each ligation procedure, two restriction digestion reactions were needed. These reactions could 
be done separately according to the instruction provided with each enzyme, where the products of 
the first digestion process were purified and re-digested with the second enzyme or, when possible, 
a double-digestion process using both enzymes simultaneously according to the instructions of 
Thermos Fischer DoubleDigest Calculator (2.10.2). Digestion was also used to check the presence 
of some inserts after ligation and transformation and the digestion reactions were visualized with 
agarose gel electrophoresis. The vector and insert digestions were incubated for 3 h at 37 °C, while 
plasmid digestion was incubated for 1 h at 37 °C. 
Table 13: Single digestion reaction components. 
Component Insert Vector Plasmid 
10x Reaction buffer  1 µl 2 µl 1  
DNA  ad 10  µl ad 20 µl 2 µl 
Restriction enzym (10 U/µl)  0.5  µl 1 µl 0.5 µl 
dH2O  -   -  ad 10 µl 
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Table 14: Double digestion reaction components. 
Component  Inserts Vectors Plasmids 
DNA solution  ad 10.0  µl  ad  20.0  µl  2.0  µl 
10X buffer  1.0  µl  2.0  µl  2.0  µl 
1st restriction enzyme 0.5–1.0  µl  0.5–1.0  µl  0.5–1.0  µl 
2nd restriction enzyme 0.5–2.0  µl  0.5–2.0  µl  0.5–2.0  µl 
dH2O  -   -  ad 20.0 µl 
 
3.3.9.2.2 Dephosphorylation of the digested vectors 
To minimize the possibility of re-circularization of the linearized vector after digestion during the 
ligation process through removing 5′ terminal phosphates.  The vector sticky ends can ligate 
together again (self-ligation) instead of ligating to the sticky ends of the insert and result in an 
empty vector which could be transformed to the host competent cells like any positive plasmid and 
this will be detected only after plasmid isolation. FastAP Alkaline Phosphatase (2.5.4) was used 
for the dephosphorylation of the digested vectors. The reaction was incubated for 12 min at 37 °C 
followed by heat-inactivation of the enzyme for 5 min at 75 °C. The dephosphorylated product 
was purified as described under 3.3.1.5 to get rid of salts and proteins in the reaction mixture.  
Table 15: Dephosphorylation reaction components. 
Component  Volume 
Digested vector  5-17  µl 
10X reaction buffer for AP  2  µl 
FastAP Alkaline Phosphatase  1 µl 
dH2O  ad  20  µl 
 
3.3.9.2.3 Ligation 
By means of this molecular biology tool, the free ends of DNA fragments can be connected 
together via the formation of a phosphodiester bond between a 5′ phosphate group in one fragment 
and a 3′ hydroxyl group in the other. Ligation was used during the course of this work to insert PT 
fragments, full-length genes via blunt-end ligation into sequencing vector (pJet 1.2, 2.3) or by 
sticky-end ligation to incorporate full genes into expression vectors (pESC-URA and pFastBac-
1). T4 DNA ligase, which is dependent on the presence of ATP and Mg2+ as cofactors are used to 
catalyze the reaction. This enzyme is suitable for blunt or sticky end ligations. Optionally 50 % 
PEG 4000 as an enhancer can be added. Ideally, the insert: vector ratio should be 3: 1. During the 
course of the work, work ratios between 2: 1 and 5: 1 were used. Ligation reaction mixture (Table 
16) was incubated at 4 °C overnight. 
Table 16: Ligation reaction components. 
Component  Volume 
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Insert DNA  6.5  µl 
Linearized vector DNA  2  µl 
10X T4 DNA ligase buffer  1  µl 
T4 DNA ligase  0.5  µl 
50 % PEG 4000 (optional)  1  µl 
 
3.3.9.3 USER cloning 
USERTM stands for uracil-specific excision reagent. This special type of ligation-free cloning was 
used to build constructs for subsequent transformation of Agrobacterium tumefaciens as a step of 
the subcellular localization sequence procedure for xanthone-related prenyltransferases (4.6.1.2). 
The linearized pCAMBIA2300-35S vector that harbors a yellow fluorescent protein (YFP) either 
at C- or N- terminus of the predicted gene to be inserted was kindly provided by our former 
colleague Dr. Elina Biedermann (AG Prof. Dr. Ute Wittstock; IPB-TU Braunschweig). Briefly, 
the vector was linearized by a two-step prolonged digestion first with PacI then with the nicking 
enzyme Nt.BbvCl (2.5.3; Table 17). PTs to be inserted, were amplified from yeast expression 
vectors by means of specific uracil-containing primers (2.4.5) in a proof-reading PCR.  
Purified linearized vector and uracil-containing PTs were mixed with USER enzyme mix (Nour-
Eldin et al., 2006). USER cloning reaction components and protocol are described in Table 18. 
The whole reaction was finally transformed to competent E.coli as a preliminary step for 
transformation in Agrobacterium tumefaciens. 
Table 17: Digestion protocol of pCAMBIA2300-35S vector. 
Function Component  Volume 
 pCAMBIA2300-35S 1.3 µg 
 PacI 1 µl 
 10x cut Smart buffer 5 µl 
 H2O ad 50 µl 
 Total volume 50 µl 
1st digestion 37°C for at least 18 h 
 10x cut Smart buffer 0.5 µl 
 PacI 0.5 µl 
 Nt.BbvCl 0.5 µl 
 H2O 3 µl 
2nd digestion 37°C for 2 h 
 
Table 18: USER reaction protocol. 
Component  Volume 
pCAMBIA2300-35S 2 µl 
Uracil-containing PT 8- 10 µl 
USER enzyme mix 1 µl 
Total volume 11- 13 µl 
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37 °C for 20 min 
25 °C for 20 min 
 
3.3.10 Construction of prenyltransferases phylogenetic tree 
An evolutionary tree was constructed using protein sequences of plant aromatic prenyltransferases 
and a soluble fungal aromatic prenyltransferase that lacks the aspartate conserved motifs AtaPT 
(Zhou et al., 2017) was used as an out-grouping to root the tree. Accession numbers are listed in 
the appendix (8.1), and sequences were aligned using the Clawstal W method in BioEdit software. 
The alignment output file positioned in MEGA 7 (Kumar et al., 2016) and an initial tree was 
constructed by a neighbor-joining method which was used then as a base for a final tree built up 
by Maximum-likelihood algorithm (ML). Poisson correction mode (Zuckerkandl and Pauling, 
1965) was used to calculate amino acid differences with partial deletion arrangement for the 
adjustment of gaps. Replicates of 1000 bootstrap are estimated for the reliability of the constructed 
tree. 
3.4 Microbiological Methods 
3.4.1 Determination of microbial count 
One ml of bacterial or yeast culture was used for photometric determination of E.coli or S. 
cerevisiae microbial count by virtue of measuring the optical density at 600 nm using a 
spectrophotometer against 1 ml of fresh media as blank. 0.1 OD600 corresponds to 1 × 10
8 cells/ml 
of bacteria or  3 × 106 cells/ml of yeast (Lech and Brent, 2001; Treco and Winston, 2001) 
3.4.2 Preparation of competent cells 
3.4.2.1 Preparation of competent E. coli cells 
Chemically competent DH5α E. coli (2.1.2.1) cells were prepared by calcium chloride method 
described by Mandel and Higa (1970).  A single colony of the bacteria was incubated overnight 
with shaking at 220 rpm in 5 ml LB medium. One ml from the pre-culture was used as an inoculum 
for 50 ml LB medium until an OD600 of 0.2- 0.3 was reached. Th 
e culture was grown again to obtain an OD600 of 0.7. Bacterial cells were then harvested from the 
medium by centrifugation at 8.000 rpm at 4 °C for 10 min. After discarding the supernatant, 
bacterial pellet was resuspended in 50 ml 50 mM ice-cold CaCl2 solution and centrifuged again 
under the same conditions. Again, the pellet was suspended in 20 ml 50 mM CaCl2 solution and 
directly incubated in ice for 20 min. The incubate was centrifuged again and the pellet was 
separated, suspended in 860 μl 50 mM CaCl2 solution, and kept on ice for another 15 min. Finally, 
140 μl sterile glycerin was mixed with the suspension and the mixture was divided into 50 μl 
aliquots. The aliquots were stored at -80 °C until used for transformation.   
3.4.2.2 Preparation of competent Saccharomyces cerevisiae cells 
S.c. EasyComp Transformation Kit (Invitrogen) which make use of lithium acetate method 
illustrated in (Dohmen et al., 1991; Becker and Lundblad, 2001). One yeast colony grown on 
selective medium was picked, used to inoculate 10 ml YPD medium (2.7.3), and incubated at 30 
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°C and 250 rpm for about ≈ 26 h. when the OD600 reached 2.6–5.0 about 600 μl of the starter culture 
were added to 10 ml fresh YPD medium until an OD600 of 0.2–0.4 was reached. The YPD culture 
was allowed to grow for about 6 h. by reaching an OD600 of 0.6–1.0 the culture was centrifuged 
for 5 min at 1500 rpm and the cells were collected. Cells were resuspended in 10 ml of Solution I 
(provided with the kit), centrifuged and the supernatant was discarded. The pellet was resuspended 
in 1 ml of Solution II (provided with the kit) then divided into 50 μl aliquots, stored at -80 °C. 
3.4.2.3 Preparation of competent Agrobacterium tumefaciens cells 
A. tumefaciens cells were made competent according to a modified protocol after McCormac et al. 
(1998). Ten ml YEP pre-culture (2.7.2) of A. tumefaciens (2.1.2.1) were incubated overnight at 28 
°C under shaking at 220 rpm. The medium was supplemented with the antibiotics rifampicin and 
gentamycin at a concentration of 100 μg/ml each. The complete overnight culture was diluted with 
300 ml of YEP medium (2.7.2) augmented by antibiotics as previous and allowed to grow until 
reaching an OD600 of 0.5- 0.7 under the same conditions. The media was then divided into 6 sterile 
falcon tubes, centrifuged (10 min at 4000 x g) and the pellet was harvested, washed three times 
with 25 ml ice-cooled 10% sterile-filtered glycerin and combined in 2 sterile falcon tubes. After 
centrifugation for 10 min at 5000 x g, pellets were collected and resuspended in 2 ml ice-cooled 
10% sterile-filtered glycerin, again centrifuged and cells were combined together and incubated 
with 10% glycerin at 4 °C for 24 h. in the next day, the suspension was aliquoted and stored at        
-80 °C. 
3.4.3 Transformation of competent cells 
3.4.3.1 Transformation of competent E. coli cells 
The ligation mixture (3.3.9.2.3) was gently mixed with 50 μl aliquot of competent on ice-thawed 
DH5α E. coli cells (3.4.2.1). The mixture was kept on ice for 20 min. Heat shock transformation 
method was carried out by heating the mixture for 45 sec on 42 °C followed by rapid cooling on 
ice for 5 min. The transformation mixture was later incubated in 250 μl of SOC medium for 75 
min at 37 °C and 220 rpm. After incubation, 250 μl were spread on LB plate supplemented with 
ampicillin and incubated at 37 °C overnight. Plasmid isolation for control for the positive insert is 
done as described under (3.3.1.2). 
3.4.3.2 Transformation of competent Saccharomyces cerevisiae cells 
Transformation of competent INVSc1 strain (3.4.2.2) is performed using S.c. EasyComp 
Transformation Kit (Invitrogen). First plasmids were isolated from E.coli and tested for the 
presence of desired inserts (3.3.1.2). A maximum of 5 μl containing 1-5 μg of positive plasmids 
was mixed with a thawed competent cells aliquot. Afterward, 500 μl of solution III was added to 
the mixture and vortexed vigorously. The transformation mixture was incubated in a water bath 
for 90 min at 30 °C with vigorous vortexing at time intervals of 15 minutes. Employing the 
auxotrophic selection, about 200 μl were spread over SD dropout plates that lack the presence of 
the marker.  
1.1.1.1 Transformation of competent Agrobacterium tumefaciens cells 
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Transformation of competent A. tumefaciens (3.4.2.3) was conducted by electroporation in a pre-
cooled electroporation cuvette. The transformation mixture was treated with an electric impulse 
with the conditions (2.5 kV, 400 Ώ, and 25 μF) using MicroPulser (BioRad laboratories GmbH). 
The mixture was mixed afterward with 1 ml antibiotic-free YEP medium then transferred to 10 ml 
of YEP and incubated for 3h at 28 °C and 220 rpm. 50-100 μl were then spread on YEP agar plates 
supplemented with the antibiotics rifampicin, gentamycin and kanamycin at concentrations 100 
μg/ml, 100 μg/ml and 50 μg/ml respectively. Plates were incubated then at 28 °C for 2- 4 days. 
3.4.4 Transfection of Spodoptera frugiperda (Sf9) cells 
3.4.4.1 Production of recombinant Bacmid 
Bac-to-Bac® Baculovirus Expression System (2.6) was used for the cultivation of the recombinant 
bacmid. The first step is the construction of respective PT genes into pFastBac™ 1 (2.3). The 
expression cassette of the donor vector pfastBac is flanked by left and right regions of Tn7 and 
composed of gentamycin resistance gene, AcMNPV polyhedrin promoter, the MCS (including the 
DNA sequence to be expressed) and an SV40 polyadenylation signal to form a miniTn7 (Figure 
14). Purified constructs of each PT into pFastBac were transformed into a special E. coli strain 
called (DH10Bac ™). This bacterial strain harbors baculovirus shuttle vector bacmid carrying a 
mini-attTn7 target site (bacmid bMON14272; 136 kb) and kanamycin resistance gene and the so-
called helper plasmid (pMON7124; 13.2 kb) which encodes for tetracycline resistance enzyme and 
transposition proteins which allow the transposition of gene of interest from pfastBac to bacmid 
(Luckow et al., 1993). After transformation and with the help of helper plasmid, the transposition 
takes place between lacZ-mini-attTn7 and mini-Tn7 transposon to generate a recombinant bacmid. 
Successful transposition disturbs the β-galactosidase gene within the lacZ-mini-attTn7 and the 
colonies appear white using the blue/white selection. 
 
Figure 14: The map of pFastBac™ 1 donor vector. 
Agar plates were incubated at 37 °C for 48 h. A single white bacterial colony is used to inoculate 
5 ml LB medium containing gentamycin, kanamycin, and tetracycline with a concentration of 7 
μg/ml, 50 μg/ml, and 10 μg/ml respectively. Tubes were incubated at 37 °C and 220 rpm for 16-
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24 h overnight. Bacmid can be isolated as described under (3.3.1.2) and used for further work in 
the Bac-Bac system or stored at -20 °C. 
3.4.4.2 Production and amplification of recombinant baculovirus 
One μg of the purified, recombinant bacmid DNA and 8 μl Cellfectin® II reagent (2.6) were 
separately and gently mixed with 100 μl basic medium. Both solutions were combined with 
caution, mixed gently, and allowed to stand at room temperature for 15-30 minutes. A complex 
was being formed between of the anionic bacmid DNA and the cationic lipophilic Cellfectin® II, 
which led to an inclusion in or an adsorption on the existing liposomes. Meanwhile, cultivated Sf9 
cells (2.1.2.2) should be first diluted with the basic medium Sf-900 ™ II SFM (2.7.4) to reach a 
cell density of 4 x 105 cells/ml. Two ml of the diluted culture was transferred to a 6-well culture 
plate and incubated at room temperature for 15 min.  
For the first baculovirus production, the bacmid-liposome mixture was added successively drop 
by drop on the Sf9 cells and afterward incubated at 27 °C for 3-5 hours, so that the liposomes fused 
with the cell membrane of the Sf9 cells by endocytosis and the bacmid DNA was transfected into 
the insect cells. Thereafter, the supernatant bacmid-liposome mixture was removed and replaced 
by 2 ml of Sf9 medium and the whole blend was then incubated at 27 °C for 3-5 days. 
After the onset of the death of the infected Sf9 cells, they were harvested by centrifugation at 4 °C 
and 4000 rpm for 2 min. The baculovirus-containing supernatant served the infection of fresh 100 
ml Sf9 cells having a cell density of 1 × 106 cells/ml, which were cultured in a shaker incubator, 
for the multiplication of baculoviruses, at 27 °C and 140 rpm for 5-7 days. After incubation, If the 
viability of Sf9 cells decreased below 40%, insect cells should be separated from virus by 10 min 
centrifugation at 4 °C and 4000 rpm. The virus-containing supernatant was sterile-filtered through 
a syringe filter with a pore size of 0.22 μm, amplified and used for a new infection-turn employing 
500 ml of fresh Sf9 cells (cell density 1×106 cells/ml) to be infected with 5 ml baculovirus solution, 
incubated as described above, centrifuged off and filter sterilized. Finally, the supernatant was 
used for protein expression in SF9 cells (3.5.1). 
3.4.5 Preparation of stock cultures  
3.4.5.1 E. coli stock cultures 
A single colony of transformed E. coli was inoculated in a 5 ml LB tube supplemented with 10 μl 
of 100 mg/ml ampicillin solution for positive selection of bacterial cells accommodating plasmids 
contain an ampicillin resistance gene. After overnight (16- 18 h) incubation at 37 °C and 200 rpm, 
1.35 ml of the grown culture was mixed with 450 μl of sterile LB- glycerol (40: 60 v/v) in a screw-
capped 2 ml tubes. The prepared tubes were stored at -80 °C. 
3.4.5.2 S. cerevisiae stock cultures 
One colony of transformed S. cerevisiae grown on the selective medium was picked and used to 
inoculate 5 ml of the same selective liquid medium to allow auxotrophic selection of cells 
accommodating desired plasmids. After incubation for 24 h at 30 °C and 220 rpm, 500 μl of the 
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grown culture was mixed with 500 μl of YPD medium and 750 μl of sterile glycerol in a screw-
capped 2 ml tubes. The prepared tubes were stored at -80 °C. 
3.4.5.3 A. tumefaciens stock cultures 
A single colony of transformed A. tumefaciens grown on YEB-agar medium supplemented with 
rifampicin and gentamycin at a concentration of 100 μg/ml each was picked and cultivated in a 5 
ml YEB tube supplemented with the same antibiotics to allow selection. After a 16-18 h overnight 
incubation at 28 °C under shaking of 220 rpm, 1.35 ml of the grown culture was mixed with 450 
μl of YEB- glycerol (40: 60 v/v) in a screw-capped 2 ml tubes. The prepared tubes were stored at 
-80 °C. 
3.5 Biochemical methods 
3.5.1 Protein expression in Insect cells-Baculovirus System 
3.5.1.1 Infection of Sf9 cells and expression of PTs 
A suspension culture of Sf9 cells bearing a cell density of 2×106 cells/ml was pipetted with 10% 
v/v baculovirus supernatant, arising from the amplification turns (3.4.4.2), expression batches were 
incubated in 27 °C and 140 rpm for 72-96 h in a shaking incubator. Based on the viral AcMNPV 
polyhedrin promoter, the introduced recombinant gene was highly expressed in virus replication. 
The heterologously expressed prenyltransferases were eventually extracted including the 
membrane proteins from the Sf9 cells and used for further in-vitro enzyme studies. 
3.5.1.2 Protein extraction from insect cells 
Protein extraction protocol was developed after Ohara et al. (2013). The complete volume of the 
culture was transferred to sterile falcon tubes and insect cells were harvested via centrifugation 4 
°C and 6000 rpm for 6 min. after discarding the culture, the pellet was gently resuspended by 
pipetting in 5 ml sonication buffer (2.8.4). The tube containing the suspension was placed in an 
ice-filled beaker and the cells were disrupted three times each 1 min (with 30-sec pause in-
between)  by means of an ultrasound Sonifier (2.9.1) with the settings (Duty Cycle = 20 and Output 
Control = 1.5). Aliquots of intact and broken cells were stained with Trypan blue solution 
controlled microscopically to ensure the disruption of the cells for efficient extraction. Cells 
residue were removed by centrifugation at 4 °C and 5.000 rpm for 5 min. The crude protein extract 
(supernatant) was then ultra-centrifuged in pre-cooled ultracentrifuge using ultracentrifugation-
suitable tubes (the volume of the supernatant was adjusted by adding sonication buffer) at 4 °C 
and 100000 x g for 80 min. After pouring off the supernatant, 2 ml of ice-cold buffer A (2.8.4) 
were added to the residue, and the pellet was carefully resuspended on ice by slow successive 
drawing up and draining using a syringe. The obtained microsomal protein fraction was quantified 
(3.5.4) and either used directly for activity testing (3.5.5) or stored at -80 °C. 
3.5.2 Protein expression in Yeast cells 
3.5.2.1 Induction of protein expression in yeast cells 
The induction of heterologous protein expression in INVSc1 yeast cells was carried out according 
to Pompon et al. (1996). A single colony of the transformed S. cerevisiae (3.4.3.2) grown on SGI-
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agar medium was picked and cultivated in liquid SGI at 30 °C and 220 rpm for 24 h. 1.5 ml of it 
was used to inoculate 150 ml of YPGE medium (2.7.3) and incubated at 30 °C and 220 rpm for ≈ 
26 h. When an OD600 of ≈ 1.6 is reached, which means the consumption of entire glucose in the 
media, induction of protein expression was initiated by adding 16.7 ml of 20% sterile-filtered 
galactose solution to the culture to obtain a final concentration of 2% galactose. Additionally, the 
absence of glucose was ensured also tested by COMPINA 11 S strips (2.6). The cells were further 
cultivated at 30 °C and 220 rpm for 14- 16 h. 
3.5.2.2 Protein extraction from Yeast 
The culture was transferred to 50 ml falcon tube and the cells were harvested by centrifugation at 
5000 rpm for 5 min then resuspended in 10 ml TEK buffer (2.8.5), transferred to 15 ml falcon tube 
and centrifuged again under the same conditions. Pellet was again resuspended in 5 ml TEK buffer 
by vortexing and kept at room temperature subsequently centrifuged and the supernatant was 
discarded. The obtained pellet was resuspended by vortexing in 3 ml of TES buffer, mixed with 3 
g of 0.45-mm acid-washed glass beads, and shaken using vortex shaker (Vortex Genie 2 Digital 
equipped with the Si-H512 Horizontal 15 ml tube holder) at 4 °C for 20 min to mechanically break 
the yeast cells. The suspension including the glass beads was centrifuged (5000 rpm for 5 min at 
4 °C). The resulted supernatant was transferred to a new falcon tube and kept on ice. Pellets 
(broken cells + glass beads) were resuspended again in 3 ml of TES buffer and the entire process 
of mechanical breaking was repeated twice. Supernatants were combined together to obtain the 
crude protein extract. Crude protein extract was ultra-centrifuged as described before (3.5.1.2) and 
the precipitated microsomal fraction was suspended in buffer A (2.8.4) instead of TEG buffer 
mentioned in the original protocol (Pompon et al., 1996) as TEG buffer contains EDTA which 
may negatively affect the subsequent activity testing (3.5.5) through chelating the divalent cation 
added to the assay.  
3.5.3 Transient expression in Nicotiana benthamiana 
This transient expression technique was used to study the subcellular localization of the xanthone-
related HsPTs. Transformed Agrobacteria (1.1.1.1) were grown on YEP-agar medium (2.7.2) at 
28 °C. One colony was selected and incubated overnight with 10 ml YEP medium provided with 
100 µg/l Rifampicin, 50 µg/L kanamycin and 100 µg/L gentamycin at 28 °C and 220 rpm for ≈ 
30 h. In the next day, cultures were centrifuged at room temperature and 4000x g for 15 min and 
the cells were suspended in activation medium (2.7.2) (Gehl et al., 2009) till OD600 reaches 1. 
Likely, helper A. tumefaciens bearing K19 gene were grown and mixed with activation medium 
till the OD600= 0.6. Cultures carrying fusion constructs of HsPTs were mixed 1:1 with K19-
containing cultures to enhance the transformation efficiency (Pan et al., 2018). After incubation 
for 2 h at 28 °C and 100 rpm, this mix was then co-infiltrated to the lower surface of 6-8 weeks 
old N. benthamiana leaves grown in soil in a climate chamber (24 °C, 65% humidity, 12 h light 
intensity) using 2 ml needleless syringe. For a maximum of 3 leaves per plant were infiltrated with 
suspension mix. A. tumefaciens harboring the localization cytoplasmic control (modified DSred 
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gene) treated equally and infiltrated as well. Three days after infiltration leaf discs were cut and 
visualized under LASER-scanning microscope (3.7). 
 
Figure 15: Schematic diagram for the transient expression of fusion constructs in Nicotiana 
benthamiana leaves. 
3.5.4 Determination of protein concentration 
The quantification of proteins was done as described by Bradford (1976), when the dye Coomassie 
Brilliant Blue G-250 binds to the protein, shifted its absorption maximum from 465 to 595 nm. 
The absorption of the protein test solution was measured at 595 nm against blank to cancel the 
effect of salts and pH on the test quality. Both test and blank solutions are blended separately and 
incubated for 5 min at room temperature. Test and blank solutions’ components are demonstrated 
in Table 19. 
Table 19: Bradford's reaction components for determination of protein concentration. 
Test solution  Blank 
Component  Volume  Component  Volume 
Protein suspension (dissolved 
in buffer A) 
2- 5 μl  - 
Buffer A ad 100 μl  Buffer A 100 μl 
Bradford solution 900 μl  Bradford solution 900 μl 
Total volume 1000 μl  Total volume 1000 μl 
 
An important factor for the determination of protein concentration by this method is the factor of 
Bradford’ solution which is the slope of the calibration curve by plotting absorbance (Y-axis) of 
the different known concentration of BSA (1- 10 µg/ml) against the amount of BSA in μg (X-
axis). The following formula was used to calculate microsomal protein concentration: 
YFP+
Fusion construct
Agrobacterium  tumefaciens
pCAMBIA 2300
Nicotiana benthamiana
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𝐶 =
𝐴595
𝐹𝐵 𝑥 𝑉
 
Where, 
C is the calculated concentration of protein in μg/μl 
A595 is the absorbance of the test solution at λ=595 nm normalized by blank solution 
V is the volume of the protein solution used for measuring in μl 
FB is the factor of Bradford solution 
 
3.5.5 Enzymatic assays 
3.5.5.1 Standard PT in vitro enzymatic assay  
For the determination of prenyltransferase activity of all recombinant proteins, a standard 250 µl 
enzymatic incubation was applied. The aromatic substrate (prenyl acceptor) was mixed with an 
equimolar concentration of the prenyl donor (DMAPP or GPP) in the presence of MgCl2 as a co-
factor. The final reaction volume was adjusted by the calculated volume of water and the reaction 
was initiated by the addition of 100 µg microsomal fraction. Reaction components and their exact 
concentrations are illustrated in Table 20. The reaction was performed in a shaker incubator for 90 
min at 35 °C with gentle mixing at 60 rpm, modified after Ohara et al. (2013). After incubation, 
the reaction was stopped via the addition of 35 µl 2N HCl, extracted twice with 350 µl ethyl 
acetate. The combined organic extracts were air-dried, dissolved in 80 µl methanol (HPLC grade) 
and analyzed by HPLC (3.6.1). 
Table 20: Standard PT in vitro enzymatic assay components. 
Component  Volume Final concentration 
Aromatic substrate (10 mM) 5 μl 0.2  mM 
Prenyl donor (50 mM) 1 μl  0.2  mM 
MgCl2 (100 mM) 15 μl 6  mM 
Tris-HCL pH 7 (1 M) 25 μl 0.1 M 
100 µg protein x μl 0.4 mg/ml 
H2O ad 250 μl - 
Total volume 250 μl   
 
3.5.5.2 Characterization of prenyltransferase activity 
The optimum assay conditions for enzymatic reactions catalyzed by active recombinant PTs were 
investigated. In this respect, each reaction parameter was individually changed and the influence 
of the modification on the activity of the enzyme was investigated as follows: 
1. pH optima of the reaction: the pH was analyzed over a pH range of 6-10 in 0.5 pH unit 
increments with mainly 2 buffer systems to cover a wide pH span, namely K3PO4 (pH 
range 5- 8) and TRIS-HCl (pH range 7- 11) 
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2. Reaction time: the reaction was inspected at different time points ranging from 2 to 180 
minutes and tested against zero time control. 
3. Protein amount: A range of 5- 500 μg membrane protein/assay was investigated to select 
the optimum amount to be used while determining kinetic parameters of each active PT. 
4. Incubation temperature:  temperature spans from 20 °C to 50 °C with 5 °C intervals were 
tested. 
5. Co-factor: different divalent cations were used (Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Zn2+). 
After the determination of the optimum reaction parameters of each enzymatic reaction, the kinetic 
parameters for each enzyme with the respective accepted aromatic substrate or preyl donor were 
explored. To achieve this aim, different concentrations of each accepted substrate (2.5- 1000 μM) 
were tested considering the optimum reaction conditions. 
3.6 Analytical methods 
3.6.1 High-performance liquid chromatography (HPLC) 
The analysis of all enzymatic assays was done by HPLC (Agilent 1260 Infinity Quaternary LC 
System; Agilent Technologies, Santa Clara, CA, USA) supplied with a diode array detector (DAD; 
G4212A) and a column (XBridge BEH C18 Column, 3.5 µm, 4.6 mm X 100 mm). The liquid 
system consisted of double distilled acidified water (A; 1 mM formic acid) and methanol (B). For 
optimum separation of enzymatic reaction components, different gradients of water/ methanol 
were used based on the nature of prenyl acceptor used. By analyzing enzymatic products using 
xanthone substrates, Gr. 1 was utilized. On the other hand, using patulone (diprenylated 1367THX) 
as a substrate, the expected products would have been less polar so Gr. 2 was used. When acyl- or 
benzoylphloroglucinol derivatives were used as prenyl acceptors, a different gradient was used, 
namely, Gr. 3. All used mobile phase gradients are listed in Table 21. Detection wavelengths for 
main substrates and enzymatic products are mentioned in Table 22. For the detection of other 
substrates or trace products, the detection wavelength was the respective absorption maximum for 
each compound. 
Table 21: Mobile phase gradients used for HPLC analyses of enzymatic assays using 
different aromatic prenyl acceptors. Gr. 1 for xanthone substrates except for patulone; Gr. 
2 for patulone; Gr. 3 for acylphloroglucinols; Gr. 4 for semi-preparative purification of 8PX. 
8PX, 8-prenyl-1,3,6,7-tetrahydroxyxanthone.  
Gr. 1  Gr. 2  Gr. 3  Gr. 4 
Time (min)  % B  Time (min) % B  Time (min) % B  Time (min) % B 
0 40  0 60  0 40  0 20 
5 60  6 80  4 60  2 40 
10 80  12 95  10 80  5 55 
19 95  32 95  12 95  12 75 
20 40  34 60  19 95  30 100 
25 40  40 60  20 20  32 20 
      25 20  35 20 
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For semi-preparative purification of 8PX (3.2.6), the enzymatic extract was dissolved in 1.5 ml 
methanol HPLC grade and purified in aliquots of 75 μl using Gr.1 and the same column described 
above for the analysis of enzymatic incubations.  
Fractions of H. sampsonii extract were obtained utilizing Gr. 4 on reversed phase column (5 µm 
C18, 250 x 4.6 mm; phenomenex jupitar). The extract was dissolved in 1 ml methanol HPLC grade, 
then successive aliquots of 50 μl were injected and fractioned by semi-preparative HPLC 
procedure.  
Table 22: Detection wavelengths for main substrates and enzymatic products. 
Compound Detection wavelength (nm) 
1367THX 254 
246TrHBP 306 
246TrHiBP 286 
246TrHiVP 286 
2MBP 286 
8PX 254 
G-246TrHBP 312 
G-246TrHiBP 292 
G-246TrHiVP 292 
G-2MBP 292 
Patulone 292 
 
3.6.2 Liquid chromatography-Mass spectrometry (LC-MS) 
For analysis of individual reaction products, about 10-25 times enzymatic reactions were combined 
together and the corresponding peak was purified and collected by HPLC. Aliquotes of the  
purified components (~10 µg/ml) were  analysed via mass spectrometry (3200 QTrap mass 
spectrometer; Applied Biosystems/MDS SCIEX, Darmstadt, Germany), supplied with an 
electrospray ionization interface (Turbo V), employing the integrated 3200 QTrap syringe pump 
of the instrument (Syringe; 1,000 ml, i.d. 2.3 mm; Hamilton, Nevada, USA) at a flow rate of 10 
ml/min. The MS/MS mode was carried out using a voltage source and declustering potential of 
5.5kV and 76V, respectively. Nitrogen was used as a nebulization gas, with the curtain gas, gas 1, 
and gas 2 settings at 10, 14 and 0, respectively. Products’ molecular ion peaks were additionally 
investigated by MS/MS in the instrument’s enhanced product ion (EPI) mode by means of nitrogen 
gas for collision-induced dissociation. 30–50V was used as collision energy. Processing of data 
was performed using the Analyst software (version 1.4.2; Applied Biosystems/MDS SCIEX) was 
used. 
3.6.3 Gas chromatography-Mass spectrometry (GC-MS) 
Fractions obtained from H. sampsonii extract were evaporated under nitrogen gas and each 
dissolved in 1 ml methanol. Aliquots of 100-300 μl were transferred to inlets of HPLC vials and 
left to evaporate under nitrogen gas. The residue was derivatized with 50 µl N-methyl-N-
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(trimethylsilyl)-trifluoroacetamide (MSTFA; ABCR, Karlsruhe, Germany) at 60 °C for 30 min. 
One microliter from each silylated fraction was injected directly into GC-MS (2.9.2). The 
apparatus is equipped with a ZB5MS column (30 m long, 0.25 mm i.d., 0.25 µm ft). The 
temperature program used was 70 °C for 3 min, followed by a linear temperature increase from 70 
°C to 310 °C over 24 min at a rate of 10 °C/min and finally 310 °C for 5 min. The split ratio was 
varied according to the concentration of the sample from 1:10 to zero. Helium was used as a carrier 
gas. The retention index (IT) for the compounds was calculated in comparison to a mixture of even-
numbered hydrocarbons (C12 to C24) according to the following equation: 
𝐼𝑇 = 100[(
𝑡Ri
𝑇 − 𝑡Rz
𝑇
𝑡R(z+1)
𝑇 − 𝑡Rz
𝑇 ) + 𝑧] 
Where, 
𝐼𝑇 is the retention index for temperature programmed GC analysis, constant heating rate 
𝑡Ri
𝑇  is the retention time of sample peak 
𝑡Rz
𝑇  is the  retention time of n-alkane peak eluted immediately before sample peak 
𝑡R(z+1)
𝑇  is the retention time of n-alkane peak eluted immediately after sample peak 
𝑧 Is the carbon number of n-alkane peak eluted immediately before sample peak 
 
3.6.4 Nuclear Magnetic Resonance (NMR) 
For structure elucidations of synthetic mono- and diprenylated phlorbenzophenones, NMR 
spectroscopy was carried out at the lab of Prof. Dr. Ludger Ernst (Institute of Inorganic and 
Analytical Chemistry, TU Braunschweig) on Bruker Avance II 600 NMR spectrometer (600 MHz 
1H and 150 MHz 13C). Samples were dissolved in a suitable deuterated solvent (CD3OD for 
monoprenylated derivative and CDCl3 for diprenylated) and analyzed at room temperature. 
3.7 Laser scanning microscopy 
Leaf discs of the lower epidermis of the transgenic leaves of N. benthamiana, four days after A. 
tumefaciens infiltration, were visualized by confocal laser scanning microscopy with the CLSM-
510META scan head connected to an Axiovert 200M (Carl Zeiss, http://www.zeiss.de) as 
described previously (Gehl et al., 2009). The excitation was carried out by Argon LASER (488 
nm for YFP and chlorophyll auto-fluorescence). Primary beam-splitting mirrors (458/514 or 488 
nm) and a secondary beam splitter at 545 nm were used for the separation of emitted light. For the 
detailed examination of samples, C-Apochromat 403/1.2 water immersion objective was us
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4 Results 
4.1 Metabolic screening of PPAP aromatic cores from H. sampsonii 
Hypericum sampsonii seedlings (six-week-old) were investigated for the presence of prenylated 
intermediates and their aromatic cores. Seedlings were extracted with MeOH and the resulting 
extract was analyzed by HPLC using gradient 4 (3.6.1). When comparing the UV spectra and the 
retention times (Rt) of the eluted compounds with authentic reference compounds, this preliminary 
investigation sketched an overview of the metabolite pattern of the in vitro plantlets. Peaks at Rt = 
7.22, 8.77, 12.12 and 18.22 min showed 1367THX-like UV spectra. In addition, peaks at 18.54 
and 24.85 min exhibited patulone-like spectra with a bathochromic shift in the absorption 
maximum from 292 to 318 nm. The peak at Rt = 22.47 min had a UV spectrum mimicking that of 
prenylated 246TrHBP with an absorption maximum at 314 nm. The most lipophilic peaks had the 
characteristic absorption maxima of reported benzoyl- and acylphloroglucinol derivatives from H. 
sampsonii (Hu and Sim, 2000), with the peaks at Rt = 22.01, 26.34, 29.65 and 32.41 min exhibiting 
similar UV spectra. The methanolic extract was fractioned via semi-preparative HPLC according 
to the retention times to result in five fractions (Figure 16; Figure 17). The properties of each 
fraction are summarized in Table 23. 
 
Figure 16: HPLC-DAD chromatogram of H. sampsonii MeOH extract. The color code 
correlates to the fractions shown in Figure 17. 
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Figure 17: Photo of H. sampsonii extract fractions. 
Table 23: Fractionation of the methanolic extract prepared from H. sampsonii in vitro 
seedlings.  
Fr. no. Collection time (min) Color  Weight (mg)  Expected compounds 
1 0- 10 Pale yellow 12.3 Polar compounds * 
2 10- 16 Yellow 0.6 Aromatic cores 
3 16- 22 Red  0.5 Prenylated intermediates 
4 22- 27 Pale red 0.6 Prenylated intermediates 
5 27- 35 Dark green 2.9 Highly prenylated compounds ** 
* For example amines, flavonoids, and phenolic acids 
** Compounds having more than C10 prenyl moieties 
The fractions obtained were deeply investigated by ESI-MS. The first fraction did not show 
significant results. On the other hand, the EMS-MS spectrum of Fr. 2 enclosed molecular ion peaks 
of some known compounds at m/z 195, 209, 229 and 259, which may correspond to [M-H]- of 
246TrHiBP, 2MBP or 246TrHVP, 246TrHBP and 1367THX, respectively (Figure 18 A). By 
studying the fragmentation spectra of those peaks, the presence of 246TrHiBP, 2MBP or 
246TrHVP, 246TrHBP and 1367THX in this fraction was confirmed because their fragmentation 
patterns agreed with those of the reference compounds (Figure 18 B, C, D, and E). The presence 
of acylphloroglucinols (246TrHiBP, 2MBP, and 246TrHBP) as potential prenylation acceptors 
was further confirmed through a GC-MS check of the fraction (Figure 19). First, Fr. 2 was 
derivatized by silylation (3.6.3). A mixture of the three references, silylated Fr. 2 and an alkane 
mixture were injected in the same GC-MS run. According to the EI-MS fragmentation of the 
references (Figure 19 A, B, and C), an extracted ion chromatogram at m/z 431, 411, 397 and 369 
was generated for both the reference mixture and Fr. 2. Peaks appeared at 17.9, 18.6 and 21.25, 
confirmed to be 246TrHiBP, 2MBP, and 246TrHBP, respectively. They shared the same Rt and 
EI-MS spectra as well as the retention indices calculated for the reference peaks, which were 
1819.70, 1858.08 and 2050.86 for 246TrHiBP, 2MBP, and 246TrHBP, respectively. In addition, 
hits generated by the GC-MS database confirmed the aforementioned results.  
Fr. 1
0- 10 min
Fr. 2
10- 16 min
Fr. 3
16- 22 min
Fr. 4
22- 27 min
Fr. 5
27- 35 min
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Figure 18: MS analyses of fraction 2 prepared from the methanolic extract of H. sampsonii. 
A) EMS spectrum showing molecular ion peaks corresponding to some known aromatic 
prenyl acceptors. B-E) ESI-MS/MS spectra of m/z 195 (B), 209 (C), 229 (D), and of 259 (E). 
Analyses were done in negative ion mode.  
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Figure 19: GC-MS analysis of fraction 2 prepared from the methanolic extract of H. 
sampsonii. A-C) EI spectra of 246TrHiBP (A), 2MBP (B), and246TrHBP (C). D, E) Extracted 
ion chromatograms at m/z 431 (green), 411 (orange), 397 (red) and 369 (blue) for reference 
mix (D) and fraction 2 (E). 
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Data acquisition from MS/MS analysis of fraction 3 confirmed the presence of a couple of 
prenylated xanthone intermediates. By comparing the mass fragmentation pattern of molecular ion 
peaks at [M-H]- m/z 327.1 and 395.2 with reference compounds, these ion peaks were elucidated 
as 8-prenyl-1,3,6,7-tetrahydroxyxanthone (8PX) and the diprenylated xanthone derivative 
patulone, respectively (Figure 20 B and C). Another ion peak at [M-H]- m/z 365 was confirmed 
to be either 3,5-diprenylated-2,4,6-trihydroxybenzophenone or 3-geranyl-2,4,6-
trihydroxybenzophenone due to its ESI spectrum (see 4.5.1 and 4.6.1.2). Mass fragmentation 
spectra of ion peaks at m/z 517, 519, 533 and 549 possibly correspond to the known compounds 
sampsonion B, a caged benzoylphloroglucinol derivative isolated previously from H. sampsonii 
extract (Hu and Sim, 2000), pseudohypericin, hypersampsone A and adhyperforin, respectively. 
The ion peak at m/z 519 proved to be pseudohypericin according to its ESI mass spectrum 
(Gadzovska et al., 2005), which justifies the red color of the fraction (Figure 17; Figure 20 D). 
The MS/MS spectrum of the ion peak at m/z 549 did not agree with that of an authentic 
adhyperforin reference (Gaid et al., 2016) and it is still unknown. Analysis of fractions 4 and 5 
gave more insight into the metabolite profiling of in vitro-grown H. sampsonii plants. Ion peaks 
found in those two fractions may coincide to molecular weights of known acyl- and 
benzoylphloroglucinol derivatives, but the reported spectral data for those metabolites is scarce. 
In addition, their structural elucidation is out of the scope of the current study. 
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Figure 20: MS analyses of fraction 3 prepared from the methanolic extract of H. sampsonii. 
A) EMS spectrum of Fr. 3 showing molecular ion peaks corresponding to some known 
aromatic prenyl acceptors. B-E) ESI-MS/MS spectra of m/z 327 (B), 395 (C), 519 (D), and 
549 (E). Analyses were done in negative ion mode. 
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4.2 RNA extraction from H. sampsonii 
H. sampsonii RNA was extracted from the entire in vitro seedlings using the RNeasy® Plant Mini 
Kit and the LiCl precipitation method (3.3.1.1). The concentration of the isolated RNA, calculated 
as described under 3.3.2, was determined as 14, 260 and 280 ng/μl for RNA samples isolated by 
the RNeasy kit and the samples 1 and 2 from LiCl precipitation, respectively. The integrity of 
RNA samples was checked and verified by running them on agarose gels. The characteristic bands 
proving the presence of 28S and 18S ribosomal RNA subunits appeared clearly for the samples 
isolated according to Jaakola et al. (2001), which indicated the higher suitability of this method to 
isolate RNA from H. sampsonii. Furthermore, the integrity of RNA samples was confirmed by the 
band intensity ratio 28S/18S of ≈ 2 (Figure 21). All samples showed good purity as indicated by 
the ratio A260/A280, which was around 1.9 for all samples.  
 
Figure 21: Agarose gel electrophoresis of one RNA sample after LiCl precipitation (750 ng) 
demonstrating 18S (below) and 28S (above) subunits. Right lane: ladder. 
4.3 Cloning of prenyltransferases 
4.3.1 Homology-based cloning of PT transcripts from H. sampsonii 
Overexpression primers (forward and reverse primers) derived from prenyltransferases identified 
in other Hypericum species (Müller, 2013; Fiesel, 2016) were applied to the reverse-transcribed 
RNA derived from H. sampsonii. Nine primer pairs were designed according to an American 
transcriptome database for H. perforatum (http://medicinalplantgenomics.msu.edu/) and another 
three were derived from the results of a subtracted cDNA library of the xanthone-producing yeast-
extract-treated H. calycinum cell culture (Gaid et al., 2012). cDNA from H. sampsonii was used 
as a template with each pair of primers. Some of the employed primers failed to give amplification 
products with H. sampsonii cDNA. In some cases, however, amplicons were formed. Each 
amplification product was purified from the gel, ligated to the vector pJet 1.2, and sequenced. 
Sequence information was blasted against the NCBI database using the “tblastn” online tool to 
examine homology with common PTs. Amplification results are listed in Table 24. 
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Table 24: Investigation of the amplification results obtained by applying Hypericum sp. 
derived primers to H. sampsonii cDNA. 
Primer pair no. Amplification  NCBI accession  
(nearest hit) * 
Name of later HsPT 
sequence 
1 No   
2 Yes PT, homogentisate 
solanesyltransferase, 
chloroplastic [Ricinus 
communis], 
XP_002531591.2, 39% 
Core fragment of HsPT5 
3 Yes  Nonspecific 
amplification 
 
4 Yes Nonspecific 
amplification 
 
5 yes Nonspecific 
amplification 
 
6 yes Nonspecific 
amplification 
 
7 yes PT, hypothetical protein 
MANES_06G022400 
[Manihot esculenta], 
OAY46726.1, 72% 
HsPT6. HsPT6a 
8 Yes Nonspecific 
amplification 
 
9 No    
10 Yes  PT, homogentisate 
solanesyltransferase, 
chloroplastic isoform 
X1 [Jatropha curcas], 
XP_012090862.1, 49% 
HsPT7 
11 Yes PT, probable 
homogentisate 
phytyltransferase 2, 
chloroplastic isoform 
X2 [Musa acuminata 
subsp. malaccensis], 
XP_018679846.1, 38% 
HsPT8 
12 No    
* NCBI nearest hit, if available. The description follows the order: name of a hit, accession number 
and % identity. 
4.3.2 Applying degenerated primers 
All known plant membrane-bound aromatic prenyltransferases have two aspartate-rich motifs with 
the characteristic amino acid sequences N(D/Q)xxDxxxD and KDxxDxxGD (Akashi et al., 2009; 
Tsurumaru et al., 2010). In our group, degenerate primer pairs corresponding to the amino acid 
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sequences of these two conserved regions were previously derived (Müller, 2013), a forward 
primer from the 1st region and a reverse one from the 2nd motif. The forward degenerate primer 
was employed with either reverse degenerate, RACE long or RACE nested in so-called different 
amplification sets to amplify core fragments from 3′-ready H. sampsonii cDNA. The obtained 
amplification products were cut and purified from the gel, cloned into pJet. Many colonies 
belonging to each of the amplification sets were tested for the presence of the desired inserts 
(3.3.1.2). A number of plasmids showed positive inserts (5, 2 and 2), corresponding to the 
amplification set number 1, 2 and 3, respectively, and were sent to sequencing. After analysis of 
the sequence results, four different middle fragments were identified (Table 25). The results from 
those amplifications are shown in Figure 22. 
 
Figure 22: Agarose gel electrophoresis shows the amplification products obtained upon using 
the degenerate forward primer with either RACE_nested or degenerate reverse primer. 
Table 25: Investigation of the amplification results from using degenerate primers with H. 
sampsonii cDNA.  
Set 
no. 
For. Primer Rev. Primer Plasmid 
no. 
Product  Length Temp. 
name 
Core for 
1 
 
 
PT_Deg_for PT_Deg_rev 1 Identical 396 Deg_2 HsPT1, 1a, 1b 
2 
4 
5 Identical  402 Deg_6 HsPT2 
6 
2 PT_Deg_for RACE_long 1 1 fragment 690 Deg_L HsPT3 
2
  
Identical 648 Deg_S HsPT4 
3  
 
 
PT_Deg_for RACE_nested 1 
2 1 fragment    Nonspecific 
  
 
DegF+rnested
DegF+DegR
1000
500
400
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4.3.3 Amplification of full-length PTs 
4.3.3.1 HsPT1 
One forward and one reverse primer were derived from fragment Deg_2 (Table 25), namely 
Hs_deg2_3R_for_1 and Hs_deg2_5R_rev_1 (2.4.6), to obtain 3ʹ- and 5ʹ- ends of the targeted 
HsPT.  Firstly, the 3ʹ-RACE was done using 3ʹ-ready cDNA as a template to yield a fragment with 
453 bp including the stop codon, followed by a 3ʹ-UTR of 151 bp and 29 adenine nucleotides. To 
extend this fragment toward its 5ʹ-terminus, three forward primers from close H. perforatum PT 
sequences (having similarities towards the Deg_2 fragment from 71.4 to 71.9 %, namely 2F, 5F, 
and 6F; 2.4.1) were used as a forward primer mix together with the reverse primer 
Hs_deg2_5R_rev_1 in a single PCR round. An amplicon of 680 bp was gleaned. Overexpression 
primers were designed using assembled sequence information from 5ʹ-end, core and 3ʹ-end 
fragments. The ORF sequence of HsPT1 was confirmed via proofreading, followed by sequencing 
of the blunt-ligated pJET 1.2/HsPT1 construct (3.3.9.1). 
 
Figure 23: Schematic representation of RACE reactions done to obtain full-length HsPT1, 
displaying the primers employed to get the sequence. The core fragment is displayed in 
yellow, missing sequence parts are shown in grey, forward primers and start codon are 
shown in green, the reverse primer is in red and the 3ʹ-UTR is in blue. 
The amplified sequence of HsPT1 was composed of 1191 bp ORF followed by 151 bp 3ʹ-UTR and 
a poly-A tail of 29 bases. It coded for 396 amino acids with a predicted molecular mass of 43.8 
kDa and an isoelectric point of 9.55. The protein contained the two conserved regions 
NQIFDIETD and KDLPDVEGD. Based on the prediction by the online tool “TMHMM”, the 
number of transmembrane helices (TMH) for HsPT1 was eight. HsPT1 has a transit peptide length 
of 21 amino acids, which targets it to the chloroplasts according to the prediction results of the 
TargetP v1.1 online tool. 
 
ATG TAG 3ʹ-UTRDeg_2
Hs_deg2_3R_for_1 Hs_deg2_5R_rev_1 
3x
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Figure 24: Representative example of an HsPT1-pJET1.2 construct.  
4.3.3.2 HsPT1a 
While screening positive clones for HsPT1, two new sequences were observed. Both sequences 
shared high identity with HsPT1 at nucleotide and protein levels. They were named HsPT1a and 
HsPT1b (4.3.3.3). HsPT1a has an open reading frame of 1176 bp encoding 391 amino acids, which 
indicates a 15 bp (5 amino acids) shorter sequence due to a gap between positions 120 and 126 in 
HsPT1 upon aligning the two sequences. It shared 99.6% and 99% similarity at the nucleotide and 
peptide levels, respectively. It was predicted that it has two TMH less, the same signal peptide 
length and the same target organ inside the cell as HsPT1. 
4.3.3.3 HsPT1b 
This sequence has a smaller gap of only six bp to give an ORF of 1185 bp and encodes for two 
amino acids less than does HsPT1, which are between positions 71 and 74 upon comparing with 
the peptide sequence of the longer allele. At the nucleotide level, it showed similarity to HsPT1 
and HsPT1a of 99.2% and 99.7%, respectively. Its anticipated properties using the online tools are 
the same as those of HsPT1. Differences between those three polymorphs are demonstrated in 
Figure 25. 
Linear pJET 1.2 vector
2974 bp
HsPT1
1191 bp
+ Blunt Ligation
pJET 1.2_HsPT1
4165 bp
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Figure 25: Multiple sequence alignment of the protein sequences of HsPT1, HsPT1a, and 
HsPT1b, showing sequence differences and gaps among the three polypeptides. Differences 
are marked in red. Numbering line is according to the sequence of the longest allele, HsPT1. 
Conserved aspartate motifs are marked in green. 
4.3.3.4 HsPT2 
The fragment Deg_6 of 402 nucleotides was stretched to its 5′- and 3′-ends by applying RACE 
techniques. The forward gene-specific primer (2.4.2; Hs_deg6_3R_for_1) was used for 3′-racing 
to extend the middle fragment by 693 bp until the stop codon. To get the 5′-end of the gene, the 
first amplification was done using RACE_long and Hs_deg6_5R_rev_2 (2.4.2) as forward and 
reverse primers, respectively. The PCR product was purified and used as a template for a second 
amplification using the complementary sequence to RACE-Long primer, RACE_short in addition 
to Hs_deg6_5R_rev_3. Sequence results of the later amplicon confirmed the extension toward the 
start codon.  
The resulting full-length sequence comprised 1452 nucleotides enclosing an ORF of 1179 bp 
surrounded by 71 bp 5′-UTR and 182 bp 3ʹ UTR with a tail of 20 adenine nucleotides. The 
recombinant polypeptide comprised 392 amino acid with a theoretical molecular weight of 42.9 
kDa and pI of 9.88. The conserved motifs NQIFDIETD and KDISDVEGD were present, denoting 
an aromatic prenyltransferase, which was designated HsPT2. The predicted number of TMH was 
eight.  N-terminal 24 amino acids were expected to be the signal peptide targeting the gene product 
to the chloroplasts inside the plant cell.  
10 20 30 40 50 60 70 80
ME L S RMP S S VL RF S DI RP VHQI I DS P RP RHT I KHL GT S KCAQI L P S RI E F S S GKS CF VHS KNGT HWL KAVP VMAQAQHGD 80HsPT1.pro
ME L S RMP S S VL RF S DI RP VHQI I DS P RP RHT I KHL GT S KCAQI L P S RI E F S S GKS CF VHS KNGT HWL KAVL VMAQAQHGD 80HsPT1a.pro
ME L S RMP S S VL RF S DI RP VHQI I DS P RP RHT I KHL GT S KCAQI L P S RI E F S S GKS CF VHS KNGT HWL KAVP - - AQAQHGD 78HsPT1b.pro
90 100 110 120 130 140 150 160
AAS S F KE GAKS E L P KKNDVI WRF L RP F P VI F T L I QF S S I L ARL VMVE NP HVL QL S NWS VF L KL L AAF T S I S CT NI YAAAI 160HsPT1.pro
AAS S F KE GAKS E L P KE NDVI WRF L RP F P VI F T L I QF S S I L - - - - - VE NL HVL QL S NWS MF L KL L AAF T S I S CT NI YAAAI 155HsPT1a.pro
AAS S F KE GAKS E L P KKNDVI WRF L RP F P VI F T L I QF S S I L ARL VMVE NP HVL QL S NWS MF L KL L AAF T S I S CT NI YAAAI 158HsPT1b.pro
170 180 190 200 210 220 230 240
NQI F DI E T DKI NKP YL P L CS GE L P I E S ARL MVMGL VAI S L L MAGI I HS MS F L AF NF CL L L VAS S YS I P P F RT KAS T F GAP 240HsPT1.pro
NQI F DI E T DKI NKP YL P L CS GE L P I E S ARL MVMGL VAI S L L MAGI I HS MS F L AF NF CL L L VAS S YS I P P F RT KAS T F GAP 235HsPT1a.pro
NQI F DI E T DKI NKP YL P L CS GE L P I E S ARL MVMGL VAI S S L MAGI I HS MS F L AF NF CL L L VAS S YS I P P F RT KAS T F GAP 238HsPT1b.pro
250 260 270 280 290 300 310 320
I T I T ML NGF GQF F VML AGAQAAL GL P F GMS L P S VF I S I F S S I F AL GMS I VKDL P DVE GDKKS NI P T VAT I I GVRRT L QI G 320HsPT1.pro
I T I T ML NGF GQF F VML AGAQAAL GL P F GMS L P S VF I S I F S S I F AL GMS I VKDL P DVE GDKKS NI P T VAT I I GVRRT L QI G 315HsPT1a.pro
I T I T ML NGF GQF F VML AGAQAAL GL P F GMS L P S VF I S I F S S I F AL GMS I VKDL P DVE GDKKS NI P T VAT I I GVRRT L QI G 318HsPT1b.pro
330 340 350 360 370 380 390
L GT L I L NHF GAL L L VF I HP E S F KS S I MI P F HI L S I L F ML YQAWKVDKANYS VAE S MKT YL T F L GVYL VQML L F P F I . 397HsPT1.pro
L GT L I L NHF GAL L L VF I HP E S F KS S I MI P F HI L S I L F ML YQAWKVDKANYS VAE S MKT YL T F L GVYL VQML L F P F I . 392HsPT1a.pro
L GT L I L NHL GAL L L VF I HP E S F KS S I MI P F HI L S I L F ML YQAWKVDKANYS VAE S MKT YL T F L GVYL VQML L F P F I . 395HsPT1b.pro
Results 
79 
 
 
Figure 26: Schematic representation of RACE reactions performed to obtain full-length 
HsPT2, displaying the primers employed to get the sequence. The core fragment is displayed 
in yellow, missing sequences are shown in grey, forward primers and start codon are shown 
in green, reverse primers and stop codon in red and UTRs are shown in blue. 
4.3.3.5 HsPT3 
The fragment generated from the PCR employing the degenerate forward primer (PT_Deg_for) 
and RACE_long (Deg_L; Table 25) was extended to its 5′-end in a 2-stage-amplification where 
the product of the first amplification served as a template for a second amplification using the 
upstream primer (Hs_degL_5R_rev_2; 2.4.2) to get a full-length cDNA of 1179 bp flanked by 5ʹ-
UTR and 3ʹ-UTR of 90 and 232 bp, respectively. The 3′-untranslated region was followed by 21 
adenine bases. A protein sequence of 392 amino acids involved the conserved motives 
NQIFDLETD and KDIPDIEGD. The expected molecular weight of the protein was 43.1 kDa with 
a pI of 9.88. This protein has eight integrated membrane domains as anticipated by the TMHMM 
online tool. The results of SignalP prediction indicated a signal peptide length of 18 amino acids. 
Plastidial subcellular localization was shown by the results of TargetP v1.1 and chloroP online 
tools.   
 
Figure 27: Schematic representation of RACE reactions performed to obtain full-length 
HsPT3, displaying the primers employed to get the sequence. The core fragment is displayed 
in yellow, missing sequence part is shown in grey, forward primers and start codon are in 
green, reverse primer and stop codon are in red and UTRs are in blue 
4.3.3.6 HsPT4 
Based on the core fragment, Deg_S, amplified from cDNA using the forward degenerate primer 
with reverse RACE_short primer (Table 25), one reverse primer designated Hs_degS_5R_rev_1 
was designed for extending this sequence to its 5′-end. This primer was used in an amplification 
program together with a mixture of nine primers belonging to previously cloned H. perforatum 
ATG TAG 3ʹ-UTR5ʹ-UTR Deg_6
Hs_deg6_3R_for_1 
Hs_deg6_5R_rev_2 
Hs_deg6_5R_rev_3 
ATG TAG 3ʹ-UTR5ʹ-UTR Deg_L
Hs_degL_5R_rev_1
Hs_degL_5R_rev_2
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prenyltransferases. The resulted amplicon had a length of 663 bp. By compiling it with the 
previously identified core fragment Deg_s, a full-length cDNA of 1354 nucleotides was obtained. 
1173 bp, 152 bp, and 29 bp were identified as ORF, 3′-UTR, and poly A-tail, respectively. High 
fidelity PCR was done to proofread the sequence, which was named HsPT4. The predicted protein 
product of 390 amino acids with a molecular mass of 43.4 kDa and pI 9.51 contained the two 
conserved regions NQIFDIEID and KDIPDIEGD. As predicted by online tools, it showed seven 
integrated membrane domains and a signal peptide of 18 amino acids targeting it to the plastidial 
membrane. 
 
Figure 28: Schematic representation of RACE reaction performed to obtain full-length 
HsPT4, displaying the primer employed to get the sequence. The core fragment is displayed 
in yellow, missing sequence part is shown in grey, forward primers and start codon are 
shown in green, stop codon is in red and the UTR is in blue. 
4.3.3.7 HsPT5 
Although the PCR product primed by primer pair no. 2 (2.4.1) showed the size of a full ORF, 
sequence analysis of the PCR product lacked the correct stop codons. However, it shared 88% 
sequence identity to the ortholog sequence isolated from H. calycinum when the same primer pair 
was used.  A forward primer (HsPT5_Fragment_f; 2.4.2) was designed from the regions near the 
3′- ends of the CDS to serve in RACE reactions. 
 
Figure 29: Schematic representation of RACE reactions performed to obtain full-length 
HsPT5 displaying the primers employed to get the sequence. The core fragment is displayed 
in yellow, missing sequence parts are shown in grey, forward primers and start codon are 
shown in green, reverse primers and stop codon are in red and UTR is shown in blue. 
The stop codon was identified to reveal an ORF of 1143 nucleotides, followed by 173 bp 3′-UTR 
and a poly-A-tail of 28 bp. The predicted protein structure consisted of 380 amino acids and housed 
the NQISDIETD and KDISDMDGD aspartate-rich motives. The protein had an expected size of 
42.1 kDa and an isoelectric point of 9.43. SignalP assigned a transit peptide of 20 amino acids. 
The confirmed sequence was then submitted to TMHMM to show predictable nine membrane 
helices. Unexpectedly, the prediction results for localization of this protein were contradictory, as 
TargetP predicted it as mitochondrial and chloroP as plastidial.   
ATG TAG 3ʹ-UTRDeg_S
Hs_degS_5R_rev_19 x
ATG TAG 3ʹ-UTRUnclear HsPT5
HsPT5_Fragment_f
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4.3.3.8 HsPT6 
HsPT6 was obtained as full-length coding sequence using the forward and reverse primers 7F and 
7R, respectively (2.4.1). The proofread-confirmed sequence was 1188 bp long and encoded 395 
amino acids with the conserved motives NQLTDIEID and KDIPDIDGD. It showed 97.4% and 
96% sequence similarity to its homolog identified from H. perforatum by aligning their nucleotide 
and translated polypeptide sequences, respectively. The size of the translation-resulted protein was 
44.6 kDa with a pI of 9.73. The number of membrane-spanning polypeptide chains of this PT was 
assigned to be seven with a targeting signal of 21 amino acids, which directs the enzyme to the 
membrane of the plastids.  
4.3.3.9 HsPT6a 
Sequence analysis of HsPT6 constructs revealed the existence of another shorter sequence. The 
new sequence named HsPT6a had an open reading frame of 1176 bp. The protein product of this 
polymorph was 391 amino acids long and shared 86.7 and 85.2% sequence similarity to HsPT6 
and the H. perforatum homolog, respectively. Similar to its homologue in H. perforatum, HsPT6a 
was predicted to have nine TMH. The length of the transit peptide (TP) was predicted to be three 
amino acids shorter than that of HsPT6 but the online software failed to forecast the target of the 
protein inside the plant cell. 
 
Figure 30: Alignment of the protein sequences of HsPT6 and HsPT6a showing sequence 
differences and gaps between the polypeptides. Differences are marked in red. Numbering 
is according to the sequence of the longer allele HsPT6. Conserved aspartate motifs are 
marked in green. 
4.3.3.10 HsPT7 
It was amplified from H. sampsonii cDNA adopting the primer pairs numbered 10 (2.4.1) in a 
touchdown PCR. The sequence of the amplified product was affirmed after a proofreading with a 
high fidelity DNA polymerase. The attained sequence was a PT ORF of 1176 bp encoding a protein 
chain of 391 amino acids with 43.7 kDa and a pI of 9.22. Similar to other aromatic PTs, the D-rich 
regions NQIFDVEID and KDLSDIDGD were identified. HsPT7 had only eight bp difference from 
the corresponding coding sequence amplified with the same primers from H. perforatum. This 
enzyme has seven TMH. A short targeting signal was anticipated by SignalP, which is only 10 
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amino acids long and targets the protein to the membrane of chloroplasts, as predicted by the two 
online software with a high probability. 
  
Figure 31: Representative example of agarose gel electrophoresis, displaying in lane 1 DNA 
marker, in lane 2 negative control PCR with no template and in lane 3 the PCR product that 
was called later HsPT7. 
4.3.3.11 HsPT8 
A primer pair (11F and 11R; 2.4.1) was employed to get an ORF, which had the tentative name of 
HsPT8. Its length was likewise 1176 bp and encoded for a protein of 391 amino acids. The 
conserved regions NQIFDLETD and KDIPDIEGD were observed. The protein sequence 
possesses eight TMH, a molecular weight of 43.1 kDa and a pI of 9.88. The sequence shared 
identities of 88.1% and 83.7% with its H. perforatum homolog (HpPT6) (Fiesel, 2016) at the 
nucleotide and amino acid levels, respectively, with sixty four-amino acids difference (Figure 32). 
A plastidial targeting signal of 18 amino acids was anticipated. Upon alignment of all HsPTs, it 
shared 99.6 % and 100 % similarities with nucleotide and peptide sequences of HsPT3, amplified 
by degenerate primers and RACE (4.3.3.5). Thus, it was not considered for further investigation. 
 
Figure 32: Alignment of the protein sequences of HpPT6, HsPT8, and HsPT3 highlighting 
the differences between these polypeptides. The differences are marked in red. Numbering 
is according to the sequence of the H. perforatum homolog HpPT6. Conserved aspartate 
motifs are marked in green. 
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Table 26: Summary of the properties of the PTs isolated from H. sampsonii. 
Name  ORF 
(bp) 
Peptide 
(Amino 
acid) 
TMH D-Motives* Size 
(KDa) 
pI TargetP ChloroP 
HsPT1 1191 396 8 NQIFDIETD  KDLPDVEGD 43.8 9.55 C - 
HsPT1a 1176 391 6 NQIFDIETD  KDLPDVEGD 43.3 9.33 C - 
HsPT1b 1185 394 8 NQIFDIETD  KDLPDVEGD 43.6 9.55 C - 
HsPT2 1179 392 8 NQIFDIETD KDISDVEGD 42.9 9.88 C C 
HsPT3 1176 391 8 NQIFDLETD KDIPDIEGD 43.1 9.88 C C 
HsPT4 1173 390 7 NQIFDIEID KDIPDIEGD 43.4 9.51 C C 
HsPT5 1143 380 9 NQISDIETD  KDISDMDGD 42.1 9.73 M C 
HsPT6 1188 395 7 NQLTDIEID KDIPDIDGD 44.6 9.73 C C 
HsPT6a 1176 391 9 NQLTDIEID KDIPDIDGD 43.7 9.68 - - 
HsPT7 1176 391 7 NQIFDVEID  KDLSDIDGD 43.7 9.22 C C 
* D is aspartate 
4.4 Heterologous expression of prenyltransferases 
According to the properties of the aforementioned PTs, which were confirmed by software 
prediction, all prenyltransferases are membrane-bound enzymes. Thus, the eukaryotic production 
platforms are expected to be superior to prokaryotes for the expression of the membrane integral 
proteins (Buchanan, 1999; Yazaki et al., 2002; Sasaki et al., 2008; Farrokhi et al., 2013; Ohara et 
al., 2013). This is discussed in detail in the discussion part under section 5.4. For the development 
of this study, two host systems for expression of identified aromatic HsPTs were chosen, namely, 
the insect cell-baculovirus system and yeast cells. 
Overexpression primers were designed for each prenyltransferase coding sequence from H. 
sampsonii. Specific restriction sites were added to every primer according to its sequence map and 
the multiple cloning site of the vector used later for expression (3.3.4). The coding sequence was 
then proofread from cDNA and subsequently cloned into the expression vector (3.3.9.2). 
4.4.1 Building up expression constructs for the insect cell-baculovirus system 
Each of the identified sequences and the vector pFastBacI were separately digested or, when 
possible, double-digested with corresponding restriction endonucleases (Table 27) and ligated into 
the expression cassette of the donor vector pfastBac under the control of the polyhedron promoter. 
After expression in Sf9 cells (3.5.1), the microsomal protein fraction was collected and used in 
activity testing, as described under sections 3.5.1.2 and 3.5.5, respectively. 
Table 27: The restriction enzymes used for digestion and subsequent cloning of the HsPTs 
into pFastBacI carrier vector. 
Gene Name 
Restriction enzymes used 
Forward Reverse 
HsPT1 EcoRI XhoI 
HsPT1a EcoRI XhoI 
HsPT1b EcoRI XhoI 
Results 
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HsPT2 BamHI KpnI 
HsPT3 EcoRI XhoI 
HsPT4 BamHI KpnI 
HsPT5 EcoRI XhoI 
HsPT6 BamHI KpnI 
HsPT6a BamHI KpnI 
 
 
Figure 33: Construction of the pFastBacI_HsPT5 plasmid by cloning the EcoRI/XhoI- 
digested HsPT5 ORF into the donor vector EcoRI/XhoI-linearized pFastBacI for Sf9 
expression. 
4.4.2 Building up expression constructs for yeast cells 
Prenyltransferases cloned from H. sampsonii cDNA were integrated into pESC-URA. Firstly, 
genes and vector were independently digested or, when possible, double-digested with 
corresponding restriction enzymes and then ligated into either multiple cloning site 1 or 2 of the 
vector under the control of GAL 10 and GAL 1 promotors, respectively. The constructed plasmids 
were transformed into INVSc1 yeast cells for expression (3.5.1; 3.5.2), the membrane protein 
fraction was isolated and subjected to prenyltransferase assays, as described under 
sections 3.5.1.2, 3.5.2.2 and 3.5.5, respectively. 
Table 28: The restriction enzymes and MCSs targeted for digestion and subsequent cloning 
of HsPTs into pESC-URA vector. 
Gene Name 
Restriction enzymes used 
MCS Promoter 
Forward Reverse 
HsPT1 EcoRI PacI 1 GAL 10 
HsPT1a EcoRI PacI 1 GAL 10 
HsPT1b EcoRI PacI 1 GAL 10 
HsPT2 BamHI KpnI 2 GAL 1 
HsPT3 BamHI XhoI 2 GAL 1 
EcoRI XhoI
HsPT5
1143 bp
+
Digestion with
EcoRI/XhoI
Ligation
pFastBacI_HsPT5
5860 bp
pFastBacI_HsPT5
pFastBacI
4776 bp
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HsPT4 BamHI KpnI 2 GAL 1 
HsPT5 EcoRI PacI 1 GAL 10 
HsPT6 EcoRI PacI 1 GAL 10 
HsPT6a EcoRI PacI 1 GAL 10 
HsPT7 EcoRI PacI 1 GAL 10 
 
 
Figure 34: Construction of the pESC-URA_HsPT2 plasmid by cloning the BamHI/KpnI-
digested HsPT2 into MCS2 of the BamHI/KpnI-linearized pESC-URA for expression in 
yeast. 
 
Figure 35: Construction of the pESC-URA_HsPT7 plasmid by cloning the EcoRI/PacI-
digested HsPT7 into MCS1 of the EcoRI/PacI-linearized pESC-URA for expression in yeast. 
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4.5 Chemical synthesis of substrates 
4.5.1 Synthesis of 3-mono- and 3,5-diprenylated-2,4,6-trihydroxybenzophenone 
The prenylation reaction of 246TrHBP was performed as described under 3.2.1. After terminating 
the reaction, the mixture was subjected to fractionation by silica gel column chromatography. 
Three fractions were identified by TLC using a system of dichloromethane: methanol 95:5. Each 
fraction was then purified on a reversed phase silica gel column. Of fraction no. 2, 60 mg of yellow 
solid was purified, analyzed by HPLC-MS and NMR for detailed structure elucidation of the 
compound. Its MS/MS pattern showed the molecular ion peak at m/z 299 equivalent to [M+H]+. 
According to the 1H NMR and 13C NMR data described under 3.2.1, the compound was identified 
as 3-prenylated-2,4,6-trihydroxybenzophenone (MPPBP; Figure 36 A). 
Two compounds were purified from Fr. 1, both of which had a molecular weight of 366 as 
concluded from MS/MS spectral data. They were sent to NMR for structure elucidation. The NMR 
spectral data of the first one did not match the expected data of 3,5-diprenylated-2,4,6-
trihydroxybenzophenone. The 1H NMR spectrum contained two triplet peaks at a chemical shift 
of 1.6 ppm and 2.55 ppm, each integrating to two protons which could be interpreted as two 
adjacent methylene groups. The 13C-DEPT spectrum showed two methylene carbons at 16 ppm 
and 32 ppm. One more quaternary carbon at 75 ppm was observed in 13C NMR. The pure 
compound was identified as the benzopyran derivative of the diprenylated 246TrHBP, namely 
(5,7-dihydroxy-2,2-dimethyl-6-(3-methylbut-2-en-1-yl)chroman-8-yl)(phenyl)methanone. The 
second purified compound from Fr. 1 was identified after interpreting its spectral data to be the 
desired product, i.e. 3,5-diprenylated-2,4,6-trihydroxybenzophenone (DPPBP; NMR data of the 
compound are described under 3.2.1). 
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Figure 36: Spectral data of the products of the prenylation reaction of 246TrHBP. A) Positive 
ionization mode for EPI mass spectrum of MPPBP. B-C) Differential NMR data between 
benzopyran derivative and DPPBP for 1H NMR (B) and 13C NMR (C). D) The positive 
ionization mode EPI mass spectrum of DPPBP. 
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4.5.2 Synthesis of 2,4,6-trihydroxyisobutyrophenone 
After analyzing the reaction mixture with TLC, a UV-active spot was observed at Rf= 0.37 
corresponding to the reference 2,4,6-trihydroxyisobutyrophenone (246TrHiBP; 3.2.2). The UV-
absorbing band was purified on preparative silica gel TLC plates (2.9.1) using a mobile system of 
petroleum ether: ethyl acetate 7: 3. The silica band bearing the desired spot was scratched and 
extracted with MeOH. The extract was dried under vacuum to result in 700 mg pure 2,4,6-
trihydroxyisobutyrophenone residue, which was dissolved in MeOH to a concentration of 0.01 M. 
 
Figure 37: TLC analysis of the synthesis of 246TrHiBP under UV light (366 nm). Lane 1 is 
reference 246TrHiBP. Lane 2 is the starting material (phloroglucinol). Lane 3 is the reaction 
mixture after consumption of reactants. 
4.5.3 Synthesis of geranyl (GPP) and prenyl (DMAPP) donors 
GPP was synthesized as described under 3.2.4. Fractions collected from a cellulose column (each 
15 ml) were subjected to cellulose TLC plates. After spraying with a freshly prepared sulfosalicylic 
acid solution, they were dried in the air and then sprayed with fresh ferric chloride solution (2.8.8). 
Fractions 79-112 exhibited white spots on a pink background with an Rf = 0.34. Pyrophosphate 
group-containing fractions were combined together and freeze-dried. A 380 mg amount of white 
powder with strong lemon odor was produced. The resulting solid was dissolved in 24.5 ml of 
MeOH: NH4OH 7: 3 solution and divided into 1 ml aliquots, each having a final concentration of 
50 mM. The product (tris-ammonium salt) was analyzed by MS/MS and it showed a molecular 
ion peak of 313 corresponding to the anion [M-H]- (Figure 38). The fragmentation pattern of the 
product displayed peaks at m/z 295 corresponding to [M-H2O]
- and peaks at m/z 158.9 and m/z 
78.8, which correspond to pyrophosphate and phosphate moieties, respectively (Jauhiainen et al., 
2009). 
Ref.
Product
1     2     3
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Figure 38: EPI mass spectrum of GPP in negative ionization mode. 
DMAPP was synthesized and identified employing the same methods as for GPP. Its MS/MS 
analysis exhibited a molecular ion peak at m/z 245 of [M-H]-. The corresponding peaks at m/z 226, 
m/z 159 and m/z 79 according to Jauhiainen et al. (2009) were also present. After lyophilization, 
640 mg of DMAPP were produced, dissolved in MeOH: NH4OH 7: 3 solution and divided into 1 
ml aliquots, each having a final concentration of 50 mM. 
4.5.4 Chemo-enzymatic production of 8-prenyl-1,3,6,7-tetrahydroxyxanthone 
Since 8PX was accepted by both xanthone-related H. sampsonii PTs, it had to be produced in 
sufficient amounts to be used as a substrate for further characterization of HsPT8PX and HsPTpat 
(see later sections 4.6.2.1 and 4.6.2.2). The lack of a commercial source or a convenient synthetic 
scheme for 8PX necessitated its enzymatic production through the reaction of 1367THX with 
DMAPP catalyzed by HsPT8PX. Thus, a 1000-fold scale-up was done applying the conditions 
that produce the maximum yield of the product (see later section 4.6.2.1). Both the prenyl donor 
and the aromatic substrate were incubated at 37 °C using Tris-HCl buffer pH 7 with MgCl2 as a 
cofactor for 90 min. A portion of 1.5 mg pure 8PX (yield ≈ 60%) was produced, purified and 
further employed as a substrate. 
4.6 Functional characterization of membrane proteins from H. sampsonii 
4.6.1 In vitro activity screening 
Microsomes isolated either from Sf9- or INVSc1- cells were subjected to activity screening with a 
number of potential aromatic substrates including acyl- and benzoylphloroglucinol, xanthone and 
flavonoid chemical groups (Figure 39) in the presence of DMAPP or GPP as prenyl donors 
according to the method mentioned under section 3.5.5.1. The formed products were analyzed by 
HPLC-DAD and ESI-MS (3.6.1; 3.6.2). The detected activities not only indicated the presence of 
prenyltransferase activity but also proved the successful expression process. 
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Figure 39: Aromatic prenyl acceptors and prenyl donors used for activity screening of 
HsPTs. 
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4.6.1.1 Insect cell-expressed recombinant proteins 
Activity assays of membrane preparations after individual expression of HsPTs in insect cells with 
potential substrates are displayed in Table 29. Out of nine PTs, only HsPT5 showed an activity 
under the applied test conditions. Enzymatic incubations of insect microsomes bearing HsPT5 with 
1,3,6,7-tetrahydroxyxanthone (1367THX) and DMAPP resulted in a single product. As indicated 
by HPLC-DAD analysis, the enzyme catalyzed the geminal addition of two prenyl groups to 
1,3,6,7-tetrahydroxyxanthone at C-8, which interrupts the skeleton conjugation with simultaneous 
oxidation of the adjacent hydroxyl group (Figure 40). The product has the same retention time 
(14.4 min) and the same characteristic absorption maxima at 236 and 292 nm like the authentic 
reference patulone (purified from cell suspension cultures of H. calycinum by Dr. Mariam Gaid). 
Furthermore, the fragmentation pattern in the mass spectral analysis was in agreement with the 
authentic reference compound exhibiting the molecular ion peak at m/z 395 equivalent to [M-H]-. 
After confirmation of the activity, this recombinant enzyme was named after its product as 
HsPTpat. 
The three alleles, namely HsPT1, HsPT1a, and HsPT1b showed prenyl- and geranyltransferase 
activity for substrates with an acylphloroglucinol skeleton. However, the observed activities were 
not reproducible, thus the approval of these HsPTs as active prenyltransferases is still open.   
Table 29: Summarized results of activity assays with insect cell-expressed HsPTs 
Recombinant PT 
Accepted Substrates 
        Product  
Acceptor Donor 
HsPT1 ? ?  
HsPT1a ? ?  
HsPT1b ? ?  
HsPT2 - -  
HsPT3 - -  
HsPT4 - -  
HsPTpat 
 
DMAPP 
 
HsPT6 - -  
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Figure 40: Incubation of insect microsomes containing HsPTpat with 1367THX. A) Stacked 
HPLC-DAD chromatograms for enzymatic reaction (red), standard (green) and negative 
control (blue). B and C) UV spectra of the aromatic substrate (B) and enzymatic product 
(C). D) Negative ion EPI mass spectrum of the enzymatic product. 
4.6.1.2 Yeast cell-expressed recombinant proteins 
Expression of HsPTs in yeast exhibited activity profiles different from those expressed in insect 
cells (Table 30, page 99). The enzymatic activity of the microsomal preparations from yeast cells 
harboring the pESC-URA-HsPT2 ORF was tested via incubation with potential substrates 
belonging to different chemical classes (Figure 39). Products were analyzed as discussed in the 
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methods section (3.6). HsPT2 was able to convert 1,3,6,7-tetrahydroxyxanthone (1367THX) to its 
8-monoprenyl derivative as the major product (Figure 41 A). Thus, the name HsPT8PX was used 
to refer to this enzyme. The product peak shared the retention time (Rt = 12.2 min) and UV 
spectrum with authentic 1,3,6,7-tetrahydroxy-8-prenylxanthone (8PX; Figure 41 C). The mass 
spectra (molecular ion peak at m/z 327 equivalent to [M-H]-) of the enzymatic product and the 
reference compound were in agreement (Fiesel et al., 2015). 8PX was further metabolized by the 
microsomal fraction via the addition of another prenyl group to the same carbon atom (C-8) to 
produce patulone (8,8-diprenyl-1,3,6,7-tetrahydroxyxanthone) as a minor product. Direct use of 
8PX as a substrate in a separate incubation led to the formation of patulone as the sole product 
(Figure 42). The retention time and UV spectrum, as well as the molecular ion peak and MS/MS 
fragmentation pattern of the enzymatically formed patulone, matched those of an authentic 
reference compound. 
When the yeast-expressed HsPTpat (previous name HsPT5) was incubated with 1367THX, it gave 
the same results as the insect-expressed protein. The diprenylated xanthone derivative patulone 
was formed (Figure 40). HsPTpat was able to catalyse the enzymatic conversion of 8PX to 
patulone (Figure 43). Thus, the recombinant protein HsPTpat produced only patulone as a sole 
product, independent of using 1367THX or its 8-prenyl derivative as a prenyl acceptor. 
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Figure 41: Incubation of yeast microsomes containing HsPT8PX with 1367THX. A) Stacked 
HPLC-DAD chromatograms for the enzymatic reaction, standards, and negative control. B) 
UV spectrum of the aromatic substrate, 1367THX. C) UV spectrum of the enzymatic product 
P1. D) UV spectrum of the enzymatic product P2. E) EPI mass spectrum of the main 
enzymatic product. 
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Figure 42: Incubation of yeast microsomes containing HsPT8PX with 8PX. A) Stacked 
HPLC-DAD chromatograms for enzymatic reaction, references and negative control. B and 
C) UV spectra of the aromatic substrate (B) and enzymatic product (C). 
 
Figure 43: Incubation of microsomes containing HsPTpat with 8PX. A) Stacked HPLC-DAD 
chromatograms for the enzymatic reaction, reference, and negative control. B and C) UV 
spectra of the aromatic substrate (B) and the enzymatic product (C). 
A third recombinant yeast-expressed prenyltransferase from H. sampsonii, namely HsPT7, 
exhibited a geranyl transferase activity, this time, with unsubstituted acyl- and 
benzoylphloroglucinol aromatic substrates. Thus, it produces mono-geranyl derivatives from each 
of the accepted substrates belonging to this group. HsPT7, after confirmation of its geranyl 
transferase activity, was given the name HsPTAPG.   
An enzymatic assay of HsPTAPG with 2,4,6-trihydroxyisobutyrophenone (246trHiBP) resulted in 
the formation of a single product (Rt = 15.0 min; Figure 44 A). This product was identified as 3ʹ-
geranyl-2,4,6-trihydroxyisobutyrophenone (G-246TrHiBP). Its UV spectrum showed a 
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characteristic absorption maximum at 292 nm, which resembled that of the substrate with ≈ 4 nm 
bathochromic shift (Figure 44 B and C). In addition, its MS spectra showed molecular ion peaks 
at m/z 331 and 333 equivalent to [M+H]- and  [M-H]+, respectively (Figure 44 D and E), which 
matched previously published data (Li et al., 2015). 
 
Figure 44: Incubation of yeast microsomes containing HsPTAPG with 246TrHiBP. A) 
Stacked HPLC-DAD chromatograms for enzymatic reaction (red), reference (green) and 
negative control (blue). B and C) UV spectra of the aromatic substrate (B) and enzymatic 
product (C). D and E) EPI mass spectra in negative ion mode (D) and positive ion mode (E). 
Another acylphloroglucinol derivative was accepted when incubated with recombinant HsPTAPG, 
namely, 2,4,6-trihydroxy-2-methylbutyrophenone (2MBP; synthesized in our laboratory by a 
former colleague, Marco Grull). A peak at Rt = 15.2 min was detected with a similar UV spectrum 
to that of the substrate, again with a bathochromic shift, to have an absorption maximum at 292 
nm. MS/MS fragmentation of the product demonstrated a molecular ion peak at m/z 347 equivalent 
to [M+H] + (Figure 45 D). Accordingly, the product was identified as 2-methyl-3´-geranyl-
2´,4´,6´-trihydroxybutyrophenone (G-2MBP). 
Similarly, membrane preparations from yeast were incubated with the benzoylphloroglucinol 
derivative 2,4,6-trihydroxybenzophenone to bring out one product with Rt = 14.8 min (Figure 46), 
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whose UV spectrum had an absorption maximum at 314 nm with ≈ 8 nm red-shift from its starter 
substrate (absorption maximum at 306 nm; Figure 46 B and C). The product was identified as the 
mono-geranylated derivative of the substrate according to its MS/MS pattern with the molecular 
ion peak at m/z 367 equivalent to [M+H]+ (Figure 46 D). Other acyl- and benzoylphloroglucinols 
were poorly accepted substrates and the resulting products were, according to their Rt and UV 
patterns, identified as mono-geranylated derivatives of the corresponding substrates. 
 
 
Figure 45: Incubation of yeast microsomes containing HsPTAPG with 2MBP. A) Stacked 
HPLC-DAD chromatograms for enzymatic reaction (red), reference (green) and negative 
control (blue). B and C) UV spectra of the aromatic substrate (B) and enzymatic product. D) 
The positive ion mode EPI mass spectrum of the enzymatic product. 
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Figure 46: Incubation of yeast microsomes containing HsPTAPG with 246TrHBP. A) 
Stacked HPLC-DAD chromatograms for enzymatic reaction (red), reference (green) and 
negative control (blue). B and C) UV spectra of the aromatic substrate (B) and enzymatic 
product (C). D) The positive ion mode EPI mass spectrum of the enzymatic product. 
Different sets of combinations of yeast microsomes harbouring recombinant proteins without 
detected catalytic activities were co-incubated, under the above-used assay conditions, with HsPTs 
that had confirmed activities. This co-incubation principle was applied to test the possibility that 
any of these inactive proteins may catalyse further prenylation on any of the products of the active 
HsPTs. Unfortunately, no further prenylated products were detected, even for the Hs-homologue 
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of H. perforatum sequence (HpPT6), which was able to add a prenyl group to the geranylated 
acylphloroglucinols, produced by the H. perforatum HsPT7-homologue (Fiesel, 2016).  
Table 30: Summarized results of activity assays with yeast cell-expressed HsPTs 
Recombinant PT 
Accepted Substrates 
Products 
Acceptor Donor 
HsPT1 - -  
HsPT1a - -  
HsPT1b - -  
HsPT2 
(HsPT8PX) 
 
DMAPP 
 
and 
 
 
 
 
DMAPP 
 
HsPT3 - -  
HsPT4 - -  
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HsPT5 (HsPTpat) 
 
DMAPP 
 
 
 
DMAPP 
 
HsPT6 - -  
HsPT7 
(HsPTAPG) 
 
GPP 
 
 
 
GPP 
 
 
 
GPP 
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4.6.2 Characterization of active recombinant proteins 
For a better understanding of the enzymatic reactions observed, the optimum conditions for each 
of the HsPT-catalyzed conversions were investigated. Optimum pH was necessary to be 
determined as the pH value can directly affect the ionization state of the protein and consequently 
its folding. Thus, the activity of proteins is commonly decreased outside of a certain range of pH 
values. Likewise, the increase in temperature, to a certain limit, can affect the activity positively, 
before the hydrogen bonds within the polypeptide start to labilize, leading to partial denaturation 
of the protein and gradual loss of the activity. The accumulation of the products is time-dependent. 
The best co-factor (divalent cation) for each reaction was investigated, testing the effect of 
different divalent cations on the amount of the resulting product. 
4.6.2.1 HsPT8PX 
This enzyme can accept two xanthones, namely, 1367THX and its prenylated derivative 8PX 
(4.6.1.2; Table 30). The reaction with the unprenylated substrate showed the highest yield at a pH 
value of 7 using a Tris-HCl buffer. Increasing or decreasing the pH value of the reaction by 0.5 
unite demonstrated a decline in the activity by ≈ 10 and 30%, respectively.  
The preferred divalent cation for the catalytic activity of HsPT8PX for the formation of either 8PX 
(the substrate is 1367THX) or patulone (the substrate is 8PX) was Mg2+. The rate of accumulation 
of enzymatically formed 8PX was linear over the first 15 minutes. However, a slow increase in the 
product formation was observed until three hours. Incubation temperatures between 35 °C - 40 °C 
showed the highest amount of product. A 5 °C increase in the temperature caused a loss of 18% of 
the activity. The product increased in a linear manner until a protein amount of 10 μg (Figure 47). 
Incubation with the prenylated derivative, 8PX, showed similar results, except that the time-
dependent product accumulation rate was linear till 20 min.  
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Figure 47:  Effect of variation of enzymatic reaction conditions on the activity of HsPT8PX 
using 1367THX as a substrate. A) pH.  B) Incubation time. C) Temperature. D) Divalent 
cations. E) Protein amount. Data represent means ± s.d. (n = 3). 
4.6.2.2 HsPTpat 
HsPTpat is a second xanthone-related prenyltransferase, which catalyzes the geminal addition of 
either two prenyl groups or only one at C-8 of the xanthone skeletons 1367THX and its 8-prenyl 
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derivative, respectively. Best conditions for the utilization of both substrates by this aPT were 
determined and are summarized in Table 31. The optimum pH for the reaction with 1367THX 
was at the weakly basic pH of 7.5 and the preferred co-factor was assigned Mn2+. With 8PX, the 
neutral pH was preferred and, like in the reactions catalyzed by HsPT8PX, the best divalent cation 
was Mg2+.   
Table 31: Optimum incubation conditions for the xanthone-related PT HsPTpat with 
1367THX and 8PX as substrates. Conditions used for the determination of Michaelis-Menten 
kinetics are also stated. 
Factor 
1367THX 8PX 
Highest yield Kinetics Highest yield  Kinetics 
pH value* 7.5 7.5 7 7 
Time 60 min 20 min 30 min 12 min 
Temperature 35- 40 °C 37 °C 35- 40 °C 37 °C 
Divalent cation Mn2+ Mg2+ Mg2+ Mg2+ 
Protein amount Linear product 
accumulation up 
to 200 μg 
100 μg Linear product 
accumulation up 
to 50 μg 
15 μg 
* The preferred buffer was Tris-HCl 
4.6.2.3 HsPTAPG 
The enzyme was able to catalyze the geranylation of almost all tested acyl- and 
benzoylphloroglucinols in the study. The first three substrates (246TrHiBP, 2MBP, and 
246TrHBP) were considerably utilized under the standard incubation conditions (3.5.5.1) and were 
thus considered for further characterization. The first investigated substrate was 246TriBP, where 
the best pH value for the reaction was 7.5 using a Tris-HCl buffer. The activity was changed 
slightly by increasing or decreasing the pH by 0.5 units. The product formed, G-246TrHiBP, 
accumulated linearly until an incubation time of 10 min, whereafter the reaction velocity 
decreased. An incubation temperature between 40 °C and 45 °C was assigned to be the optimum 
for this reaction. Around 13-17% loss of activity was observed for incubations done at 35 °C and 
50 °C, respectively. Opposite to Co2+ and Ca2+, which caused 90 and 85% loss of activity, 
respectively, Mg2+ was the most effective co-factor for catalysis. Linear accumulation of the 
geranylated product was observed till 16 µg protein in the reaction mixture, however, higher 
protein amounts were accompanied by decreases in the reaction rate.  
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Figure 48: Effect of varied reaction conditions on the activity of HsPTAPG using 246TrHiBP 
as a substrate. A) pH.  B) Incubation time. C) Temperature. D) Divalent cations. E) Protein 
amount. Data represent means ± s.d. (n = 3). 
Similar characterization results were observed when another acylphloroglucinol was employed as 
an aromatic geranylation acceptor, namely, 2MBP, except for a slightly higher pH optimum. The 
same conditions were used for the investigation of Michaelis-Menten kinetics for both substrates. 
On the other hand, the enzymatic reaction with the benzoylphloroglucinol needed a slightly basic 
pH (Tris-HCl pH 8), more protein amount and longer incubation time to reach the maximum yield 
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of the produced G-246TrHBP. The characterization results of HsPTAPG are summarized in Table 
32. 
Table 32: Optimum incubation conditions for the acylphloroglucinol-related PT HsPTAPG 
with 2MBP and 246TrHBP. Conditions used for the determination of Michaelis-Menten 
kinetics are also stated. 
Factor 
2MBP 246TrHBP 
Highest yield Kinetics Highest yield  Kinetics 
pH value* 8 8 8 8 
Time 90 min 6 min 120 min 20 min 
Temperature 40- 45 °C 42 °C 40- 45 °C 42 °C 
Divalent cation Mg2+ Mg2+ Mg2+ Mg2+ 
Protein amount Linear product 
accumulation up 
to 16 μg 
8 μg Linear product 
accumulation up 
to 80 μg 
40 μg 
* The preferred puffer was Tris-HCl 
The series of potential substrates were used to test the substrate preference of HsPTAPG at pH 8 
and 42 °C for 6 min in the presence of GPP and Mg2+ as a co-factor (conditions for linear velocity 
of the enzyme with acylphloroglucinol substrates). The most preferred substrate for the enzyme 
was 2MBP. The activity towards this aromatic substrate was assigned to 100% and the relative 
activity for other geranyl acceptors was calculated as a percentage in terms of nmol product for 
each substrate (Figure 49). The second best substrate was 246TrHiBP (55%), followed by the 
benzoyl derivative 246TrHBP (13%). Other substrates such as tetrahydroxybenzophenone 
(THBP), phloracetophenone (PAP), and phlorisovalerophenone (246THiVP) were poorly 
accepted (3- 9.5%; Figure 49). By applying the preferred for 246TrHBP (increasing the incubation 
time and amount of protein used), the utilization of this substrate increased from 13% to ≈ 30%. 
However, trials to change the incubation conditions of HsPTAPG failed to enhance the enzymatic 
acceptance of prenylated substrates and maclurin. 
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Figure 49: Substrate specificity of yeast-expressed HsPTAPG using various acyl- and 
benzoylphloroglucinol derivatives as geranyl acceptors. The relative enzyme activity is 
calculated as a percentage of the most accepted substrate in terms of nmol product for each 
substrate. Data represent means ± s.d. (n = 3). 
4.6.3 Kinetic parameter determination  
4.6.3.1 Xanthone prenyltransferases 
Both xanthone-related PTs accept 1367THX and 8PX as prenyl acceptors to produce xanthone 
derivatives with different degrees of prenylation. HsPT8PX catalyzes the formation of 8PX from 
1367THX and, at the same time, it can add a second prenyl group to 8PX to form patulone. In 
contrast, HsPTpat produces always patulone from either 1367THX or 8PX. Thus, the affinities of 
this pair of enzymes, in terms of Michaelis-Menten constants (Km), for both substrates had to be 
determined to assure the preferred substrate for each recombinant aPT (Table 33).  
The Km values for 1367THX and 8PX upon reaction with HsPT8PX were 53.17 ± 1.5 μM and 83.8 
± 8.3 μM, respectively. On the other hand, the Vmax values for these reactions were greatly different 
(9.46 ± 0.083 nkat/μg and 0.26 ± 0.007 nkat/μg, respectively). In the reactions with the second 
enzyme HsPTpat, the values for the two substrates were almost reversed. The Km values for 
1367THX and 8PX were 200.27 ± 16.38 μM and 73.56 ± 6 μM, respectively, and the Vmax values 
were 0.24 ± 0.012 and 5.2 ± 0.2 nkat/μg for the reactions with 1367THX and 8PX, respectively. 
These results indicate that the main substrate for the enzyme HsPT8PX is the 
tetrahydroxyxanthone and the main substrate for HsPTpat is the prenylated xanthone. 
The Km values of each enzyme for DMAPP in the presence of its main substrate were also 
determined. Calculated Km and Vmax values for HsPT8PX with DMAPP in the presence of 
1367THX were 15.82 ± 5.7 μM and 8.24 ± 0.5793 nkat/μg, respectively. Similarly, the kinetic 
parameters for DMAPP in the reaction HsPTpat + 8PX + DMAPP were 23.7 ± 3.26 μM and 4.1 ± 
0.27 nkat/μg, respectively. 
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Figure 50: Hyperbolic regression curves for the determination of the Michaelis-Menten 
constants (Km values) of HsPT8PX with the substrates 1367THX (A) and 8PX (B). 
 
Figure 51: Hyperbolic regression curves for the determination of the Michaelis-Menten 
constants (Km values) of HsPTpat with the substrates 1367THX (A) and 8PX (B). 
 
Figure 52: Hyperbolic regression curves for the determination of the Michaelis-Menten 
constants (Km values) of HsPT8PX for DMAPP in the presence of 1367THX (A) and of 
HsPTpat for DMAPP in the presence of 8PX (B). 
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Table 33: Kinetic parameters of HsPT8PX and HsPTpat 
 1367THX 8PX 
Km (μM) Vmax (nkat/μg) Km (μM) Vmax (nkat/μg) 
HsPT8PX 53.17 ± 1.5 9.46 ± 0.083 83.8 ± 8.3  0.26 ± 0.007 
HsPTpat 200.27 ±16.38 0.24 ± 0.012 73.56 ± 6 5.2 ± 0.2 
 
4.6.3.2 Acyl/benzoyl prenyltransferase 
The affinity of the enzyme HsPTAPG towards the first three accepted substrates, as indicated by 
its substrate specificity (4.6.2.3), was also measured. The lowest Km and highest Vmax values were 
confirmed for the substrate 2MBP, calculated as 62.68 ± 1.6 μM and 20.82 ± 1.065 nkat/mg, 
respectively (Figure 53). The measured kinetic parameters for HsPTAPG supported the results 
obtained for the substrate specificity (Table 34). In addition, the kinetic parameters for HsPTAPG 
with GPP were determined as 33.7 ± 3.37 μM and 15.48 ± 1.85 nkat/μg for Km and Vmax, 
respectively. Michaelis-Menten constants and maximum velocities of the enzyme with other 
substrates are listed in Table 34. 
 
Figure 53: Hyperbolic regression curves for the determination of the Michaelis-Menten 
constants (Km values) of HsPTAPG with the substrates 2MBP (A), 246TrHiBP (B), and 
246TrHBP (C). 
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Table 34: Kinetic parameters of HsPTAPG with 2MBP, 246TrHiBP, and 246TrHBP 
Substrate 
HsPTAPG 
Km (μM) Vmax (nkat/μg) 
2MBP 62.68 ± 1.6 20.82 ± 1.065 
246TrHiBP 87.65 ± 3.1 12.17 ± 0.1 
246TrHBP 91.54 ± 6.2 3.34 ± 0.04 
 
4.7 Phylogenetic analysis of H. sampsonii prenyltransferases 
Another important characterization tool was employed to infer the evolutionary history of the 
identified H. sampsonii PTs and to correlate them to their previously published ancestors, which 
supports the right positioning of these functionally novel aPTs among other aPTs. Amino acid 
sequences of membrane-bound aPTs from various bacterial and plant (monocots, dicots) origins, 
which shared low to moderate homology (12.7- 61.3%) with the HsPTs, were used to construct a 
phylogenetic tree. A soluble fungal aPT, which lacked the conserved aspartate motifs (Zhou et al., 
2017) was used as an outgroup to root the tree.  
The resulting tree was functionally clustered by the nature of the accepted aromatic substrates into 
aPT groups specific for xanthones, flavonoids, homogentisate, coumarins, plastoquinones, 
phloroglucinols, and 4-hydroxybenzoate (Figure 54). All H. sampsonii PTs identified in the 
present study, except for HsPT6 and its isoform HsPT6a, originated from the same clade with 
almost 100% strapping. The xanthone-specific PTs HsPT8PX and HsPTpat grouped together with 
HcPTpat and the recently published xanthone-specific HcPT (Fiesel et al., 2015) into the same 
subclade. HcPT8PX and HsPTAPG represented individual subbranches within the clade of 
Hypericum PTs. Thus, HsPTAPG did not group together with the acylphloroglucinol-related 
prenyltransferases isolated from hop and cannabis (Tsurumaru et al., 2012; Page and Boubakir, 
2014). The two isoenzymes HsPT6 and HsPT6a were incorporated with low bootstrapping value 
(10) into the clade consisting of homogentisate PTs, which might suggest their involvement in the 
primary metabolism of Hypericum. 
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Figure 54: Phylogenetic tree illustrating the evolutionary relationships between aPTs from 
Hypericum sp. and previously identified aPTs from other plants. The maximum likelihood 
tree was constructed using amino acid sequences through MEGA 7 with 1000 bootstrapped 
value support and a Poisson model. The bootstrap values are indicated at the branch points. 
The scale bar represents 0.5 of amino acid substitution per site. 
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4.8 Localization of xanthone specific H. sampsonii prenyltransferases 
The subcellular localization of the PTs was determined through the generation of fusion constructs 
with yellow fluorescent protein (YFP), which were transiently expressed in Nicotiana 
benthamiana leaves (3.5.3). HsPT8PX and HsPTpat were fused with YFP at both the N- and the 
C-termini. N-terminal and C-terminal fusion proteins were also generated for the truncated 
proteins, which lacked the targeting signal. For C-terminal fusions, the stop codons of the PT 
sequences were deleted. A construct of truncated DsRed was co-expressed to act as a cytoplasmic 
control. 
4.8.1 Subcellular localization of HsPT8PX in fusion with YFP 
Four fusion constructs with yellow fluorescent protein were established as described under 3.3.9.3. 
The full-length and transit peptide-lacking sequence (truncated HsPT8PX, formerly assigned as 
HsPT2) were assembled with the YFP sequence at either the N- or the C-terminus of the PT 
(Figure 55). The HsPT2 fusion constructs were transferred into the DH5α E. coli strain. Afterward, 
the plasmids were extracted and transferred into A. tumefaciens, which was cultivated for 
infiltration into the lower surface of N. benthamiana leaves. At the same time, A. tumefaciens 
harboring truncated DsRed as a cytoplasmic control were co-infiltrated. The leaves were allowed 
for three days to transiently express the different fusion proteins (3.5.3). N. benthamiana leaf discs 
were cut and visualized via laser scanning microscope (3.7). Strong yellow fluorescence was 
observed around the red autofluorescence of chlorophyll, indicating an integration of this aPT into 
the membranes of the chloroplasts and thus its plastidial subcellular localization. The truncated 
version of the aPT exhibited a cytoplasmic localization, as the yellow fluorescence of the fusion 
construct coincided with that of the cytoplasmic control, truncated DsRed (Figure 56). Similar 
results as with the truncated versions were obtained with the N-terminal fusions due to the masking 
of the aPT transit peptide. 
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Figure 55: Fusion constructs of HsPT2 (HsPT8PX) with YFP. A) Schematic representation 
of the stepwise assembly of the fusion construct for full-length HsPT2 with YFP. B, D) Fusion 
construct of truncated HsPT2 with YFP. (A, B) YFP at the C-terminus of the protein. (C, D,) 
YFP at the N-terminus of the protein.    
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Figure 56: Subcellular localization of HsPT8PX and its truncated version lacking the signal 
peptide in N. benthamiana leaves. (A, E) Red autofluorescence of chlorophyll. (B, F) Yellow 
fluorescence of the PT-YFP fusion. (C, G) Blue fluorescence of the truncated version of 
DsRed. (D, H) Superimposed photos. TP, transit peptide; S, stop codon. 
4.8.2 Subcellular localization of HsPTpat in fusion with YFP 
Fusion plasmids of the HsPTpat (HsPT5) with YFP were generated employing the corresponding 
primers in the manner described under scetion 3.3.9.3. They were co-expressed together with the 
DsRed control in N. benthamiana leaves (3.5.3; Figure 57).  Results detected via laser-scanning 
microscopy were similar to those observed for HsPT8PX. The full-length fusion construct showed 
its yellow fluorescence at the membranes of the plastids. When the signal peptide was removed, 
the fluorescence remained in the cytoplasm of the plant cell, as it exhibited the same fluorescence 
pattern like the cytoplasmic control, truncated DsRed (Figure 58). 
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Figure 57: Fusion constructs of HsPT5 (HsPTpat) with YFP. (A, C) Fusion construct of full-
length HsPT5. (B, D) Fusion constructs of truncated HsPT5 lacking the coding sequence for 
the signal peptide. (A, B) Fusion constructs with YFP at the C-terminus. (C, D) YFP at the 
N-terminus.  
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Figure 58: Subcellular localization of HsPTpat and its truncated version lacking the signal 
peptide in N. benthamiana leaves. (A, E) Red autofluorescence of chlorophyll. (B, F) Yellow 
fluorescence of the aPT-YFP fusion. (C, G) Blue fluorescence of the truncated version of 
DsRed. (D, H) Superimposed photos. TP, transit peptide; S, stop codon.
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5 Discussion 
5.1 In vitro cultivated Hypericum sampsonii as a source of PPAPs 
Metabolite profiling provoked by HPLC-MS/MS and/or GC-MS is an important biochemical 
readout, which can be used for numerous applications. For example, chemotaxonomical 
classification of organisms, analysis of environmental stimuli, chemical characterization of a plant 
to estimate the risk of using it medicinally, assessment of plant breeding effects (Robinson et al., 
2005; Hill and Roessner, 2013), and better understanding of plant biosynthetic mechanisms 
(Vickery et al., 2016). In the current study, the metabolic screening of six-week-old H. sampsonii 
in vitro seedlings by HPLC, MS-MS, and GC-MS provided an overview of the metabolic profile 
and assured the existence of biosynthetic aromatic precursors, which could accept prenyl groups 
after comparing the results with previous metabolic reports of field-grown H. sampsonii (Li et al., 
2004; Zhu et al., 2017) In this respect, eight compounds bearing different chemical structures were 
identified in the extract. Xanthones, namely 1,3,6,7-tetrahydroxyxanthone (1367THX), its 8-
prenylated derivative (8PX) and its 8,8-diprenylated derivative (patulone) were identified in the 
extract. The 1,3,6,7-tetrahhydroxyxanthone precursor was previously reported for the plant (Don 
et al., 2004). Furthermore, the identified prenylated derivatives were isolated from the wild plant 
growing in the Yunnan province of China (Li et al., 2004). Acyl- and benzoylphloroglucinols with 
caged and complex structures bearing the basic scaffolds of 2,4,6-trihydroxyisobutyrophenone and 
2,4,6-trihydroxybenzophenone were repeatedly described for the plant (Hu and Sim, 2000; Li et 
al., 2004; Xiao et al., 2007; Xin et al., 2012; Zhu et al., 2016). This reasonably justifies the finding 
of these scaffolds and the geranylated-PBP in the extract investigated in the current work. In 
addition, the geranylated benzoyl derivative was identified along with complex acyl- and benzoyl- 
metabolites in the plant (Lin and Wu, 2003). The current study reports the presence of 2-methyl- 
2´,4´,6´-trihydroxybutyrophenone (2MBP) for the first time because neither 2MBP itself nor a 
polyprenylated compound derived from this precursor have been reported before for H. sampsonii. 
Hyperjapones C and E, isolated recently from Hypericum japonicum (Lam et al., 2016), and 
adhyperforin occurring in the H. perforatum (Klingauf et al., 2005), are examples of polycyclic 
polyprenylated compounds bearing this core structure. Similar to previous reports, a 
naphthodianthrone, pseudohypericin,  was identified in the H. sampsonii extract (Liu et al., 2007). 
Furthermore, MS/MS analysis of most non-polar H. sampsonii fractions revealed a number of 
peaks that corresponded to molecular weights of known PPAPs from H. sampsonii. Due to the 
limited Ms/Ms spectral data available for these metabolites, the compounds corresponding to the 
detected peaks could not be fully identified and, anyway, full structural elucidation of the 
constituents was beyond the scope of this study. However, the confirmed existence of PPAP core 
structures and prenylated intermediates validated the in vitro-cultivated plant material as a source 
of aromatic PTs. Together with reported metabolic data, it also supported a proper experimental 
design and gave a good idea of the chemical classes of aromatic prenyl acceptors to be used later 
in functional characterization of the identified HsPTs. 
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5.2 Prenylation as a key for the structural and biological diversity of plant 
metabolites 
5.2.1 Structural diversity 
Prenylation is a key step in the diversification of natural aromatic compounds from different 
chemical groups due to the number and length of prenyl chains, such as prenyl (C5), geranyl (C10), 
farnesyl (C15) or longer side chains, as well as the positions of prenylations on the aromatic 
nucleus. Furthermore, subsequent biosynthetic modifications can occur to the added prenyl groups, 
for example, cyclization or hydroxylation (Adam et al., 2002; Yazaki et al., 2009). As a result, 
various secondary metabolites with diverse chemical and biological characters can arise from one 
common precursor. Demethylsuberosin, osthenol, and 8-geranylumbelliferone are three 
compounds that are derived from the same core structure, umbelliferone, using different aromatic 
prenyltransferases. A prenyltransferase from Petroselinum crispum (parsley), namely PcPT, was 
able to add a prenyl group (C5) to either position C-6 or C-8 on the coumarin structure to form 
demethylsuberosin and osthenol, respectively (Karamat et al., 2014). These C6- and C8- 
prenylated coumarin derivatives are intermediates in the biosynthetic pathways of the 
furanocoumarins psoralen and angelicin, respectively. Umbelliferone can undergo a C8-
geranylation reaction catalyzed by another aPT identified from lemon (Citrus limon), namely 
ClPT1. The enzymatic product, 8-geranylumbelliferone, was identified in the peel of some species 
belonging to the citrus family, Rutaceae (Munakata et al., 2014). Pastinaca sativa 
prenyltransferases (PsPT1 and PsPT2) also catalyzed the attachment of a prenyl moiety to either 
C-6 or C-8 of the coumarin structure, respectively (Munakata et al., 2016). Examples of 
modification by prenylation on a xanthone structure are clearly given by the polyprenylated 
1367THX metabolites identified in roots of Hypericum chinense (Tanaka et al., 2010) and later in 
root cultures of H. perforatum (Tocci et al., 2013; Tocci et al., 2017). Biyouxanthones A and B 
differed only in the number of prenyl groups attached to the basic xanthone structure. 
Prenyltransferases responsible for the formation of those compounds are not yet fully explored. 
Different α- and β-bitter acids are derived from acylphloroglucinols by the action of two aPTs 
identified in hop. They differ in the number of the prenyl moieties attached to the starter units. 
Furthermore, hydroxylation occurs on the α-acids. Examples of structural diversity due to 
prenylations are shown in Figure 59. 
Prenyltransferases account for the amazing diversity among H. sampsonii metabolites. The first 
example from H. sampsonii, which highlights this chemical variation, is the isolation of mono- 
and diprenylated 1,3,6,7-tetrahydroxyxanthone (8PX and patulone, respectively), which arise from 
the same 1367THX chemical scaffold (Li et al., 2004). Two series of complex and caged 
metabolites, assigned the names sampsoniones A-R (Hu and Sim, 2000; Xiao et al., 2007) and 
hyperisampsins A-O (Zhu et al., 2014; Zhu et al., 2015; Zhu et al., 2017) were described from H. 
sampsonii. They shared the precursor phlorbenzophenone but differed not only in the arrangement 
of the prenyl and geranyl groups but also in the downstream biosynthetic steps done by cyclases 
and hydroxylases on the prenyl side chains.  In the same context, hypersampsone A, B, C and S 
are examples of H. sampsonii metabolites that have the acylphloroglucinol scaffold 
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phlorisobutyrophenone and are differentiated through the substitutions on the cyclized prenyls (Lin 
and Wu, 2003; Chen et al., 2014). The structural diversity of metabolites in H. sampsonii sharing 
a common precursor is displayed graphically in the introduction and results parts of this study 
(Figure 3). 
 
Figure 59: Examples of the structural diversity of plant secondary metabolites due to changes 
in the prenylation pattern on a core scaffold. 
5.2.1 Biological diversity 
Introduction of one or more prenyl groups to an aromatic system results in the formation of more 
lipophilic compounds with enhanced affinity for the interaction with biological membranes. This 
augmented lipophilicity accounts for better pharmacological activities of prenylated plant 
secondary metabolites, derived from different chemical nuclei, over their unprenylated ancestors 
(Alhassan et al., 2014; Gaid et al., 2018).  
Prenylated acridone alkaloids, isolated from members of the family Rutaceae, glycocitrine-II and 
O-methylglycocitrine II, showed more inhibitory effect on 12-O-tetradecanoylphorbol-13-acetate 
(TPA)-induced Epstein–Barr virus early antigen (EBV-EA) activation (short-term in vitro assay), 
when compared to 1,3-dihydroxy-10-methylacridone without prenyl side chains, as concluded 
from the IC50 values of the prenylated alkaloids (8.96 and 8.99 nmol against 32 pmol TPA-induced 
activation) (Itoigawa et al., 2003). Furthermore, the naturally occurring oxyfarnesyl coumarin 
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derivative umbelliprenin, isolated from Ferula persica (Iranshahi et al., 2004) exhibited 
antioxidant, anti-inflammatory and lipoxygenase inhibitory activities (Khaghanzadeh et al., 2017). 
 
Figure 60: Prenylated plant secondary metabolites of different chemical classes exhibiting a 
wider biological activity range than their non-prenylated core structures. 
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These activities were further supported by a series of research works, in which a number of 
oxyprenyl-, oxygeranyl- and oxyfarnesylcoumarine derivatives were synthesized and their 
lipoxygenase inhibitory effect was tested against soybean 15-lipoxygenase (SLO) and human 15-
lipoxygenase-1 (HLO-1). Interestingly, the most active inhibitors were the oxyfarnesyl coumarins, 
namely  5-farnesyloxycoumarin, 2-oxyfarnesylcoumarin and umbelliprenin (7-
oxyfarnesylcoumarin), with IC50 values of 0.8 ± 0.1, 1.7 ± 0.1 and 3.1 ± 0.1 μM, respectively 
(Iranshahi et al., 2012). In contrast, 5-hydroxycoumarin did not have any significant antioxidant 
activity (Steffan et al., 2010). Attaching a prenyl group at the C-8 position of the flavone or 
flavanone skeleton of apigenin and liquiritigenin, respectively, boosted the cytotoxic activity of 
their derivatives. Applying increasing concentrations of the unprenylated flavonoids or even of 
apigenin-C8-glucoside (vitexin) up to 250 μmol/L displayed no cytotoxic effect on H4IIE and C6 
cell lines. In comparison, licoflavone C (8-prenylapigenin) and isobavachin (8-
prenylliquiritigenin) had IC50 values of 42 ± 5 and 96 ± 19 μmol/L and IC50 values of 37 ± 6 and 
69 ± 3 μmol/L against the two cell lines, respectively Upon assessing the inhibitory effect of 
naringenin chalcone and its prenylated and geranylated derivatives, especially xanthohumol, 
desmethylxanthohumol and 2´,4´,6´,4-tetrahydroxy-3´-C-geranylchalcone, on the copper-
mediated oxidation of LDL, only prenylated compounds exhibited around 70% inhibition after 5 
hours of incubation at a concentrations of 5 and 25 µmol/L, whereas non-prenylated naringenin 
chalcone had a pro-oxidation effect (Miranda et al., 2000). The formation of 
desmethylxanthohumol from naringenin chalcone was catalyzed by HlPT-1, an 
acylphloroglucinol-specific PT identified in hop (Humulus lupulus) female flowers (Tsurumaru et 
al., 2010; Tsurumaru et al., 2012). The identified aPT together with another aPT, namely HlPT-2, 
forms a metabolon, which is responsible for the biosynthesis of α- and β-bitter acids (Tsurumaru 
et al., 2012; Li et al., 2015). Humulone induced apoptosis in promyeloid leukemia HL-60 cells in 
concentrations of 1 to 100 µg/mL. In addition, the overall content of bitter acids proved to be 
responsible for the sedative effects of hop cones (Schiller et al., 2006; Van Cleemput et al., 2009). 
Biological activities of prenylated 1367THX derivatives, which are common among members of 
the family Hypericaceae, were also reported. Biyouxanthones A and B (Figure 59) showed 
antiviral activity against the hepatitis C virus (Tanaka et al., 2010). Biyouxanthone D also isolated 
from the roots of H. chinense (Tanaka et al., 2010) and later from the root cultures of H. perforatum 
had a significant antifungal activity against Cryptococcus neoformans and dermatophytes with 
MICs of 20.16 and 22.63 μg/ml, respectively (Tocci et al., 2013). Other species of the family like 
Garcinia mangostana contain a number of pharmacologically active poly-prenylated xanthones. 
α-Mangosgtin induced apoptosis in PC12 rat pheochromocytoma cells with an EC50 of 4 μM (Sato 
et al., 2004) It also constricted the aggregation of β-amyloid in primary rat cerebral cortical 
neurons, which may be a method for controlling the progression of Alzheimer’s disease (Wang et 
al., 2012). γ-Mangostin and garcinone B, another two poly-prenylated 1,3,6,7-
tetrahydroxyxanthones from Garcinia sp., inhibited COX-1 and COX-2 with potent anti-
inflammatory effects (Yamakuni et al., 2006). This broad activity range is not reported for the lead 
compound tetrahydroxyxanthone, from which all above mentioned prenylated xanthones 
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originate. A cytotoxic prenylated xanthone, elliptoxanthone A, was isolated from the aerial parts 
of Hypericum ellipticum and it showed moderate cytotoxic activity (IC50 = 104 μg/mL) against a 
number of human colon cancer cell lines (Manning et al., 2011). HcPT and MalDT are two plant 
aPTs, which were identified recently in cell cultures of Hypericum calycinum (Fiesel et al., 2015) 
and Morus alba (Wang et al., 2016) and were able to catalyze the regiospecific attachment of a 
prenyl group to positions C-8 and C-2 on the xanthone skeleton of 1367THX and 137TrHX, 
respectively. 
H. sampsonii metabolites are not excluded from the prenylation-enhanced pharmacological 
activities. Biological activities of PPAPs, which were reported for this plant and descend from 
prenylated xanthones and acyl/benzoylphloroglucinols, are discussed in detail in the introduction 
part of this work (1.2.2.2). Aromatic prenyltransferases responsible for the biosynthesis of some 
xanthone-PPAP metabolites along with aPTs involved in the biosynthesis of complex Hs-PPAPs 
are extensively discussed in the sections 5.5.1 and 5.5.2, respectively.   
5.3 Aromatic prenyltransferases from H. sampsonii 
Based on the transcriptomic data available for a plant of the same genus, Hypericum perforatum, 
and previous cloning done in the workgroup using degenerate primers targeting the conserved 
motifs of aPTs, ten full-length aromatic prenyltransferase sequences were isolated and identified 
from Hypericum sampsonii. To date, the plant is not explored at the genetic and proteomic levels. 
Thus, the identified genes and the described enzymatic activities of their expressed recombinant 
proteins are functionally novel. Sequence analysis of these enzymes proved that they possess not 
only the structural but also the common functional features characterizing plant aromatic 
prenyltransferases and differentiate them from members of the ABBA PT-superfamily. Explicitly 
mentioned are the presence of a signal peptide at the N-terminus of the protein, the presence of 
transmembrane α-helices (Sasaki et al., 2008; Yazaki et al., 2009; Tsurumaru et al., 2010) as well 
as the occurrence of two aspartate-rich motifs having the amino acid sequences NQxxDxxxD and 
KDxxDxxGD (Akashi et al., 2009; Tsurumaru et al., 2010). Functionally, active HsPTs showed a 
narrow range of accepted aromatic prenyl substrates and absolute dependence on a divalent cation 
as a cofactor for the catalysis 
Previously, X-ray crystallography showed that soluble aromatic prenyltransferases from bacteria 
and fungi have in their secondary structure a 10-stranded, antiparallel β-sheet of five repeating 
αββα structural motifs, after which they were named as ABBA family. This β-sheet structure forms 
a barrel-like reaction cylinder, in which the prenylation takes place (Heide, 2009; Saleh et al., 
2009; Winkelblech et al., 2015). This large reaction pocket rationalizes the wide substrate 
specificity of bacterial and fungal aPTs and distinguishes them from plant aPTs, which have a 
quite limited spectrum of accepted substrates (Schuller et al., 2012; Winkelblech et al., 2015; Chen 
et al., 2017). All known plant membrane-bound aromatic prenyltransferases have two aspartate-
rich motifs, which are essential for the enzymatic activity (Akashi et al., 2009; Tsurumaru et al., 
2010). The first one with the amino acid sequence N(D/Q)xxDxxxD is proposed to be involved in 
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prenyl diphosphate binding via metal ions (Guo et al., 2005; Brandt et al., 2009). The second motif 
KDxxDxxGD assigned to membrane-bound prenyltransferases is responsible for the binding of 
their aromatic substrates (Kuzuyama et al., 2005; Stec and Li, 2012). On the other hand, aPTs of 
the ABBA family have no aspartate-rich conserved motifs and, as a result, their catalytic 
mechanism does not involve the coordination of Mg+2. Instead, the active center of soluble aPTs 
bears positively charged amino acids to take over the function of Mg2+  (Tello et al., 2008). There 
is only one exception among the bacterial aPTs, namely NphB, whose activity is dependant on the 
presence of Mg2+ in the enzymatic reaction (Heide, 2009). This enzyme, together with CloQ, forms 
a subfamily of soluble a PTs (Winkelblech et al., 2015). 
Multiple sequence alignment of HsPTs with reported plant aPTs (Figure 61) revealed that all 
known plant aPTs, including the currently identified aPTs, have not only the conserved aspartate-
rich motifs essential for the catalytic activity but also another highly conserved three-amino-acid 
motif directly behind the first motif, assigned as asparagine-lysine-proline. However, no report 
about the role of these amino acids is available. The extended first motif has the amino acid 
sequence N(Q/E)xxDxxxD(K/R)(I/V)NKPx(L/S)P. The next motif has the amino acid 
arrangement KDx(P/S)DxxGD.  
All sequences identified in this study express the availability of membrane-spanning helices, as 
predicted by the results of TMHMM and SOUIS online tools. The number of predicted TMH 
ranged from six to nine. In addition, the usage of the TargetP and ChloroP online platforms for the 
prediction of the targeting signal revealed that all HsPTs have a targeting signal directing them to 
chloroplasts, except for HsPT5 (HsPTpat) whose prediction results for the signaling peptide were 
contradictory. TargetP predicted it as mitochondrial whereas chloroP resulted in expected 
chloroplast targeting (Table 26). The incidence of these typical plant aromatic prenyltransferase 
traits was confirmed practically for two representative examples of HsPTs, namely HsPT2 
(HsPT8PX) and HsPT5 (HsPTpat). As indicated by the subcellular localization of C-YFP-marked 
fusion constructs of the two proteins (4.8), they were localized to the membranes of chloroplasts 
in comparison to the cytoplasmic subcellular localization of their corresponding truncated versions 
(Figure 56 and Figure 58). With the exception of the geranyltransferase LePGT-1, which was 
found to be integrated into the membranes of the endoplasmic reticulum (Ohara et al., 2009), all 
other reported members of the plant aPT family showed subcellular localization in the plastids 
(Sasaki et al., 2008; Akashi et al., 2009; Karamat et al., 2014; Munakata et al., 2014; Munakata et 
al., 2016).  
The phylogenetic positioning of H. sampsonii-identified prenyltransferases fulfilled the 
expectation that most of them were grouped in the same clade, which included the HsPT xanthone-
DMAPP transferases (HsPT8PX and HsPTpat) and the closely related xanthone PTs characterized 
from H. calycinum (Nagia et al., submitted). HsPTAPG did not cluster together with the 
functionally related aPTs that utilize phloroglucinol derivatives as prenyl acceptors.  HlPT1 and 
HlPT2 catalyze the formation of bitter acids in hop (Li et al., 2015) and Cannabis sativa 
PT1(CsPT1) catalyses the geranylation of olivetolic acid to form cannabigerolic acid in Cannabis 
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sativa (Page and Boubakir, 2014). This evolutionary positioning of the HsPTs emphasizes and 
bioinformatically justifies the enzymatic activities settled in the current study. Two polymorphs 
also identified in H. sampsonii and assigned the names HsPT6 and HsPT6a were located on the 
clade together with homogentisate phytyltransferases involved in the biosynthesis of tocopherol 
(Venkatesh et al., 2006; Wang et al., 2015a), which rationalizes the lack of activity towards any of 
the substrates used in this study.   
 
Figure 61: Multiple sequence alignment of HsPTs with known aPTs denoting the highly 
conserved aspartate regions. Highly conserved amino acids are colored red and less 
conserved amino acids are colored orange.  
An observable phenomenon among the analyzed aPT genes is the polymorphism, where the same 
primer pair can fish different alleles whose sequences are closely related to each other 
(Biedermann, 2017). HsPT1, HsPT1a, and HsPT1b are three alleles with high sequence similarity. 
The longer isoform, HsPT1, has a high homology of 99.6% and 99.7% at the nucleotide level and 
99.0% and 99.2% at the polypeptide level to HsPT1a and HsPT1b, respectively (Figure 62 A and 
B). Shorter alleles have a sequence identity of 99.5% and 99.7% at the nucleotide and amino acid 
levels, respectively. Comparing the amino acid sequences revealed, besides a 4-amino acid-gap, 
four amino acid differences between HsPT1 and HsPT1a, of which the only significant one was 
the exchange of positively charged lysine (K96) with negatively charged glutamic acid (E96) at the 
corresponding position. In addition, one of the two amino acid differences between HsPT1 and the 
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AAI NQI F DI ETDKI NKP YLP LCS GELP IHsPT1
AAI NQI F DI ETDKI NKP YLP LCS GELP IHsPT1a
AAI NQI F DI ETDKI NKP YLP LCS GELP IHsPT1b
S GI NQI F DI ETDKI NKP YLP LAS GELS LHsPT2
TGI NQI F DLETDKI NKP HLP LCS GEVS MHsPT3
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GI LKDI S DMDGDRKNNI P TLATI I GAK
S LF KDI P DI DGDQMF GI RS F S VRLGP E
ALF KDI P DI DGDRI F GI RS F S VRLGAQ
AI I KDLS DI DGDRKHKVP TLTAAI GVR
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third allele, HsPT1b, may be considered compelling and affect the structure or function of the 
protein because the hydrophilic serine moiety S198 is replaced with the small hydrophobic leucine 
L200 in the HsPT1 structure. Mostly, these amino acid changes are considered as silent 
polymorphism, when they are far from the active site and do not affect the conformation. After 
sequencing the amplicon of HsPT6, another allele emerged which was more divergent than 
described in the previous situation with HsPT1. HsPT6 and HsPT6a have a similarity of 91.2% 
and 86.7% at nucleotide and protein levels, respectively (Figure 62 C and D). HsPT6a encodes 
four amino acid less than its longer polymorph HsPT6 and they differ by 52 amino acids. This 
high level of polymorphism expresses the fast evolutionary rate within the species (Wang et al., 
2015a). 
 
Figure 62: Sequence similarity percentages between polymorphs. A, B) Alleles HsPT1, 
HsPT1a, and HsPT1b at nucleotide and amino acid levels, respectively. C, D) Alleles HsPT6 
and HsPT6a at nucleotide and amino acid levels, respectively. 
5.4 Challenging heterologous expression system 
The natural abundance of proteins is too low to provide sufficient amounts for their isolation, 
identification, and structural or functional characterization, thus heterologous overexpression is a 
crucial molecular biology tool to get a considerable supply of naturally occurring proteins (Wagner 
et al., 2006; Wagner et al., 2008). A second advantage of the heterologous expression is ensuring 
the study of only one isoform of the desired protein, thus bypassing overlapping substrate 
specificities and providing proteins for further purposes, such as purification of enzymes for 
kinetic and structural studies (Anna et al., 2005). 
Despite the fact that protein overexpression in E. coli affords a robust system for heterologous 
protein expression, it is not applicable for the production of eukaryotic membrane proteins 
(Farrokhi et al., 2013). Expression of such proteins interferes with the membrane viability and is 
toxic for the prokaryotic cell system (Wagner et al., 2006). Most of the overexpressed membrane 
proteins are located in the cell membrane of the bacteria and the toxicity is primarily caused by 
the narrow capacity of the Sec translocon, resulting in aggregation of the overexpressed protein 
and formation of inclusion bodies with a severe negative effect on not only the plasma membrane 
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but also the cytoplasmic proteome (Buchanan, 1999; Wagner et al., 2007). In addition, 
heterologous membrane protein overexpression disturbs the cytoplasmic protein homeostasis and 
reduces the level of energy-producing enzymes in the cell. Wagner and co-workers (2007) reported 
that the degree of bacterial cell toxicity was dependent neither on the number of TMH nor on the 
length of the proteins but only on the amount of the expressed material (Wagner et al., 2007). Out 
of the toxicity on the bacterial cells, the eukaryotic post-translational machinery is not always 
functional in prokaryotic cells (Bencúrová et al., 2003), which necessitates the production of 
stable, active and accurately folded proteins (Drew et al., 2003; Pagny et al., 2003). One E. coli 
strain, namely Lemo21 (DE3, New England Biolabs) was developed for the overexpression of 
membrane proteins, where the activity of T7 RNA polymerase can be tuned by its natural inhibitor 
T7 lysozyme (T7 lys), which in turn is under the control of the well-titrable L-rhamnose promotor 
(rha BAD) to regulate the extent of overexpression. The fusion construct of YidC-GFP was used 
to test the suitability and the yield of expression in the Lemo21 strain (Wagner et al., 2008). YidC 
is prokaryotic membrane integrated insertase and constitutes a part from the Sec translocon in E. 
coli (Samuelson et al., 2000), which can facilitate the insertion of membrane proteins either 
autonomously or in cooperation with SecYEG14–16 (Sachelaru et al., 2017). However, 
overexpression of HsPT5 in the Lemo21 strain failed to yield active protein (data not shown). A 
reasonable explanation of this unexpected result lays in the difference in structural features 
between eukaryotic and prokaryotic membrane proteins as the partial folding of the β-barrel of the 
later occurs before insertion into the prokaryote membrane (Eppens et al., 1997). In addition, β-
barrel enzymes contain a relatively high number of charged residues that make their insertion quite 
easier than that of heterologous plant membrane integral proteins with highly hydrophobic α- 
helices (Booth and Curran, 1999). 
A model of comparison between the eukaryotic against bacterial platforms was introduced by 
Farrokhi et al. (2013), who compared the overexpression of plant membrane proteins involved in 
the biosynthesis of plant cell wall in bacteria (E.coli), yeast (Pichia pastoris), N. benthamiana, 
insect, and mammalian cells was compared. The prokaryotic expression system failed to produce 
any functionally active protein, whereas, all eukaryotic systems yielded biochemically active, 
accurately folded proteins because they are expected to have the eukaryotic post-translational 
modification machinery, which simulates processes found in higher plants.  
The aforementioned discussion reflects, to a far extent, the superiority of eukaryotic expression 
systems over the prokaryotic platform for the overexpression of plant membrane proteins including 
prenyltransferases. Furthermore, to date, no published recombinant plant aPT was functionally 
expressed in any of the bacterial systems. Most of the identified recombinant plant 
prenyltransferases were overexpressed in yeast (Saccharomyces cerevisiae) (Yazaki et al., 2002; 
Sasaki et al., 2008; Akashi et al., 2009; Shen et al., 2012; Munakata et al., 2014). Some others 
were heterologously expressed either in insect, namely HlPT-1 (Tsurumaru et al., 2012) and 
LePGT1 (Ohara et al., 2013) or plant systems like Petroselinum crispum, namely PcPT (Karamat 
et al., 2014) and PsPT1 and PsPT2 (Munakata et al., 2016). According to the published literature, 
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there is no homogeneous or generalized best eukaryotic expression system for the production of 
recombinant plant aromatic PTs. Therefore, three overexpression systems were used throughout 
the course of the current study. Yeast and insect systems were used for overexpression of proteins 
for activity testing and the plant system was used to express fusion constructs with yellow 
fluorescent marker gene to test the subcellular localization of xanthone HsPTs. The difference in 
the number of active HsPTs between yeast- and insect-expressed proteins confirmed the fact that 
there is no united system for overexpression for the aPTs.  
5.5 Functional characterization of recombinant HsPTs 
5.5.1 Xanthone-related HsPTs 
5.5.1.1 Enzymatic activity screening 
Activity testing of Hs-identified PTs revealed two xanthone-prenylating enzymes, namely 
HsPT8PX and HsPTpat. The former converts 1367THX to its monoprenylated derivative, and 
patulone is formed as a minor product within the same reaction. HsPT8PX can also catalyze further 
prenylation on its own product (8PX) to produce patulone (4.6.1.2; Figure 63 A). HsPTpat can 
form patulone as a single product either from 1367THX by attaching two geminal prenyl moieties 
at C-8 on the xanthone skeleton or by adding only one prenyl group to the prenylated xanthone 
derivative (8PX) when this is utilized as a substrate (4.6.1.2; Figure 63 B). Two paths were 
suggested for the biosynthesis of the diprenylated patulone. The first route is the stepwise 
attachment of two prenyl-groups, where HsPT8PX catalyzes the formation of the monoprenylated 
intermediate (8PX), which then undergoes prenylation to the diprenylated derivative (patulone) 
catalyzed by HsPTpat (path A; Figure 63 C). The second path postulates a direct formation of 
patulone by successive addition of two prenyl groups to 1367THX employing only HsPTpat (path 
B). 
Upon analyzing the kinetic parameters of both enzymes, it was apparent that the Km value for 
1367THX with HsPT8PX is about 4-fold less than that upon the use of the same substrate by 
HsPTpat. Furthermore, the Vmax of the reaction catalyzed by HsPT8PX is 40-fold higher than that 
for the reaction catalyzed by HsPTpat. Both enzymes showed comparable Km values for 8PX. 
However, the rate of the reaction with HsPTpat was ≈ 20 times higher than that with HsPT8PX, 
which explains the significant consumption of 8PX by HsPTpat. Thus, it was experimentally 
supported that the main substrate for HsPT8PX is 1367THX and the major substrate for HsPTpat 
is 8PX. As a result, path A is confirmed where these enzymes catalyze two successive prenylation 
steps. Firstly, 1367THX is consumed by HsPT8PX to form the mono-prenylated derivative and 
then 8PX is used as a substrate for the subsequent prenylation on the same carbon atom (C-8) to 
yield the di-prenylated derivative patulone (Figure 63). Further confirmation of this successive 
prenylation pattern was achieved by real-time gene expression analysis of the two HsPTanalogues, 
i.e. the xanthone PTs identified in the cell culture of H. calycinum. After applying yeast extract as 
elicitor, the gene for the 1,3,6,7-tetrahydroxy-8-prenylxanthone-forming enzyme, HcPT8PX, 
exhibited the maximum expression level eight hours post-elicitation and the gene for the patulone-
forming enzyme, HcPTpat, showed the highest expression level twelve hours post-elicitation 
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(Biedermann, 2017; Nagia et al., submitted). So far, nothing is recorded about gem-diprenylation 
of the xanthone skeleton, except for a single report about similar reactions on acylphloroglucinols. 
Thus, this one is the first concerning with the successive prenylation of xanthones (Tsurumaru et 
al., 2012; Li et al., 2015). 
 
Figure 63: Enzymatic activities of xanthone HsPTs. A) The catalytic activity of HsPT8PX. 
B) The catalytic activity of HsPTpat. C) Alternative biosynthetic pathways converting 
1367THX to patulone. Based on the kinetic measurements, path A is the preferred one. 
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5.5.1.2 Proposed biosynthetic pathway of pharmacologically active plant constituents 
bearing a xanthone skeleton  
The above results led us to the assumption of a biosynthetic pathway for a series of xanthone 
derivatives reported for H. sampsonii. 8PX, the anti-inflammatory patulone (Li et al., 2004; 
Yamakuni et al., 2006) and its structurally related antibacterial compound hyperixanthone A (Xiao 
et al., 2008) are derived from 1367THX as a core xanthone skeleton through the formation of the 
di-prenylated xanthone derivative patulone as an intermediate. The biosynthesis of this special 
type of PPAPs is achieved in two stages: first the formation of the tetrahydroxyxanthone nucleus 
and then the decoration by addition of side chains. The 1,3,6,7-tetrahydroxyxanthone nucleus is 
biosynthesized through the BPS-catalyzed condensation of three molecules of malonyl-CoA and 
one molecule of benzoyl-CoA originating from phenylalanine (Gaid et al., 2012) to form 2,4,6-
trihydroxybenzophenone (Liu et al., 2003). Subsequently, the latter intermediate undergoes a 
regioselective para-phenol coupling and intramolecular cyclization to produce 1,3,7-
trihydroxyxanthone. Recently, a bifunctional cytochrome P450, namely CYP81AA1, was capable 
of both hydroxylation and subsequent cyclization (El-Awaad et al., 2016). Finally, an enzyme 
called xanthone 6-hydroxylase serves to add a hydroxyl group to C-6 on the xanthone skeleton to 
form the 1,3,6,7-tetrahydroxyxanthone scaffold (Schmidt et al., 2000). Subsequently, HsPT8PX 
and HsPTpat catalyze the consecutive attachment of prenyl side chains on the formed 
tetrahydroxyxanthone nucleus and form the anti-inflammatory patulone. An antimicrobial agent, 
namely hyperixanthone A, is formed by the following step, a reverse prenylation. To date, 
however, no plant reverse prenyltransferase was reported. Reverse prenylation has been described 
for dimethylallyl tryptophan synthases (DMATS) on the nitrogen atom of the tryptophan moiety 
by an enzyme called CymD (Qian et al., 2012) or on C3 position of an indol system using the 
enzymes CdpNPT, AnaPT, or CdpC3PT (Yin et al., 2009; Yin et al., 2010; Tanner, 2015). The 
assumption of the participation of both Hs enzymes in the same biosynthetic pathway is boosted 
by the results of localization studies, where both proteins were targeted to the plastids. 
The formed prenylated tetrahydroxyxanthone skeleton can undergo downstream modifications, 
which justify the biosynthesis of related xanthone metabolites in other species of the genus 
Hypericum or other genera within the family Hypericaceae. An example is the pyranoxanthone 
phytoalexin metabolite hyperxanthone E, identified previously in H. calycinum cell cultures (Gaid 
et al., 2012) as well as H. scabrum and Garcinia esculenta (Tanaka et al., 2004; Zhang et al., 
2014). The formation of a 2,2-dimethylbenzopyran ring could be accomplished spontaneously 
through the intramolecular cyclization of the γ-carbon atom of the prenyl group attached to the 
xanthone skeleton with the o-hydroxy group. This reaction is feasible under the biosynthetic 
conditions inside plant cells (Molyneux and Jurd, 1970). Alternatively, the ring closure is catalyzed 
by a cyclase, as described by Batista et al. (2017) for o-prenylated phenyl compounds. This 
intramolecular cyclization could be catalyzed regardless of the electronic environment of 
substituents on the ring, to which the prenyl and hydroxyl groups are connected (Nicolaou et al., 
2000) (Figure 64). 
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Figure 64: Proposed biosynthesis of patulone and hyperixanthone A in H. sampsonii as well 
as other related xanthone derivatives identified in members of the family Hypericaceae. BPS, 
benzophenone synthase; 1,3,7-TXS, 1,3,7-trihydroxyxanthone synthase; X6H, xanthone 6-
hydroxylase. 
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Despite the potential pharmacological activities of H. sampsonii chemical constituents including 
prenylated xanthone derivatives, their limited isolation yields (0.0015-0.000026% w/w from plant 
material for hypersampsone G and sampsonion B, respectively) and the lack of a convenient 
regioselective synthetic scheme restrict their use in clinical trials or even in exploring their 
pharmacological activities. The cytotoxic prenylated xanthone derivative elliptoxanthone A (8-
prenyl-1,4,7-trihydroxyxanthone) was isolated from H. ellipticum in a yield ≈ 0.005% from the 
starting plant material (Manning et al., 2011). Its total synthesis was accomplished in 2016, which 
comprises 12 steps with an overall yield of only 28% via anion-accelerated aromatic oxy-Cope 
rearrangement (Fujimoto et al., 2016). Through the reaction of different tri- or tetra-hydroxylated 
xanthone derivatives with prenyl bromide, a non-selective mixture of O- and C-prenylated 
synthetic products could be formed with yields ranging from 1% to 5% (Lim et al., 2011; Lim et 
al., 2012; Yen et al., 2012). An additional challenge is the formation of undesired artifacts, mostly 
the production of pyranoxanthone derivatives which form through the intramolecular cyclization 
between the prenyl group and the adjacent hydroxyl group. A good illustration was shown for the 
synthesis of the anti-inflammatory γ-mangostine (1,3,6,7-tetrahydroxy-2,8-bis(3-methyl-2-
butenyl)-9H-xanthen-9-one) by demethylation of α-mangostin, when the desired product was 
formed only at a yield of 3% while the benzopyran derivative was produced as a major product at 
40% (Gokaraju et al., 2009). 
The utilization of structurally related xanthone derivatives (Figure 39) as aromatic substrates for 
HsPT8PX and HsPTpat revealed the strict structural selectivity of H. sampsonii xanthone-PTs. 
Considering the accepted substrates, only 1367THX and its monoprenylated derivative could be 
prenylated specifically at position C-8. However, the closely related compound 137TrHX showed 
only trace activity, being prenylated to form a trace product, which may be according to the 
retention time and the UV spectrum the mono-prenylated 137TrHX. On the other hand, no 
prenylated products were detected when closely related tetrahydroxyxanthone (1356THX) or its 
trihydroxylated analog (135TrHX) were used as substrates under the utilized test conditions. 
Furthermore, when C-8 in the xanthone skeleton is blocked or no longer available for a reaction 
like in hyperxanthone E and patulone, respectively, no products were formed. These results, 
together with the high and specific conversion yield within 90 min (≈ 60%) upon upscaling the 
8PX-producing enzymatic reaction (3.2.6), acknowledge the utilization of enzymatic bio-catalysis 
to overcome the problems of conventional chemical synthesis of PPAPs.  
5.5.2 Acylphloroglucinol-related HsPT 
5.5.2.1 Enzymatic activity screening 
An acylphloroglucinol alkylating enzyme was detected during activity screening of HsPTs. 
HsPTAPG catalyzes the conversion of some of the tested acylphloroglucinols to their 
corresponding 3-monogeranylated derivatives. Significant geranyltransferase activity was 
observed for 246trHiBP, 2MBP, and 246TrHBP, whereas other accepted aromatic substrates from 
the same chemical group showed only trace activity and even no products were detected when 
prenylated benzoylphloroglucinol and pentahydroxylated benzophenone (maclurin) were 
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employed as geranyl acceptors. On the other hand, the narrow substrate utility window of this 
enzyme was further confirmed when no xanthones or flavonoids were accepted (Heide, 2009; 
Yazaki et al., 2009). HsPTAPG showed the highest affinity, in terms of nmol product formation 
and Michaelis-Menten kinetics, for 2-methyl-2`,4`,6`-trihydroxybutyrophenone (2MBP) among 
the acylphloroglucinol family. This affirms the first report of an acylphloroglucinol PT not only 
from the plant H. sampsonii but also from the genus Hypericum. Currently, all reported plant 
acylphloroglucinol-active PTs are from the family Cannabinaceae. The geranylating enzyme 
CsPT1, identified in Cannabis sativa, adds a geranyl moiety to olivetolic acid (Page and Boubakir, 
2014). For another plant belonging to the same family, Humulus lupulus, a heteromeric 
prenyltransferase complex of two prenyltransferases, namely HlPT-1 and HlPT-2, was reported 
and had a more flexible substrate spectrum extended to chalcones and prenylated 
acylphloroglucinols (Tsurumaru et al., 2012; Li et al., 2015). Acyl- and benzoylphloroglucinol 
dimethylallylation was also reported for two fungal aPTs with wide substrate acceptance. AnaPT 
and AtaPT, apart from their main tryptophan-related substrates (Liu and Walsh, 2009; Chen et al., 
2017), also catalyzed the formation of monoprenylated 246TrHiBP, 246TrHVP, and 246TrHBP. 
Furthermore, AtaPT can even use the formed product for additional prenylation steps and it also 
has an extended prenyl donor promiscuity for DMAPP, GPP, and FPP (Zhou et al., 2015; Zhou et 
al., 2017), which may be attributed to the β-barrel structure of fungal PTs in the DMATS 
superfamily, as discussed before (see 5.3). 
 
Figure 65: Catalytic activities of HsPTAPG. 
5.5.2.2 First-step geranylation in the biosynthesis of PPAPs 
H. sampsonii is a rich source of type A and to a lesser extent type B PPAPs developed from small 
different acyl- and benzoylphloroglucinol scaffolds, for example the phlorbenzophenone 
derivatives sampsoniones and hyperisampsins, the phlorisobutyrophenone derivatives 
hypersampsones, and the phlorisovalerophenone building block in sampsonol F (Hu and Sim, 
2000; Xiao et al., 2007; Xin et al., 2012; Chen et al., 2014; Zhu et al., 2015; Tian et al., 2016) 
(1.2.2.2.2). To date, no reports about PPAPs bearing the 2-methylbutyrophenone nucleus could be 
traced for H. sampsonii, which, according to the present results, offers the chance that in vitro 
cultivated plants form a novel PPAP bearing this scaffold similar to adhyperforin in H. perforatum 
(Klingauf et al., 2005).  
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The first section of the biosynthesis of the above-mentioned Hs-PPAPs should be the formation of 
acylphloroglucinol starter units through the condensation of 3 molecules of malonyl CoA with 
isobutyryl-, 2-methylbutyryl-, isovaleryl- and benzoyl-CoAs to form 246TrHiBP, 2-MBP, 
246TrHVP, and 246TrHBP, respectively. These condensation reactions are done by IBS or VPS 
for the aliphatic building blocks and by BPS for the aromatic moiety (Okada and Ito, 2001; 
Beerhues and Liu, 2009; Beerhues, 2011). HsPTAPG is supposed to catalyze the first step of C-
geranylation in the biosynthesis cascade of the above-mentioned caged pharmacologically active 
metabolites descending from different lead acylphloroglucinols. The suggested biosynthetic 
pathways mimic that proposed for the model PPAP hyperforin (Adam et al., 2002; Beerhues, 2006, 
2011), where the construction of a monocyclic polyprenylated acylphloroglucinol (MPAP) 
intermediate is achieved through the addition of one GPP and two DMAPP molecules to form an 
intermediate comparable to α- and β-bitter acids in hop cones originating from 246TrHiVP (Okada 
and Ito, 2001; Li et al., 2015) (Figure 66). Afterward, the formed MPAP undergo intramolecular 
cyclization at different positions on the carbon skeleton of the starter molecule, followed by 
different cascades of hydroxylation or further prenylation reactions to give rise to the caged 
molecules (Figure 7; Figure 9) (Cuesta-Rubio et al., 2001)   
HsPTAPG accepts multiple substrates, which encourages its future adaptation to the production of 
PPAPs identified not only in H. sampsonii but also in other related plants, such as hyperforin and 
garsubellin A, whose pharmacological activities are well established but their syntheses are still 
challenging due to the complex substitution patterns and the presence of multiple chiral centers  
(Cuesta-Rubio et al., 2001; Adam et al., 2002; Ciochina and Grossman, 2006). The first total 
synthesis of a PPAP was achieved in 2005 for garsubellin A (Kuramochi et al., 2005; Siegel and 
Danishefsky, 2006), a neurotropic isobutyrophenone-PPAP identified in the wood of Garcinia 
subelliptica (Fukuyama et al., 1997; Fukuyama et al., 1998). Subsequently, many approaches were 
introduced to enhance the prenylation, cyclization, and stereochemistry, hence the yield of the 
chemical synthesis of this type A PPAP (Ciochina and Grossman, 2006). Numerous trials were 
also approached towards the total synthesis of hyperforin. However, the first success was 
accomplished in 2010 for the synthesis of ent-hyperforin, the antipode of hyperforin, which 
comprised 51 steps including Diels–Alder reaction augmented by a chiral cationic iron, a 
diastereoselective Claisen rearrangement, an intramolecular aldol condensation, and a vinylogous 
Pummerer rearrangement (Shimizu et al., 2010). Since then, many trials to simplify the synthetic 
scheme of hyperforin were attempted. Through an 18-step scheme, the enantioselective synthesis 
of hyperforin was totally attained in 2013 (Sparling et al., 2013). Later in 2016, the synthetic 
pathway of this important PPAP was shortened to 10 steps but the low yield and selectivity (Ting 
and Maimone, 2016) were the marked disadvantages. 
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HsPTAPG
 
Figure 66: Involvement of HsPTAPG in the proposed biosynthesis of various PPAP series in 
H. sampsonii. 
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Attempts for the synthesis of type B PPAPs were succeeded first in 2011 (Biber et al., 2011) 
introducing a simplified scheme for the synthesis of three benzoyl phloroglucinols, namely 
oblongifolin A (Hamed et al., 2006), hyperibone L (Tanaka et al., 2004), and epi-clusianone 
(Piccinelli et al., 2005; Santos et al., 2007) and one phlorisobutyrophenone derivative, 
hyperpapuanone (Winkelmann et al., 2001). These compounds were isolated previously from 
different members of the Hypericum and Garcinia genera and have verified antimicrobial and 
anticancer activities. The main problem with the introduced synthetic scheme is the low yield 
ranging from 6- 22% and the formation of non-natural products due to the difficult configuration 
of the asymmetric quaternary carbons (Biber et al., 2011). Sampsonione P, a caged 
phlorbenzophenone isolated from H. sampsonii (Xiao et al., 2007), together with hyperibone I 
from H. scabrum (Matsuhisa et al., 2002) were fully synthesized in 2013 applying a regioselective 
bidirectional prenylation synthetic approach from a common core (Lindermayr and Plietker, 2013). 
Another disadvantage of the chemical synthesis of prenylated PPAPs was practically touched 
during the present study by the formation of the benzopyran derivative while attempting the 
synthesis of mono- and diprenylated 246TrHBP (4.5.1). 
5.6 The proposed catalytic mechanism of prenylation 
Biochemical reactions catalyzed by aromatic prenyltransferases involve the C-C coupling between 
isoprenyl diphosphate units of different lengths and an aromatic substrate, which is usually a 
phenol (Bräuer et al., 2008; Wessjohann et al., 2009). This carbon-carbon, or even carbon-oxygen 
bond formation is mediated by two defined catalytic mechanisms (Kuzuyama et al., 2005; Luk and 
Tanner, 2009), namely dissociative and associative mechanisms. 
5.6.1 Dissociative mechanism SN1 
This SN1 or dissociative route invokes an initial ionization of the alkyl donor with the diphosphate 
as a leaving group to form an allyl cation/pyrophosphate ion pair. The activated carbon on the 
skeleton of the prenyl acceptor then adds to the formed carbocation and an arenium ion 
intermediate is generated. Finally, a step of deprotonation explains the re-aromatization of the 
aromatic substrates (Figure 67). Terpene cyclases as an example of aPTs involved in secondary 
metabolism (Cane, 1999), FPP synthase from primary metabolism (Tarshis et al., 1994) and fungal 
aPTs from the DMATS family (Luk and Tanner, 2009) follow this prenylation mechanism. 
5.6.2 Associative mechanism SN2 
A second, associative mechanistic pathway involves the nucleophilic attack of the aromatic ring 
onto C-1 on the prenyl pyrophosphate with a simultaneous displacement of the diphosphate group 
and direct formation of the arenium ion intermediate (Figure 67). This SN2 pathway was 
previously reported for protein farnesyltransferase (Long et al., 2002; Luk and Tanner, 2009). A 
protein farnesyltransferase catalyzes the attachment of a farnesyl group to nucleophilic cysteines 
on the substrate protein with a direct separation of pyrophosphate by a thiolate (Long et al., 2002). 
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Figure 67: Postulated catalytic mechanisms of tryptophan prenylation by DMATS. Adapted 
from Luk and Tanner (2009).  
5.6.3 Mechanism of HsPTs 
The family UbiA was named after the prototype enzyme EcUbiA, identified for the first time from 
E. coli. The enzyme catalyzes the condensation of isoprenyl units of different lengths with p-
hydroxybenzoic acid (PHB) for the formation of the electron carrier ubiquinone (Young et al., 
1972). UbiA is a membrane-integrated protein that contains two shorter conserved Asp-rich motifs 
with the amino acid sequence DXXXD and depends on magnesium cation for its catalytic activity 
(Melzer and Heide, 1994). The reaction mechanism catalyzed by UbiA was confirmed to follow 
the dissociative (SN1) pathway through several pieces of evidence. First is the calculations of 
reaction enthalpies for several steps of the catalytic action through the models provided for UbiA 
(Bräuer et al., 2004; Bräuer et al., 2008), where the cleavage of the C-O bond of the oligoprenyl 
diphosphate and the consecutive protonation of the pyrophosphate anion by proton transfer from 
a protonated neighboring lysine or arginine moiety was energetically favored (Brandt et al., 2009). 
Furthermore, the existence of a dimethylallyl carbocation intermediate in the prenylation of 
tryptophan was evidenced by the usage of 18O radio labeled DMAPP (Luk and Tanner, 2009). 
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In a trial to understand catalytic mechanisms and substrate recognition for UbiA, Bräuer et al. 
(2008) introduced a model based on five single mutations D71A, D75A, R137A, D191A, and 
D195A. All mutants lost the activity, except only 5% activity for the mutant R137A, which 
indicates the participation of the two Asp-rich motifs in one active site (Bräuer et al., 2008). These 
results were confirmed by the first X-ray crystal for an EcUbiA homolog from the bacterium 
Aeropyrum pernix (ApUbiA) in Apo- and substrate-bound forms using non-cleavable geranyl 
thiolopyrophosphate (GSPP). Conserved sequences of ApUbiA D54XXXD58 and D182XXXD186 
constituted one active site that accommodates both the prenyl donor (GSPP) and acceptor (PHB) 
(Cheng and Li, 2014). As a conclusion by combining the modelling and thermodynamic results 
(Bräuer et al., 2008; Brandt et al., 2009) with the crystal structure of ApUbiA (Cheng and Li, 2014), 
the 2 D-residues in the first motif of UbiA-father aPT (D71 and D75) are responsible for the fixation 
of one magnesium ion, which coordinates simultaneously with the oxygen atoms of diphosphate, 
thus, the activation of the pyrophosphate leaving group. The aromatic acceptor (PHB) binds 
directly to one aspartate moiety (D191) through which the phenolate ion is stabilized. Asp195 has 
an indirect effect by stabilization of the side chain of Arg137 to form a salt bridge with the 
diphosphate and grants the recognition and correct positioning of the prenyl substrate relative to 
4-hydroxybenzoate. The condensation of the prenyl group at the ortho-position of a hydroxyl 
group is favored as indicated by characterization studies involving electron donating/withdrawing 
groups (Brandt et al., 2009; Luk and Tanner, 2009). A model for the plant UbiA homolog LePGT 
(Ohara et al., 2009) revealed that the same mechanism applies for this enzyme and supports a 
similar catalytic mechanism of other phylogenetically-related UbiA family members.  
     
Figure 68: Multiple amino acid sequence alignment of active HsPTs with previously studied 
aPTs belonging to the UbiA superfamily and soluble bacterial aPTs. The highly conserved 
aspartate residues in the two motifs of the membrane-bound aPTs are in red. They are absent 
from soluble aPTs. Three bacterial Mg+2-dependant membrane-bound aPTs are E.coli UbiA 
(EcUbiA; ANK04607), Aeropyrum pernix UbiA (ApUbiA; BAA80570.1), and Stigmatella 
aurantiaca AuaA (SaAuaA; AM404078). The plant UbiA homolog from 
Lithospermum erythrorhizon (LePGT1; AB055078), and one soluble bacterial aPT from 
Streptomyces roseochromogenes (cloQ; AF329398). The ruler displays sequence numbering 
of EcUbiA. 
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Active aromatic prenyltransferases identified from H. sampsonii were aligned with LePGT, three 
bacterial Mg+2-dependant membrane-bound aPTs, namely EcUbiA, ApUbiA, and SaAuaA (Stec 
and Li, 2012) and one soluble bacterial aPT that lacks the conserved motifs (cloQ) (Figure 68). 
Multiple sequence alignment (MSA) confirmed the conservation of D-residues in the motifs of 
EcUbiA and ApUbiA in all UbiA superfamily members. The same was true for PTs described in 
the course of this study (Figure 61), which collects evidence to follow the same electrophilic 
aromatic substitution mechanism described above. 
5.6.3.1 Successive prenylation catalyzed by xanthone prenyltransferases 
First, the aspartate residues D161 and D165 of HsPT8PX coordinate with Mg
+2, which itself fixes 
the pyrophosphate group of DMAPP, and D291 activates the hydroxyl group at C-7 of the skeleton 
of 1367THX. Finally, a proton is abstracted for the rebuild of the aromatic structure of the product 
8PX. The second round of prenylation is started by HsPTpat as exactly described for HsPT8PX 
involving the corresponding aspartate moieties D149, D153, and D279. The last aspartate, D295 or D283 
in the second conserved motif of HsPT8PX and HsPTpat, respectively, might be indirectly 
involved in right positioning of both substrates for the regiospecific prenylation at C-8 on the 
xanthone skeleton, as indicated by crystal study of the role model UbiA (Cheng and Li, 2014). 
This indirect arrangement through arginine or lysine residues together with the proton transfer to 
the diphosphate group may offer a function to the amino acid rests (NKP; Figure 61) in the 
extended conserved regions of plant aPTs (5.3). The stepwise prenylation of 1367THX for the 
production of patulone is graphically represented in Figure 69. 
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Figure 69:  Stepwise electrophilic aromatic substitution on the tetrahydroxyxanthone 
skeleton catalyzed successively by HsPT8PX and HsPTpat.  
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5.6.3.2 First step geranylation catalyzed by acyl- and benzoylphloroglucinol HsPT 
Likely, the geranylation of acylphloroglucinols by HsPTAPG involves the magnesium-mediated 
stabilization of the leaving diphosphate group from the alkyl donor to form a geranyl carbocation 
by D160 and D164. The aromatic alkyl acceptor is then hooked by the residue D290 and the 
regioselective geranylation is pursued by the virtue of D294 with a final abstraction of hydrogen for 
reconstruction of the aromaticity of the formed product.  
 
 
 
 
Figure 70: Stepwise electrophilic aromatic substitution on the acylphloroglucinol skeleton 
catalyzed by HsPTAPG. 
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5.7 Viewpoint 
Hypericum-PPAPs possess a complex caged system arising from multiple isoprene units attached 
to the core structure, giving them a distinctive property among plant natural products. A long 
biogenetic cascade passing by polyketide, phenylpropanoid, and methylerythritol phosphate 
pathways along with post modification processes, which occur in different cellular compartments, 
give PPAPs their unique structural and biological diversity. The bottle-neck reactions leading to 
the formation of these complex skeletons are the prenylation steps catalyzed by aromatic 
prenyltransferases. Despite the intriguing biological activities of PPAPs, they did not find their 
way to clinical studies, except for the well-known hyperforin. The scarce occurrence inside plants, 
which results in low isolation yields (section 5.5.1.2), as well as the challenging chemical synthesis 
because of the multichiral centers and multi-ring system, are the obstacles hindering their use as 
drug leads. These reasons necessitate the discovery of an alternative production system to provide 
a continuous supply of these natural products. 
Hypericum sampsonii is the richest source of caged PPAPs with diamond-like skeletons (Yang et 
al., 2018), Unfortunately, there is no report about molecular or transcriptomic data. Therefore, this 
study started with the approach of homology-based cloning of aPTs and applying degenerate 
primers to fish a number of aPTs. After activity testing and characterization, Hs-identified aPTs 
can be positioned as biocatalysts in chemoenzymatic synthesis or pave the way, together with the 
already known steps, for future engineering of the whole pathway for biotechnological and de 
novo production of pharmacologically active PPAPs in microbes. These alternative ways mimic 
the biosynthetic pathways of PPAPs in the plant and overcome the disadvantage of conventional 
chemical synthesis. Long and tedious synthetic schemes, low specificity, the formation of artifacts 
and the questionable regioselectivity that can affect the bioactivity of the resulting compounds and 
result in low yield are the main drawbacks. The produced compounds (i.e. 8PX, patulone, and 
geranylated acylphloroglucinols) may be used as starting nuclei for an in depth-research of the 
downstream reactions, i.e. more prenylation and caging steps. Further, upscaling of the enzymatic 
production of 8PX gives insight into the explicit positional bio-catalysis for producing compounds 
with high yield and purity.   
Additionally, HsPTs are hits that facilitate the isolation and identification of aPTs from related 
plant species, whose transcriptomic data are yet unexplored, or offer a possibility to discover 
metabolons, gene clusters, and catalytic complexes (Li et al., 2015). Bioinformatics-based 
phylogeny can suggest functions for the inactive aPTs. A future perspective that will allow more 
understanding of the underlying mechanism of the here-identified aPTs is the combined modeling 
and site-directed mutagenesis to define precisely the amino acids that are responsible for the 
activity. This will enable the design and expression of manipulated proteins with higher activity, 
altered regiospecificity, and the ability to produce new scaffolds.  
  
Summary 
 
141 
 
 
6 Summary 
 Polycyclic polyprenylated acylphloroglucinol derivatives (PPAPs) are a group of compounds 
with fascinating structures and affluent biological activities. They are widely distributed in the 
genera of Hypericaceae and Clusiaceae. 
 Biosynthesis of PPAPs is achieved in two stages. First, the formation of the aromatic 
acylphloroglucinol skeleton, followed by the attachment of prenyl moieties. The latter step is 
catalyzed by a group of enzymes, assigned the name aromatic prenyltransferases. 
 Aromatic prenyltransferases are distributed among plants, bacteria, and fungi. They are 
subgrouped in two superfamilies, the UBiA, and ABBA superfamilies. The members of the 
former one are membrane-bound enzymes with two aspartate-rich conserved motifs and their 
activities are dependant on the presence of divalent cations as a co-factor, whereas the ABBA 
family members are soluble proteins and do not depend on cations for the activity. All plant 
aPTs belong to the UBiA superfamily.  
 One member of the genus Hypericum, namely H. sampsonii, was identified as a rich source of 
caged PPAPs. Thus, the plant was the main focus of the present study. Metabolic profiling of 
in vitro H. sampsonii seedlings aimed at the detection of aromatic acylphloroglucinol cores 
that can be prenylated in later biosynthetic steps. 246TrHiBP, 246TrHBP, 2MBP, 1367THX, 
8PX, patulone, G-246TrHBP, and pseudohypericin were detected and identified in the 
methanolic extract of H. sampsonii.   
 Ten aPT cDNAs of the plant were identified, based on publicly and internally available 
transcriptomes for the related species H. perforatum and H. calycinum, respectively, together 
with the use of degenerate primers designed according to the sequence of conserved motifs of 
aPTs, which was an additional strategy to glean the target sequences. The cDNAs were 
expressed in yeast and insect cell (Sf9) expression systems. 
 Potentially accepted substrates, prenyl donors, and prenylated intermediates were chemically 
synthesized, namely 246TrHiBP, GPP, DMAPP, 3-prenyl-2,4,6-trihydroxybenzophenone, and 
3,5-diprenyl-2,4,6-trihydroxybenzophenone. 
 Yeast or insect microsomes containing the recombinant proteins were individually tested for 
prenyl- and/or geranyltransferase activities against a number of aromatic substrates belonging 
to different chemical nuclei, namely acyl- and benzoylphloroglucinols, xanthones, and 
flavonoids. Three recombinant enzymes showed activity. 
 The enzyme HsPT8PX (HsPT2) expressed in yeast was able to convert 1367THX to 8PX, 
which then was further converted to the diprenylated xanthone patulone, i.e. geminal addition 
of a prenyl group to C-8 of 8PX. 
 Another xanthone PT, namely HsPTpat (HsPT5), accepted both 1367THX and 8PX, resulting 
only in a single product, which was patulone. The enzyme catalyzed either parallel addition of 
two prenyl residues to 1367THX or addition of a gem-prenyl group to 8PX. 
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 A third enzyme assigned as HsPTAPG (HsPT7) adds a geranyl residue to acyl phloroglucinols, 
producing the corresponding 3-monogeranyl derivatives. A substrate specificity test revealed 
that the two most preferred substrates are 2MBP and 246TrHiBP. Since 246TrHBP is a 
potential physiological substrate, it was also considered for further kinetic studies, regardless 
of its poor acceptance by HsPTAPG (13% relative to 2MBP). 
 All active enzymes and catalysed reactions were characterised with respect to biochemical 
(pH, incubation temperature, incubation time, protein amount, preferred co-factor) and kinetic 
parameters (Km and Vmax). 
 Xanthone-related HsPTs preferred neutral pH and Mg2+ as a co-factor, except for the patulone-
producing reaction (1367THX + HsPTpat + DMAPP) that preferred slightly basic pH (Tris-
HCl pH 7.5) and Mn2+. The main substrates for HsPT8PX and HsPTpat were 1367THX and 
8PX, respectively, as indicated by the kinetic parameters. This result confirms the successive 
catalytic activities of these enzymes, as the product of the first enzyme is accepted by the 
second one. Hence, patulone is formed by sequential regiospecific prenylation of 1367THX. 
Subcellular localization of xanthone-related HsPTs was confirmed to be plastidial, which 
augments the assumption of the contribution of these enzymes to the same biosynthetic 
pathway. Patulone may be an intermediate of the structurally related antibacterial agent 
hyperxanthone A, which is formed in a further step through the reverse prenylation at position 
C-4. 
  HsPTAPG preferred basic pH and Mg2+ for the incubation medium and cofactor, respectively. 
The Km and Vmax values confirmed the order of catalytic preference of the enzyme for 2MBP 
and 246TrHiBP, followed by 246TrHBP, which agrees with the substrate specificity results. 
The enzyme is supposed to catalyze the first prenylation step in the biosynthetic cascade of 
Hs-PPAPs, such as hypersampsones and sampsoniones/hypersampsins, by addition of a 
geranyl moiety to 246TrHiB and 246TrHBP, respectively. The results also suggested the 
possibility of isolating new, 2MBP-derived PPAPs from in vitro-cultivated H. sampsonii. 
 Phylogenetic reconstruction positioned all HsPTs in a single clade. Xanthone HsPTs were 
closest to the already known xanthone-specific aPTs (Fiesel et al., 2015; Nagia et al., 2017; 
Nagia et al., submitted), whereas HsPTAPG did not group with the known acylphloroglucinol 
aPTs (Page and Boubakir 2014; Li et al 2015). 
 Prenyl moieties are attached to the aromatic substrates via electrophilic substitution. The 
underlying stepwise mechanism of action is described. 
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8 Appendix 
8.1 Accession numbers of aPTs used for reconstruction of phylogenetic 
analysis 
Sequence name\ Accession no. Species  Family 
ApUbiA a BAA80570.1 Aeropyrum pernix Desulfurococcaceae 
ApVTE2-1  DQ231057 Allium ampeloprasum Amaryllidaceae 
AtaPT b KP893683 Aspergillus terreus Trichocomaceae 
AtPPT1  NP_567688.1 Arabidopsis thaliana Brassicaceae 
AtVTE2-1  AY089963 Arabidopsis thaliana Brassicaceae 
AtVTE2-2  DQ231060 Arabidopsis thaliana Brassicaceae 
Cl-PT1a  AB813876  Citrus limon Rutaceae 
CpVTE2-1  DQ231058 Cuphea pulcherrima Lythraceae 
CsPT-1  WO 2011017798 A1 c Cannabis sativa Cannabaceae 
GmG4DT  AB434690 Glycine max Fabaceae 
GmVTE2-1  DQ231059 Glycine max Fabaceae 
GmVTE2-2  DQ231061  Glycine max Fabaceae 
GuA6DT  KJ123716  Glycyrrhiza uralensis Fabaceae 
HcPT KT325851 Hypericum calycinum Hypericaceae 
HcPT8PX MH461102 Hypericum calycinum Hypericaceae 
HcPTpat MH461103 Hypericum calycinum Hypericaceae 
HIPT-1  AB543053  Humulus lupulus Cannabaceae 
HIPT-2  KM222442  Humulus lupulus Cannabaceae 
HvHGGT  AY222860  Hordeum vulgare Poaceae 
LaPT1  JN228254  Lupinus albus Fabaceae 
LePGT1  AB055078  Lithospermum erythrorhizon Boraginaceae 
LePGT2  AB055079 Lithospermum erythrorhizon Boraginaceae 
OsHGGT  AY222862  Oryza sativa Poaceae 
OsPPT1  AB263291  Oryza sativa Poaceae 
OsVTE2-2 XP_015646905.1  Oryza sativa Poaceae 
PcPT AB825956  Petroselinum crispum Apiaceae 
PsPT1 KM017083  Pastinaca sativa Apiaceae 
PsPT2 KM017084  Pastinaca sativa Apiaceae 
SfFPT  KC513505  Sophora flavescens Fabaceae 
SfG6DT  AB604224  Sophora flavescens Fabaceae 
SfiLDT  AB604223 Sophora flavescens Fabaceae 
SfN8DT-1  AB325579  Sophora flavescens Fabaceae 
SfN8DT-2  AB370330  Sophora flavescens Fabaceae 
SfN8DT-3  AB604222  Sophora flavescens Fabaceae 
TaHGGT  AY222861  Triticum aestivum Poaceae 
TaVTE2-1  DQ231056 Triticum aestivum Poaceae 
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ZmVTE2-1  DQ231055 Zea mays Poaceae 
a bacterial sequence,  b fungal sequence,  c patent number. 
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8.4 NMR spectra  
 
1H NMR spectrum of 3-prenyl-2,4,6-trihydroxybenzophenone (MPPBP). 
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13C NMR spectrum of 3-prenyl-2,4,6-trihydroxybenzophenone (MPPBP). 
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13C-Dept NMR spectrum of 3-prenyl-2,4,6-trihydroxybenzophenone (MPPBP). 
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1H NMR spectrum of 3,5-diprenyl-2,4,6-trihydroxybenzophenone (DPPBP). 
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13C NMR spectrum of 3,5-diprenyl-2,4,6-trihydroxybenzophenone (DPPBP). 
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13C-Dept NMR spectrum of 3,5-diprenyl-2,4,6-trihydroxybenzophenone (DPPBP). 
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1H NMR spectrum of (5,7-dihydroxy-2,2-dimethyl-6-(3-methylbut-2-en-1-yl)chroman-8-yl)(phenyl)methanone. 
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13C NMR spectrum of (5,7-dihydroxy-2,2-dimethyl-6-(3-methylbut-2-en-1-yl)chroman-8-yl)(phenyl)methanone. 
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13C-Dept NMR spectrum of (5,7-dihydroxy-2,2-dimethyl-6-(3-methylbut-2-en-1-yl)chroman-8-yl)(phenyl)methanone. 
 
